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Antiretroviral treatment (ART) has reduced opportunistic infections and enabled 
children living with HIV (CLHIV) to develop similarly to their peers who are HIV negative.  
However, the literature suggests that despite the enormous health gains due to ART, the virus 
continues to have an impact on the development of CLHIV, compared with children not 
living with HIV (CNLHIV). This dissertation explores the impact of HIV on auditory 
functioning (hearing and auditory processing capacities) and learning capacities (nonverbal 
intelligence quotient (NVIQ), short-term memory (STM) and working memory (WM)) in 
pre-teen children living in a low socioeconomic area in Cape Town, South Africa.  
Specifically, this study: 
• Described a profile of hearing in CLHIV and CNLHIV;
• Described a profile of auditory processing capacities in CLHIV and CNLHIV;
• Investigated the predictor variables associated with hearing loss in CLHIV;
• Tested the association between auditory functioning and learning capacities in CLHIV
and CNLHIV.
Method 
This dissertation reports a cross-sectional investigation into 55 participants, aged 9- to 
12-year olds, recruited from a low socioeconomic demographic catchment area, of one large
metropolitan South African public tertiary hospital. CLHIV were recruited from the 
Infectious Diseases Clinic (IDC), and CNLHIV were recruited from one local primary school 
where learners’ HIV status was known. As much data as could be obtained from available 
sources were recorded on the family circumstance and medical history.  
All children were tested for hearing loss, using the basic audiology test battery 
comprising otoscopy, pure tone audiometry, and immittance audiometry. All children were 
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also tested using the Test of Nonverbal Intelligence Fourth Edition (TONI 4). Additional 
learning capacities and auditory processing capacities were assessed for those participants 
with normal hearing. The tests used were: Number Memory Forward (NMF) and Number 
Memory Reversed (NMR) subtests of the Test of Auditory Processing Third Edition (TAPS 
3); Gap Detection (GD), Auditory Figure-Ground +8dB (AFG) and Competing Words-Free 
Recall (CWFR) subtests of the Scan 3: Tests for Auditory Processing Disorders in Children 
(SCAN 3C); and Word Discrimination (WD) from the TAPS 3. Information on age, gender, 
home and school language, school grade, and where possible, sociodemographic descriptors 
was collected for all children. Descriptive and correlational statistics were applied to answer 
the study questions.  
Results 
There was a low response rate to recruitment, with only 23 CLHIV (20.9% invited 
CLHIV) and 32 CNLHIV (19.7% invited CNLHIV) being enrolled. The primary language 
spoken at home was Afrikaans (46.4%), and English and African languages (26.8%) were 
equally represented. Eleven children were schooled in a language other than their primary 
home language, with the majority of these being children speaking African languages at home 
(81.8%). Hearing loss prevalence was 66.7% for CLHIV and 33.3% for CNLHIV. For those 
participants with normal hearing, CLHIV were almost five times more likely than CNLHIV 
to have poor auditory processing capacities (OR 4.95 (95%CI 1.24-19.69). Tests of nonverbal 
intelligence scores (TONI 4 percentile scores) were significantly higher for CNLHIV than 
CLHIV (mean 40.6% (SD 19.2); mean 20.4% (SD 10.1) respectively) (OR 4.3 (95%CL 1.0-
23.4)). Hearing loss was not associated with TONI 4 percentile scores (OR 0.9 (95%CL 0.3-




   
Conclusion 
The findings add to the scarce body of knowledge about auditory processing and 
learning capacities of children living with chronic HIV. These skills appear to be significantly 
poorer in CLHIV than CNLHIV. Ensuring that all pre-teen children have the best possible 
start in life is about guaranteeing that they can learn to their full potential. Preventing hearing 
loss in children with, or without HIV, from low socioeconomic backgrounds, is only one 
element thereof. The more subtle effects of HIV on a child’s capacity to process auditory 





   
Opsomming 
Agtergrond 
Antiretrovirale terapie (ART) het opportunistiese infeksies in kinders wat met MIV 
saamleef verminder en hul in staat gestel om soos hul MIV-negatief portuurgroep te 
ontwikkel. Vanuit die literatuur blyk dit egter dat, ten spyte van die groot 
gesondheidsvoordele teweeggebring deur ART, daar steeds ŉ impak is op die wyse wat 
kinders wat met MIV saamleef kognitief ontwikkel in vergelyking met kinders wat MIV-
negatief is. Hierdie tesis het die impak van MIV op ouditiewe funksionering (gehoorverlies, 
ouditiewe prosessering) en sekere ander vermoëns om te leer (nieverbale 
intelligensiekwosiënt, korttermyngeheue en werkgeheue in pre-tiener kinders afkomstig uit ŉ 
laer sosio-ekonomiese area in Kaapstad, Suid-Afrika, verken. Hierdie studie het spesifiek: 
• Die gehoorprofiel van kinders wat met en sonder MIV saamleef beskryf; 
• Die ouditiewe prosesseringsprofiel van kinders wat met en sonder MIV saamleef 
beskryf; 
• Die voorspellingsveranderlikes geassosieer met gehoorverlies in kinders wat met MIV 
saamleef ondersoek; 
• Die assosiasie tussen ouditiewe funksionering en leervermoë van kinders wat met en 
sonder MIV saamleef, getoets 
Metode 
Hierdie proefskrif rapporteer ŉ dwarsdeursnit ondersoek na 55 deelnemers, ouderdom 
9 tot 12-jaar, wat gewerf is uit ŉ laer sosio-ekonomiese opvangsgebied van een groot 
metropolitaanse openbare tersiêre hospitaal in Suid-Afrika. Kinders wat met MIV saamleef is 
gewerf by die hospitaal se Kliniek vir Infektiewe Siektes en ongeïnfekteerde kinders is 




   
data is verkry uit beskikbare bronne met betrekking tot gesinsomstandighede, akademiese 
vordering en mediese geskiedenis.  
Alle kinders is getoets vir gehoorverlies deur middel van die basiese oudiometriese 
toetsbattery bestaande uit otoskopie, suiwertoon oudiometrie en imitansieoudiometrie. Alle 
kinders is ook getoets vir leervermoë met behulp van die Test of Nonverbal Intelligence 
Fourth Edition (TONI 4). Bykomende toetsing is gedoen vir kinders met normale gehoor: 
bykomende aspekte van leervermoë is getoets met behulp van die Number Memory Forward 
en Number Memory Reversed subtoetse van die Test of Auditory Processing Third Edition 
(TAPS 3). Ouditiewe prosesseringsvaardighede is getoets deur middel van drie subtoetse van 
die Scan 3: Tests for Auditory Processing Disorders in Children (Scan 3C); naamlik Gap 
Detection (GD), Auditory Figure Ground +8dB (AFG), Competing Words-Free Recall 
(CWFR), asook een subtoets van die TAPS 3 (Word Discrimination). Inligting oor al die 
kinders met betrekking tot ouderdom, geslag, huis- en skooltaal, skoolvlak, en waar moontlik, 
sosio-demografiese beskrywings, is verkry. Beskrywende en korrelasie statistiek is gebruik 
om die navorsingsvrae te beantwoord. 
Resultate 
Daar was ŉ swak respons op werwingspogings en slegs 23 kinders wat met MIV 
saamleef (20.9% van kinders in dié groep wat uitgenooi is) en 32 kinders wat nie met MIV 
saamleef nie (19.7% van kinders in dié groep wat uitgenooi is) ingesluit in die studie. Die 
primêre huistaal van deelnemers was Afrikaans (46.4%), Engels (26.8%) en Afrika-tale 
(26.8%). Elf kinders het skoolonderrig in ‘n ander taal as hul huistaal ontvang, en die 
meerderheid van hierdie kinders was moedertaalsprekers van ‘n Afrika-aal (81.8%). Die 
prevalensie van gehoorverlies was 66.7% vir kinders wat met MIV saamleef en 33.3% vir 
kinders wat nie met MIV saamleef nie. Vir deelnemers met normale gehoor, was kinders wat 




   
prosesseringsvaardighede te hê as kinders sonder MIV (kansverhouding 4.95 (95% 
vertrouensinterval 1.24-19.69). Tellings van nie-verbale intelligensietoetse (TONI 4 
persentieltellings) was beduidend hoër vir kinders sonder MIV as vir kinders wat met MIV 
saamleef (gemiddeld 40.6% (SA 19.2); gemiddeld 20.4% (SA 10.1) onderskeidelik) 
(kansverhouding 4.3 (95% vertrouensvlak 1.0-23.4)).  Gehoorverlies het geen verskil aan 
TONI 4 persentieltellings gemaak nie (kansverhouding 0.9 (95% vertrouensvlak 0.3-3.5)).  
Toetsing vir strengelveranderlikes was beperk weens onvoldoende data-insameling.  
Gevolgtrekking 
Bevindinge dra by tot die beperkte kennis oor ouditiewe prosesseringsvaardighede en 
die vermoë om te leer in kinders wat met chroniese MIV saamleef. Hierdie vaardighede het 
beduidend swakker voorgekom as in kinders wat MIV-negatief is. Om te verseker dat alle 
pre-tiener kinders die beste moontlike voorsprong in die lewe het, moet hulle potensiaal om 
te leer na die beste van hul vermoëns verseker word. Die voorkoming van gehoorverlies in 
kinders met of sonder MIV, wat afkomstig is uit laer sosio-ekonomiese omstandighede, is 
slegs een faktor. Die meer subtiele implikasies van saamleef met MIV op kinders se vermoë 
om ouditief te prosesseer en te leer, is waarskynlik die volgende uitdaging vir 
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List of Terms  
Acquired Immune Deficiency Syndrome (AIDS): A disease of the immune system due to 
infection with HIV. Acquired immunodeficiency syndrome (AIDS) is the most advanced 
stage of HIV infection (AIDSinfo, 2018, p.2). 
Adherence: Taking medications (or other treatment) exactly as instructed by a health care 
provider (AIDSinfo, 2018, p.4). 
Antiretroviral drugs (ARVs): A drug used to prevent a retrovirus, such as HIV, from 
replicating. The term primarily refers to antiretroviral (ARV) HIV drugs (AIDSinfo, 2018, 
p.10). 
Antiretroviral treatment/therapy (ART): The daily use of a combination of HIV medicines 
(called an HIV regimen) to treat HIV infection. A person’s initial HIV regimen generally 
includes three antiretroviral (ARV) drugs from at least two different HIV drug classes 
(AIDSinfo, 2018, p.10). The terms ART and highly active (ART) are often used 
interchangeably in literature. 
Auditory functioning: Functioning at the level of body or body part (World Health 
Organization, 2013, p.10), which for the current study encompasses hearing and auditory 
processing capacities. 
Auditory processing: Perceptual processing of auditory information in the central nervous 
system and the neurobiologic activity that underlies that processing and gives rise to 
electrophysiologic auditory potentials (American Speech-Language and Hearing Association, 
2005a). For the purposes of this study, this definition contained in a technical report compiled 
by the American Speech-Language and Hearing Association (2005a) was used. 
Auditory processing capacities (skills): Discrete auditory processes such as localization, 
lateralization, temporal resolution (Canadian Interorganizational Steering Group for Speech-




   
recognition and auditory performance in competing acoustic signals (American Speech-
Language and Hearing Association, 2005a). In line with the Canadian Interorganizational 
Steering Group for Speech-Language Pathology and Audiology (2012) guidelines, the term 
auditory processing capacities was used as it reflects the discrete processes that were 
assessed. 
CD4 count: A laboratory test that measures the number of CD4 T lymphocytes (CD4 
cells) in a sample of blood. In people with HIV, the CD4 count is the most important 
laboratory indicator of immune function and the strongest predictor of HIV progression 
(AIDSinfo, 2018, p.24). 
Fluid intelligence: The innate learning capacity of an individual, not dependent on education 
or experience, which is used with relatively novel tasks, reasoning, and information analysis. 
Based on the Cattell-Horn theory of crystallized and fluid intelligence (American 
Psychological Association, 2019). Also considered to reflect nonverbal intelligence 
(McCallum, 2013). 
Highly active antiretroviral treatment (HAART): See Antiretroviral Therapy. 
Hearing loss: Reduction in hearing ability (Stach, 2010). 
Human Immunodeficiency Virus (HIV): HIV is a virus that weakens the immune system, 
ultimately leading to AIDS (UNAIDS, 2015). 
Learning capacities: For the purpose of the study, learning capacities refer to discrete 
cognitive processes that affect learning, including memory and intelligence (IQ) (Byrnes, 
2012).   
Neurocognitive: May affect executive function, motor skills and/or general intellectual 
functioning. 
Nonverbal intelligence: See Fluid intelligence. 




   
Mortality: The state of being mortal (subject to death) (AIDSinfo, 2018, p.113). 
Opportunistic infection: An infection that occurs more frequently or is more severe in people 
with weakened immune systems, such as people with HIV or people receiving chemotherapy, 
than in people with healthy immune systems (AIDSinfo, 2018, p.126). 
Short-term memory: The ability to retain a small amount of information in a highly 
accessible state for a short time (Vergauwe & Cowan, 2014). 
T-helper cells: See CD4 count. 
Undetectable viral load: When the amount of HIV in the blood is too low to be detected with 
a viral load (HIV RNA) test (AIDSinfo, 2018, p.175). 
Viral load: The amount of HIV in a sample of blood (AIDSinfo, 2018, p.179). 
Viral suppression/virally suppressed: When antiretroviral therapy (ART) reduces a person’s 
viral load (HIV RNA) to an undetectable level (AIDSinfo, 2018, p.180). 
Working memory: The small amount of information that can be held in an especially 








Research into the management of HIV in the last three decades has seen HIV become 
a chronic disease, and no longer a fatal one. The HIV landscape has changed from a situation 
where children typically died of AIDS to one where children are living with HIV. Research is 
now required to understand how children live with HIV as a chronic condition and how it 
affects their educational performance.  
The importance of quality education has been highlighted by its inclusion as 
Sustainable Development Goal 4 (SDG 4) (United Nations, n.d.). Inclusive and quality 
education, particularly in low- and middle-income countries, is a priority as it is a crucial step 
towards escaping the poverty cycle (United Nations, n.d.). However, childhood hearing loss 
has been identified as a “significant barrier to achieving sustainable development goal 4” 
(LeClair & Saunders, 2019). Hearing loss in young children may lead to delays in cognition 
(Lederberg, Schick, & Spencer, 2013), as well as delays in speech and oral language 
development (Tye-Murray, 2009). Subsequently, communication skills, academic 
achievement, psychosocial behaviour and emotional development (Most, 2006) may be 
affected. In order to minimise the educational effects of hearing loss and achieve SDG 4, a 
better understanding of the burden of disease in South Africa is needed. This will enable 
health and education sectors to provide inclusive, quality services.  
There is a growing body of literature focusing on hearing disorders in people living 
with HIV (PLHIV), as well as the changes that the disease may produce in the auditory 
system. Hearing loss, tinnitus and vertigo have all been reported (Khoza-Shangase, 2010; 





these disorders in the auditory system may be due to a range of causes. This may include the 
disease itself, opportunistic infections associated with the disease, and ototoxicity, which may 
be due to the medication administered for the treatment of the opportunistic infections and/or 
ART being used to manage the disease (de Jong, Luder, & Gross, 2019; Ensink & Kuper, 
2017). 
Research Focus 
The increasing body of research in the field of hearing loss and HIV provides 
essential information regarding the disease process and its clinical impact on hearing. This 
body of research is primarily based on a bio-medical approach to the measurement of disease 
impact. The research reported in this dissertation is underpinned by concerns that it is 
essential to also understand the impact of living with chronic HIV and its manifestations on 
children, by considering their auditory functioning (hearing, as well as auditory processing 
capacities), and learning capacities (nonverbal intelligence (NVIQ), short-term memory 
(STM) and working memory (WM)).  
Research Problem 
Currently, there is a paucity of research related to auditory manifestations of HIV in 
the paediatric population, particularly with how these relate to auditory functioning and the 
relationship to NVIQ, STM, and WM. A shortcoming in current research is the perspective 
that auditory functioning is limited to hearing loss. The idea of assessing hearing as a discrete 
physical entity does not consider that children with normal hearing may continue to 
experience difficulties in environments that require the child to process acoustic information, 







The study was underpinned by the following research questions:  
1. Is there a difference in auditory functioning (hearing and auditory processing 
capacities) between CLHIV and CNLHIV? 
2. Which predictor variables are associated with hearing loss in CLHIV? 
3. Are there associations between auditory functioning, HIV status, and learning 
capacities (NVIQ, STM, and WM)? 
Epidemiological Framework  
An epidemiological framework was established to facilitate consideration of the 
potential relationships between study elements and to consider the rationale for the inclusion 
of each study measure.  
An a priori causal pathway was hypothesised that specified the most proximal 
Exposure and Outcome variables, the possible Antecedent causes to the Exposure, and the 
potential Confounders (Rothman, 2002). This pathway assisted in defining putative 
associations for testing. The proposed causal pathway is outlined in Figure 1. A summary of 
the components of the causal path is provided. These are discussed in more detail in 













Figure 1. Proposed Causal Pathway 
Antecedent causes are factors that are likely to be causally associated with the 
Exposure (Rothman, 2002). In this study, compromised auditory functioning (hearing loss 
and poor auditory processing skills/capacities) was the Exposure and HIV was proposed as an 
Antecedent cause. This proposal was based on research indicating that compromised auditory 
functioning was potentially a result of HIV and could be associated with the disease itself, the 
treatment for the disease, or with opportunistic infections (Assuiti et al., 2013; Maro et al., 
2014). Furthermore, opportunistic infections were more likely to occur in CLHIV (Iroezindu, 
2016), as well as chronic otitis media and conductive hearing loss (Smith et al., 2017).  
Outcome, in this study, was learning capacities as measured by NVIQ, STM and WM. 
Compromised neurocognitive abilities have been observed in CLHIV with Sherr et al. (2018) 
reporting significantly lower scores for nonverbal cognitive ability. Musindo et al. (2018) did 
not only observe high occurrences of major neurocognitive disorders in the area of nonverbal 





executive function has also been reported in CLHIV (Ezeamama et al., 2016), with Cockcroft 
and Milligan (2019) and Sherr et al. (2018) observing difficulties with WM in CLHIV. 
Confounders are variables that are associated with both Exposure and Outcome but 
are not proxies for Disease (Rothman, 2002). In this study, socioeconomic variables were 
proposed as a possible confounder. This confounder was included as the population under 
investigation not only had a disease (HIV) which may have affected the Exposure (auditory 
functioning) and Outcome (learning capacity), but typically came from socioeconomic 
backgrounds that have been associated with hearing loss (He et al., 2018), auditory 
processing difficulties (Tabone et al., 2017) and compromised learning (Maswikiti, 2008), 
even in the absence of HIV. 
Placing the Researcher within the Research 
As an audiologist, my motivation for undertaking this study was to develop new 
knowledge about the way in which children with and without HIV, process auditory 
information and how this translates into a capacity to learn - as measured by NVIQ, STM, 
and WM. HIV is still a challenging disease in South Africa, despite widespread provision of 
HAART to children born with HIV. The use of HAART has been a significant factor in 
moving HIV from a fatal disease to a chronic one. However, it has long been suspected by 
audiologists and others working within the paediatric population, that ART may have subtle 
effects that have yet to be understood. The personal motivation for undertaking this research 
was to ensure that CLHIV have the same opportunities to learn, compared with their peers 
who are not living with the virus. Little is known about the impact of HIV on pre-teen 
children (9 - 12-year-olds) as most attention has been focussed on young children (5 years 
and younger), adolescents, and adults. There will be significant lifelong impacts if pre-teen 





opportunities. South Africa needs a more employable next generation to reduce the current 
burden on its limited capacity to provide social welfare services (Hanass-Hancock & 
McKenzie, 2017). Retaining children in the schooling system for as long as possible is one 
way of ensuring their employability, particularly their capacity to continue to tertiary 
education and to earn a liveable wage (Statistics South Africa, 2019b). 
 
The dissertation, as briefly described below, is presented as a compilation of two 
published papers and traditional chapters. The dissertation is divided into five main parts, 
which are further subdivided into chapters. Figure 2 provides an overview.  
Part 1:  
Chapter 1 provides the background to the study and presents the research problem, as 
well as the research questions. Furthermore, a summary of the epidemiological framework 
that was considered is provided.  
Chapters 2 to 4 form the literature review. Chapter 2 provides an overview of HIV 
and presents the neurocognitive sequelae of HIV, which may influence learning. Chapters 3 
and 4 are standalone papers. These papers systematically present the effects of HIV on 
hearing and auditory processing capacities.   
Part 2: 
Chapter 5 describes the study methodology. The aims and objectives are presented.  
The research design, as well as descriptions of the participants, procedures and measures used 









Chapter 6 reports the results of the study. The results as reported, reflect the four 
objectives of the study. Standalone papers reporting on these results are included as 
appendices (Appendices A-C). 
Part 4:  
Chapter 7 is a standalone chapter presenting case-case and case-control dyads. The 
rationale for including this chapter is to provide insight into the complexities of having 
CLHIV in the classroom. 
Part 5:  
Chapter 8 provides a discussion of the results of the study. It begins by presenting the 
objectives and then continues by discussing these results relative to the stated objectives. 
Limitations of the study and clinical and research implications are presented.  




   
 
 







Overview of HIV 
“AIDS today is not a death sentence. It can be treated as a chronic illness or a chronic 
disease.” (Yusuf Hamied, April 2004) 
This chapter presents a brief history of HIV and discusses the challenges faced by 
children with HIV in the school system, focusing on some of the capacities involved in 
learning. The subsequent chapters discuss auditory functioning (hearing and auditory 
processing capacities) related to HIV. These chapters are reported separately as they are both 
systematic scoping reviews. Both reviews were best undertaken as scoping reviews to answer 
broad questions about what had been published on HIV and hearing loss, and HIV and 
auditory processing. A further aim in the scoping reviews was to describe how hearing loss 
and auditory processing had been measured in the literature. 
A Brief History of HIV 
In 1983, HIV was identified as the cause of a terminal disease that had first been 
documented in 1981 (Melhuish & Lewthwaite, 2018; Whiteside, 2019). This disease was 
called acquired immunodeficiency syndrome (AIDS). 
HIV is a retrovirus, more specifically, a lentivirus that continuously replicates, 
leading to the destruction of CD4 lymphocytes, which contribute to the immune system of 
the body. This slow-growing virus eventually destroys the CD4 lymphocytes, leaving the 
body susceptible to opportunistic infections and, if left untreated, eventually leads to AIDS 
(Melhuish & Lewthwaite, 2018). Initially, two types of viruses were identified, namely HIV1 
from Central Africa and HIV2 from West Africa. However, the viruses were not contained 
and eventually spread throughout the world, reaching South Africa, the current epicentre of 





Despite treatment being available from 1996, most patients still died as the treatment 
was expensive, and there was restricted access thereto (Melhuish & Lewthwaite, 2018; 
Whiteside, 2019). However, 35 years later, effective ART has become readily available and 
more affordable, resulting in a near-normal life expectancy (Melhuish & Lewthwaite, 2018) 
with a 45% decrease in mortality since 2000 (UNAIDS, 2019).  
Global estimates for 2018 reflect a total population of 37.9 million PLHIV, with 1.7 
million being children younger than 15 years of age (World Health Organization, 2019). 
Although global statistics have shown a reduction of 33% in mortality and 16% in annual 
new infections when compared to 2010 figures, the virus continues to be omnipresent in 
Africa (World Health Organization, 2019).  
Despite a  recent decrease of 24% in new infections annually (compared to 2010) , 
Africa continues to have the majority of PLHIV, namely 25.7 million (World Health 
Organization, 2019). The decline in the number of AIDS-related deaths (40% decrease in 
mortality relative to 2010) is evident in the increasing number of PLHIV (World Health 
Organization, 2019), and this can be attributed to the roll-out of ART. Estimated ART 
coverage in sub-Saharan Africa in 2018 was approximately 67% (AVERT, 2019a; Statistics 
South Africa, 2019a; World Health Organization, 2019).  
Globally, as well as within the African region, South Africa continues to have the 
largest HIV epidemic, with estimates of PLHIV ranging from 13.5% (Statistics South Africa, 
2019a) to 20.4% (AVERT, 2019b) of the total South African population. This equates to 7.7 
million PLHIV, of which 260 000 are children under the age of 15 years (UNAIDS, 2018). 
South Africa also has the most extensive ART programme in the world, with 63% of adults 
and 64% of children being on Highly Active (HA) ART (AVERT, 2019b). Access to 





lifespan of many South Africans (Statistics South Africa, 2019a). Despite the continued 
presence of HIV, life expectancy at birth is currently estimated at 61.5 years for males and 
67.7 years for females (Statistics South Africa, 2019a), with implications for CLHIV, who 
are no longer impacted by issues of mortality, as much as morbidity. 
HIV as a Chronic Illness 
The extensive rollout of ART in Southern Africa has changed the HIV landscape 
(Gates & Cysique, 2016) with HIV now being considered a chronic illness. Effective 
treatment, coupled with better treatment adherence, has led to better CD4 counts and viral 
loads, less opportunistic infections, and less HIV-related morbidity and mortality (Gates & 
Cysique, 2016).  
However, chronic illness, by its very nature, is often associated with specific medical 
protocols such as aggressive treatment routines and multiple hospital appointments (Eiser, 
1997), which may have an impact on an individual’s everyday functioning. For many 
PLHIV, HAART has provided them with a better prognosis and improved life expectancy. 
However, the need for lifelong compliance, the possibility of long-term toxicity, and the 
complications of poor adherence are realities that PLHIV face, similar to persons living with 
other chronic health disorders (Lewthwaite & Wilkins, 2009). 
Hence, the impact of living with HIV on quality of life and the capacity to engage 
fully with the community cannot be ignored. Research focusing on quality of life issues in 
CLHIV indicates that school functioning may be severely affected, with academic 
competence and performance being compromised (Bomba et al., 2010). Despite the efficacy 
of the medication, the research suggests that the availability of HAART does not necessarily 





HIV in the Paediatric Population 
Approximately 1.3 million to 2.2 million children (aged 0 to 14 years) are living with 
HIV, with the majority calling sub-Saharan Africa their home (World Health Organization, 
2019).  
Most of these children acquired HIV via mother-to-child transmission (MTCT), 
where the virus was transmitted during pregnancy, childbirth, or breastfeeding (AVERT, 
2018). Although the number of new infections has decreased due to the recent introduction of 
Prevention of Mother-to-Child Transmission (PMTCT) programmes (with an estimated 1.4 
million infections among children being prevented over the period 2010 to 2018 (AVERT, 
2018)), new HIV infections, particularly transferred via breastfeeding, are still occurring 
(AVERT, 2018; Le Roux et al, 2019). Despite these new infections (estimated at 160,000 
[110,000 to 260,000] per year (World Health Organization, 2019)), CLHIV are living longer 
due to decreased mortality rates (Melhuish & Lewthwaite, 2018). This has significant 
implications for both health and education services.   
HIV and Learning 
Advances in PMTCT programmes and HIV treatment have resulted in near normal 
life expectancy for these children (61.1 years for males and 67.3 years for females) (Statistics 
South Africa, 2019a). However, CLHIV  are now faced with HIV-associated conditions that 
may affect their ability to function in their everyday environment, including their learning 
environment (Phillips et al., 2016). 
One of the most prevalent conditions affecting PLHIV is HIV-associated 
neurocognitive disorders (HAND) (Farhadian, Patel, & Spudich, 2017). HAND encompasses 





concentration, and attention), motor skills, and general intellectual functioning (intelligence) 
(Ezeamama et al., 2016; Farhadian et al., 2017; Hoare et al., 2016). 
There is no clarity on how HIV causes these neurological complications. However, 
the central nervous system (CNS) may be affected in two ways, namely:  
• by the virus itself (primary HIV CNS disease); or 
• by an opportunistic infection as a result of a compromised immune system (secondary 
CNS disease) (Ellis, Calero & Stockin, 2009).  
During acute infection, HIV enters the CNS via infected immune cells that cross the 
blood-brain barrier, causing CNS infection and immune activation (Farhadian et al., 2017). 
This CNS infection leads to the CNS macrophages releasing inflammatory cytokines and 
neurotoxins, resulting in damage to neurons, which in turn may cause primary HIV CNS 
disease (Ellis et al., 2009). Infants are particularly susceptible to neurologic complications as 
their blood-brain barrier is more permeable, and thus more vulnerable to damage caused by 
HIV (Moretti et al., 2015).  
Hence, despite early initiation of ART, brain abnormalities indicating cerebral injury, 
has been observed in young CLHIV (Musielak & Fine, 2016). The neurologic consequences 
affecting these children include cerebrovascular disease, epilepsy, and cognitive impairment 
(Farhadian et al., 2017).  
In their meta-analysis of 22 studies, Phillips et al. (2016) reported greater impairment 
in CLHIV for certain cognitive domains. They reported large effect sizes for working 
memory (ESE=16.46), processing speed (ESE=9.36), executive function (ESE=3.68), and 
visual memory (ESE=2.71).  However, only statistically significant effects were found for 
executive function and processing speed. One interpretation for these findings may be that 





affected in CLHIV. However, the authors acknowledged that effect estimates might have 
reflected the heterogeneity in cognitive domains, as well as testing methods used (Phillips et 
al., 2016). Similar findings have been reported by other researchers (Ezeamama et al., 2016; 
Musindo et al., 2018; Cockcroft & Milligan, 2019), with Ezeamama et al. (2016) observing 
poorer executive function in CLHIV, despite the children receiving ART. Cockcroft and 
Milligan (2019) and Sherr et al. (2018) also reported on poorer executive functions in 
CLHIV, more specifically difficulties with working memory. 
A high occurrence of major neurocognitive disorders, specifically in the areas of 
nonverbal intelligence, planning ability, and simultaneous processing was reported by 
Musindo et al. (2018). These findings were similar to those reported by Brahmbhatt et al. 
(2017), who observed that CLHIV presented with poorer scores for simultaneous processing, 
learning, and composite nonverbal cognitive performance measures than CNLHIV. Other 
researchers have also noted compromised intellectual functioning in CLHIV: According to 
James and Ittyerah (2016) and Patel et al. (2019), CLHIV had lower intelligence quotients 
(IQ), as measured by the WISC III, when compared to CNLHIV. Domains that were affected 
included verbal IQ, performance IQ, verbal comprehension index, and perceptual 
organization index (James & Ittyerah, 2016). It should be noted that the norms that were used 
to interpret the tests scores in this study were UK-based (James & Ittyerah, 2016) and US-
based (Patel et al., 2019) even though the studies were conducted in India and 
Cambodia/Thailand respectively, where English is not the home language of the children. 
This may have impacted upon the results. The authors also postulated that the children’s poor 
performance on tests of verbal ability reflected the environment in which they were growing 
up, as most of the children lived in care homes: Sherr et al (2017) proposed that poor 





environmental stimulation. However, in contrast to James and Ittyerah’s (2016) findings, 
Patel et al (2019) found that children who were living with their biologic parent(s), were 
more likely to present with lower scores on the Beery VMI Test of Visual-Motor Integration. 
Possible reasons for lower cognitive scores in these children may include lack of stimulation 
due to parental illness, or poverty (Harrison et al., 2017; Patel et al, 2019). On the other hand, 
positive predictors such as early initiation of ART (Patel et al., 2019), longer duration on 
ART (Brahmbhatt et al., 2017), as well as virologic suppression at a young age  have been 
associated with better neurocognitive outcomes in school aged CLHIV (Crowell et al., 2015).  
Considering that the research shows that CLHIV experienced higher occurrences of 
neurocognitive disorders, it is understandable that these children displayed educational 
difficulties (Musindo et al., 2018; Nkwata et al., 2017; Sherr et al., 2018) such as grade 
repetition, slow academic progression and higher rates of absenteeism (Anabwani, Karugaba, 
& Gabaitiri, 2016; Rukuni et al., 2018). Pufall et al. (2014), however, observed similar 
academic performances between Zimbabwean CLHIV and CNLHIV. Factors that they 
considered as having an adverse effect on academic performance, included socioeconomic 
factors (Pufall et al., 2014). 
HIV and Socio-Economic Status 
The World Bank estimated that in 2011, 46.8% of the population of sub-Saharan 
Africa lived in poverty (World Bank, 2012). Not only is sub-Saharan Africa affected by 
poverty, but it is also home to the majority of PLHIV (World Health Organization, 2019). 
The impact of socioeconomic status on PLHIV is, therefore, relevant when considering the 
causal path for health conditions that have been attributed to the disease.  
The association between HIV and poverty depends on the geographical location of the 





However, a relationship between HIV, AIDS, and poverty has been reported, with poor 
people experiencing more AIDS-related illnesses (Steinert et al., 2017), as well as a higher 
prevalence of HIV (Bunyasi & Coetzee, 2017). Existing studies attribute financial hardship 
caused by HIV, to increased expenses (as a result of hospital visits and treatment) and lower-
income (as a result of missed workdays and limited employment opportunities) (Poudel, 
Newlands, & Simkhada, 2017; Punpanich, Gorbach, & Detels, 2012).  
Socioeconomic status may have far-reaching consequences for CLHIV. According to 
Smith (2011), poorer children tend to perform more poorly at school due to their lack of 
access to good nutrition, proper housing, and adequate security. Furthermore, children from 
lower socio-economic groups typically attend schools that do not have adequate 
infrastructure and staff to optimise the learning process (Smith, 2011). In addition, the 
schooling of CLHIV may be negatively affected if they are required to care for ill parents or 
have been orphaned due to the disease (Pufall et al., 2014). Researchers, such as Pufall et al. 
(2014), thus suggests that other factors besides HIV be considered as possible contributors to 
poor educational outcomes, especially within the context of sub-Saharan Africa, where HIV, 
hearing loss, and poverty is prevalent.  
This study focuses on auditory functioning (hearing and auditory processing 
capacities) and learning capacities as measured by NVIQ, STM and WM. This information 
will be used to increase awareness of the more subtle difficulties experienced by CLHIV, 
which in turn will guide interventionists and educators in planning suitable programmes for 








Summary of Chapter 2 
CLHIV currently have near-normal life expectancy due to HAART. However, HIV is 
now considered a chronic condition / disease, and may be associated with other co-morbid 
conditions. Although PMCTC programmes have been effective, new infections continue to 
occur in the paediatric population with half of these being ascribed to breastfeeding.  
HIV crosses the blood-brain barrier through the immune cells, causing damage in the 
CNS with resultant neurocognitive impairments. Despite the early initiation of HAART, 
cognitive impairment continues to be observed in CLHIV. Deficits in executive function 
(including WM) and processing speed are evident. Academic consequences of HIV have also 
been noted, including higher absenteeism, grade repetition, and slow progress, while socio-
economic factors may further impact on the effects of the virus.  
Health and educational services will therefore need to consider the implications of 
HIV and its co-morbidities in children living with this disease. As Krishnakumar (2007, p. 
40) succinctly states: “We believe it is as important to be able to say something about the 
capabilities as it is to say how we can enhance them and thus promote human development. It 
is not enough to be able to measure how much is achieved, but it is also essential to be able to 










HIV and Hearing Loss 
This chapter consists of a scoping review published in the International Journal of 
Pediatric Otorhinolaryngology (April 2020). The aim of the review was to explore the current 
body of evidence regarding the nature, extent, and associates of hearing loss in CLHIV. The 
review was undertaken to assist the primary investigator to set the scene for understanding 
what is known, and not known, about hearing loss in CLHIV. A secondary aim of the review 
was to explore current assessment measures used to measure hearing status. 







Antiretroviral therapy has had a major impact on life expectancy from HIV, as many people 
now live with it as a chronic disease.  Chronic HIV has been associated with a range of 
comorbid disabilities and health conditions, one of which is hearing loss. Undiagnosed and 
untreated hearing loss, particularly in children, has been linked to poorer spoken language 
skills, with subsequent effects on academic performance.  
Methods 
This systematic scoping review aimed to summarize the available peer-reviewed literature on 
hearing loss in HIV-infected children, specifically to describe its extent and nature. The 
review followed the framework proposed by Arksey and O’Malley. Key search terms 
included hearing loss (and synonyms), child (and synonyms), and HIV.  Electronic databases 
(EBSCOhost Research Platform, PubMed, Web of Science and Scopus databases) were 
searched for any relevant articles published from 1 January 2000 to 30 June 2019.  Reference 
lists of included articles were pearled for additional relevant articles not already identified. 
Each stage of the selection process was conducted independently by two authors. The results 
were then collated by a third author who also resolved any discrepancies. Extracted data 
included sample descriptors, audiologic tests, hearing loss prevalence, hearing loss descripts, 
and factors associated with hearing loss.  
Results 
Seventeen articles were included; 10 from Africa, four from South America, two from North 
America and the remaining article from Asia. Although most of the articles reported on pure 





heterogenous. Prevalence of hearing loss varied across articles (from 6% to 84%).  
Conductive hearing loss occurred more frequently than sensorineural or mixed hearing loss. 
ART use and ear infection were reported as significant in three of five articles that reported 
on significant associates of HIV-related hearing loss.  
Conclusion 
There was a modest volume of research from a limited number of countries.  Heterogeneity 
in sampling and audiometric methods precluded a clear understanding of potential 
associations between chronic HIV-related hearing loss and contributing factors.   


















Effective treatment for HIV has resulted in a significant decrease in mortality rates over the 
last 10 years, with AIDS deaths globally for 2016 recorded at being 48% lower than the 1.9 
million reported in 2005 [1]. This decrease has resulted in a subsequent increase in the 
number of people living with the disease, and in the life expectancies of these individuals. 
Since HIV is no longer one of the top ten global causes of death [2] , the research agenda for 
HIV is changing from mortality to morbidity [3]. 
HIV is associated with conditions that can affect learning, including HIV-neurocognitive 
disorders [4,5] and hearing loss [6].  Hearing loss in young children in particular, may lead to 
delays in speech and spoken language development [7,8], and therefore can impact a child’s 
communication skills, academic achievement, psychosocial behavior and emotional 
development [9,10]  
Current literature reports on the prevalence of hearing disorders in both adults and children 
living with HIV, as well as the changes that the disease may produce in the auditory system. 
Studies have shown that adults who are infected with HIV may exhibit auditory and otologic 
disorders such as hearing loss, tinnitus and vertigo [11–15], with [15] reporting prevalence 
for tinnitus (26%), vertigo (25%), hearing loss (27.5%) and middle ear abnormalities (41%).  
Studies, involving HIV-infected children, have also reported abnormal audiological findings, 
including otitis media and hearing loss [6,16,17], with hearing loss prevalence reportedly 
ranging from 4% to 85% with conductive hearing loss being more prevalent in children [6].  
Although hearing loss, in this population, has been associated with various factors such as 





diseases; the evidence is not conclusive as hearing loss in HIV-infected individuals may be 
due to multiple factors [18]   
Aim: This scoping review aimed to explore the current body of evidence regarding the nature, 
extent and associates of hearing loss in HIV-infected children. This information will afford 
relevant role-players (including parents, educators, medical professionals and governmental 
agencies), in both the education and health sectors, the opportunity to provide better services, 
by addressing the specific needs of HIV-infected children.  
Methods  
Protocol registration: No protocol was registered for this scoping review.  
Choice of review methods: A scoping review of the literature was considered to be the most 
suitable design for this study, which had the aim of summarizing the available evidence 
related to hearing loss in HIV-infected children [19,20].  
Reporting standard: The Joanna Briggs Institute Reviewer’s Manual, specifically Chapter 11 
[21] and the PRISMA-ScR checklist [22] guided reporting. The scoping review was 
conducted according to the frameworks proposed by [20], and Levac et al. [19]. 
Search timeframe: The literature search was conducted from 1 January 2000 until 30 June 
2019. The year 2000 was selected as it corresponded to the approximate period when the 









Eligibility criteria: Table 1 summarizes the inclusion and exclusion criteria. 
Table 1. Inclusion and exclusion criteria 
Inclusion  Exclusion 
HIV-infected children  Study participants were HIV infected 
adults  
Articles reporting prevalence of hearing loss Articles not reporting prevalence of 
hearing loss 
Peer-reviewed journal articles Non peer-reviewed journal articles, 
conference proceedings and any sources of 
grey literature 
Research articles Reviews, opinions and commentaries 
Articles written in English Articles not written in English 
 
Research question: This review informed a larger subsequent study into the auditory skills of 
children with HIV/AIDS. The specific research question was “What is currently known about 
hearing loss in HIV-infected children?”. 
Identifying relevant studies: A comprehensive search strategy (Table 2) was designed in 
collaboration with a university librarian. The literature search involved: EBSCOhost 
Research Platform (Medline, Africa Wide, Academic Search Primer and CINAHL), PubMed, 
Web of Science and Scopus databases. These databases were considered to be the ones that 








Table 2. Search strategy across databases  
Database Search/Mesh terms 
EBSCOhost 
research 
hearing loss or deafness or hearing impairment or deaf or hard of hearing  
AND children or adolescents or youth or child or teenager or teens or young 
people or kids or paediatric or pediatric 
AND HIV or human immunodeficiency virus or HIV/AIDS 
 
Pubmed 
hearing loss or deafness or hearing impairment or deaf or hard of hearing 
AND children or adolescents or youth or child or teenager or teens or young 
people or kids or paediatric or pediatric 
AND hiv or human immunodeficiency virus or hiv/aids 
 
Web of Science  
hearing loss or deafness or hearing impairment or deaf or hard of hearing 
AND children or adolescents or youth or child or teenager or teens or young 
people or kids or paediatric or pediatric 
AND hiv or human immunodeficiency virus or hiv/aids 
 
Scopus 
hearing loss or deafness or hearing impairment or deaf or hard of hearing 
AND children or adolescents or youth or child or teenager or teens or young 
people or kids or paediatric or pediatric 
AND hiv or human immunodeficiency virus or hiv/aids 
 
 
The literature search was conducted by one author (E.O), with the assistance of a librarian  
Study selection: The study selection procedure was based on the PRISMA process [24] as 
depicted in Figure 1. Each step was independently completed by two authors (H.E. & E.O.) 
and the results were then collated by a third author (G.D.). All discrepancies were noted and 
returned to H.E. and E.O. for discussion. If these authors could not resolve the discrepancy, 
G.D. was consulted for a final decision 
Charting the data: Data extraction sheets (Tables 3 – 5), as recommended by [19,20,25], 
were used to extract and summarize the relevant data.  Information was extracted on 





audiologic tests, prevalence of hearing loss and nature of hearing, factors associated with 
hearing loss.   
Collating, summarizing and reporting the results: Tables, figures and numerical analysis, as 
recommended by [20], were used to report the results.  
Results 
Study Selection: Figure 1 outlines the study selection process. Of the initial 630 articles, 280 
remained after duplicates were removed. The titles of these articles were screened for 
relevance, resulting in 209 articles being excluded. The abstracts of the remaining 71 articles 
were then screened for relevance. Thirty-five articles were included for full text review of 
which 18 were excluded as not meeting inclusion and exclusion criteria (Table 1). The 
remaining 17 articles were considered to be relevant to the research question [16,17,26–40]. 











Study characteristics: The studies were all cross-sectional observational designs and included 
a total of 2617 children (study samples ranging from 23 to 380 children). Two studies [26,30] 
reported on the same sample, therefore, their sample numbers were only included once in the 
calculation of total subject numbers. The ages of the children ranged from three months to 20 
years. Although the exclusion criteria for age was 18 years, two studies were included despite 
the age ranges of the study participants being four to 19 years [41] and seven to 20 years 
[16].  Not all studies reported mean ages, thus it was not possible to estimate average age of 
the participants. Based the available data, it was postulated that most of the children were 
younger than 12 years.  The two studies that included 19 and 20 year olds, reported mean 
ages of nine years, nine months [41] and 13 years, six month [16] respectively.  Thus, it was 
a assumed that the majority of participants in these two studies were within the inclusion 
criteria of 18 years (Table 3). A second study included adults [30], however, data were 
reported separately for children and adults and the elements required for the review could be 
extracted for children.   
Eight studies were surveys which did not include control groups [17,27,28,31,32,34,35,37], 
while nine were case-control studies, with the controls being uninfected children 
[16,26,29,30,33,36,38–40]. The studies were all conducted in urban settings; with 10 studies 
based in Africa, four in South America two in North America and the remaining study in 








Table 3. Demographic information of each study 
Author(s), 
year 






Age range, (years / 
years:months) 






51 50 3 to 10  











Survey 62 -  1:06 to 6 






51 50 3 to 10 




Survey 78 -  0:03 to 12 (mean = 5:03) 
Taipale et al. 
2011 
Luanda, Angola Case 
Control 
78 78 0:09 to 14:08 (median = 
4:03 HIVP; 4:02 HIVN) 
Chao et al. 
2012 
Lima, Peru Survey 139 -  4 to 19 (mean = 9:09) 
Makar et al. 
2012 
Kolkata, India Survey 67 -  4 to 16 (mean = 11:06) 






145 86  
(HEU) 
7 to 17 (mean = 12:02) 










Survey 370 -  0:06 to 5 (mean = 3:02) 






296 296 2 to 9 (mean = 5:06 
HIVP; 6:01 HIVN) 






37 24 4-14 (mean = 7.01) 




Survey 380 -  4 to 14 (mean = 8:06) 
Maro et al. 
2016 




131 113 0:8 to 18 (mean = 10:01 
HIVP; 10.01 HIVN) 






148 79 6 to 12 (mean = 9.2) 






107 147 7 to 20 (mean = 13:06 
HIVP; 13 HIVU) 
HIVP = HIV positive; HEU = HIV exposed and uninfected; HIVN = HIV negative; HIVU = 





Synthesis of the results  
The 17 articles reported on 16 datasets. Not only did the study samples differ in age, but they 
also differed in selection criteria and health status.  Although all articles reported on the 
sampling location, information on how children were selected for study participation was 
generally absent.  Overall, the included papers reported on 1940 HIVP children (cases) and 
677 uninfected children (controls). The uninfected children included children who were 
exposed to HIV, but not affected, as well as children who were reported to be uninfected 





Table 4: Key characteristics of included articles as these relate to extent of hearing loss 
Author(s), year Audiologic assessment measure 
(hearing loss cut-off) 
Prevalence of hearing 
loss in HIVP children  
Prevalence of 
hearing loss in 
Controls 
Significant findings related to 
prevalence 
Matas et al. 2006 Otoscopy, PT (>15 dB), 
neurologic ABR, tympanometry 
and acoustic reflexes 
37% (19/51) 0% (0/50) Significant difference in hearing 
loss prevalence between cases 
and controls 
Palacios et al. 2008 Otoscopy, PT (>20dB), ABR 
(>20dB), speech discrimination 
33% (4/12) – PTA 
23% (6/23) – ABR   




screening protocol for DPOAE 
and TEOAE (refer)   
32% (20/62) 
 
-  Not applicable 
Matas et al. 2010 Otoscopy, PT (>15dB), neurologic 
ABR, tympanometry and acoustic 
reflexes, speech audiometry 
28% (14/51) 0% (0/50) Not applicable as comparison 
between children and adults 
Govender et al. 2011 Clinical suspicion of hearing loss  6% (5/78) (confirmed 
with ABR)                 
-  Not applicable 
Taipale et al. 2011 Otoscopy, PT (>25dB), ABR 
(>40dB) 
26% (20/78) 15% (12/78) Cases significantly more likely to 
have bilateral hearing loss than 
controls  
Chao et al. 2012 Otoscopy, PT (>25dB), 
tympanometry 
39% (54/139) -  Not applicable 
Makar et al. 2012 Otoscopy, PT (unspecified), 
tympanometry and acoustic 
reflexes, speech recognition 
threshold 





Torre et al. 2012 PT (≥20dB), tympanometry 20% (29/145)  10% (9/86)  Mean pure tone average in worse 
ear significantly higher in cases 
than in controls 
Buriti et al. 2013 Otoscopy, PT(>15dB), 
tympanometry and acoustic 
reflexes 
84% (39/46 ears)  -  Not applicable 
Christopher et al. 2013 Otoscopy, ABR (>25dB), 
tympanometry 
33% (121/370)       -  Not applicable 
Devendra et al. 2013 WHO TQS, Follow up 
Questionnaire 
12% (36/296) 2% (7/296) Odds of hearing loss significantly 
higher in cases than controls 
Torre et al. 2015 Otoscopy, PT (>15dB), DPOAE, 
tympanometry 
21% (8/37) 8.3% (2/24) Mean pure tone average in worse 
ear significantly higher in cases 
than in controls 
Hrapcak et al. 2016 Otoscopy, PT (>20dB), TEOAE, 
tympanometry 
24% (90/380)          -  Not applicable 
Maro et al. 2016 PT (>25dB), ABR, DPOAE, 
tympanometry, gap detection 
17% (16/97)   6% (5/80)      Cases had a significantly higher 
proportion of pure tone averages 
greater than 25dB than controls 
Nakku et al. 2017 Otoscopy, PT (not specified) 22%* (33/148) 23%* (18/79) None 
Smith et al. 2017 Otoscopy, PT (>25dBHL) 38% (41/107) 12% (18/147)     Significantly more cases than 
controls presented with hearing 
loss 
Conductive loss occurred 
significantly more in cases than 
on controls 





Audiologic assessment measures: As reported in Table 4, the assessment measures primarily 
comprised routine audiologic tests which included: otoscopy, pure tone audiometry (PT), 
tympanometry, auditory brainstem response testing (ABR), distortion product (DPOAE) and 
transient evoked (TEOAE) otoacoustic emissions. All but one study [32] specified which 
tests were used.  The majority of studies used PT as the measure of hearing sensitivity 
[16,17,26–30,35–37,39–42]. Only Christopher et al. [28] used ABR to determine hearing 
status. The cut-off points for normal hearing was 15dBHL in four studies [26,30,37,43] , 
20dBHL in three studies [17,27,36], 25dBHL in five studies [16,28,33,39,41] and 40dBHL 
(for ABR) in one study [33]. Two studies did not specify cut-off criteria [35,40]. 
Two studies did not include tests of hearing sensitivity.  One used otoacoustic emissions as a 
screening measure [31] and the other used the WHO Ten Question Screen (WHO TQS) and a 
follow-up questionnaire [38].  
Extent of hearing loss: Among the HIVP children, the prevalence of hearing loss ranged 
from 6% to 84% (Table 4). The four studies that categorised hearing loss as a pure tone 
average greater than 15dB, reported prevalence rates between 22% and 84%. The studies that 
had a pure tone average of greater than 20dB as the criteria for diagnosing a hearing loss, 
reported prevalence ranging from 16% to 39%. Three studies reported a significant difference 
in the prevalence of hearing loss between cases and controls [16,26,38]. However, all case-
control studies consistently reported a greater prevalence of hearing loss in HIV-infected 







Table 5: Key characteristics of included articles as these relate to nature of hearing loss in HIVP children 
Author(s), year Symmetry  Type of hearing loss Degree of HL Significant HIV-factors 
associated with HL  
Matas et al. 2006 Not specified Peripheral HL = 58%                      
Auditory brainstem disorders = 
18%                          
Combination HL = 26% 
Not specified Not a study objective 
Palacios et al. 
2008 
Bilateral = 33% (2/6)  
Unilateral = 67% (4/6) 
Auditory brainstem results:  
Conductive = 75% (6/8 ears)       
Sensorineural = 25% (2/8 ears) 
Mild = 25% (2/8 ears)  
Moderate = 75% (6/8ears) 




& Turnball 2009 
Bilateral = 65% (13/20)  
Unilateral = 35% (7/20) 
Conductive = 90% (18/20)  
Sensorineural = 10% (2/20) 
Not applicable Inferential statistics not 
reported 
Matas et al. 2010 Not specified Conductive = 93% (13/14)  
Sensorineural = 7% (1/14) 
Not specified Not a study objective 
Govender et al. 
2011 





Taipale, et al. 
2011 
Bilateral = 50% (10/20)  
Unilateral = 50% 
(10/20) N - 
extrapolated 
Not specified Moderate hearing loss or 
greater = 25% (5/20) 
Not a study objective 
Chao et al. 2012 Bilateral = 52% (28/54) 
Unilateral = 48% 
(26/54) 
Conductive = 89% (48/54) 
Sensorineural = 2% (1/54) 
Mixed = 9% (5/54) 
Mild = 54% 
Moderate = 7% 
Moderate-severe = 4% 
Severe = 1% 
CD4 count ≤ 500cells/ml) * (OR 
3.53(1.21-22.4)) 
Undetectable viral load* (OR 
4.33(1.58-11.9)) 
TM perforation* (OR 7.08(1.65-
30.5)) 
Abnormal tympanometry* (OR 
2.71(1.09-6.75)) 
*Adjusted OR 
Makar et al. 2012 Not specified Conductive = 45% (10/22) 
Sensorineural = 55% (12/22) 
Not specified Not study objective 
Torre et al. 2012 Bilateral = 48% (14/29) 
Unilateral = 52% 
(15/29) 
Conductive = 38% (11/29) 
Sensorineural = 62% (18/29) 
Not specified CDC class C (OR 2.81(1.22-6.48)) 







Christopher, et al. 
2013 
Not specified Conductive = 36% (44/121) 
Sensorineural = 64% (77/121) 
Mild = 36%  
Moderate = 58% 
Severe = 6% 
Not a study objective 
Devendra et al. 
2013 
Not specified Not specified Not specified Not a study objective 
Torre et al. 2015 Bilateral = 25% (2/8) 
Unilateral = 75% (6/8) 
Conductive = 62.5% (5/8) 
Sensorineural = 37.5% (3/8) 
Not specified Findings not significant 
Hrapcak et al. 
2016 
Bilateral = 40% (36/90) 
Unilateral = 60% 
(54/90) 
Conductive = 82% (103/126 
ears) 
Sensorineural = 14% (17/126 
ears) 
Mixed = 4% (6/126 ears) 
Mild = 66.7% (84/126 
ears) 
Moderate = 20.6% 
(26/126 ears) 
Severe = 7.1% (9/126 
ears) 
Profound = 5.6% (7/126 
ears) 
Frequent ear infection (OR 7.4(4.2-
13.0)) 
Ear drainage (OR 6.4(3.6-11.6)) 
WHO stage 3 (OR 2.1(1.2-4.5))  
WHO stage 4 (OR 6.4(2.7-15.20 
Maro et al. 2016 Not specified Not specified Only better ear results 
reported 





Nakku et al. 2017 Not specified Conductive = 64% (21/33) 
Sensorineural = 33 % (11/33) 
Mixed = 3% (1/33) 
Not specified Increasing age of child (p=0.01) 
History of ear infection (p<0.01) 
Tuberculosis treatment (P<0.01) 
More than 6 years on ART 
(p<0.01)  
Smith et al. 2017 Not specified Conductive = 59% (24/41) 
Sensorineural = 24% (10/41) 
Mixed = 17% (7/41) 
Not specified Inferential statistics not reported 





Nature of hearing loss: Table 5 summarizes key findings of the studies, relating to the 
nature of hearing loss reported in the HIV-infected children. 
Seven of the 17 articles reported on laterality. The majority of articles (four) reported a higher 
occurrence of unilateral hearing loss [17,27,36,44]. Of the remaining three articles, two  
found that bilateral hearing loss occurred more often than unilateral hearing loss [31,45], 
while one reported an equal amount of unilateral and bilateral hearing loss [33]. 
Of the 13 articles describing type of hearing loss, one article [26] categorised hearing loss as 
peripheral hearing loss, auditory brainstem disorders and mixed (peripheral + auditory 
brainstem disorders), one article only reported on sensorineural hearing loss [32] while all the 
other articles referred to conductive, sensorineural and mixed (conductive + sensorineural) 
hearing loss. Of the 11 articles that used the latter description for type of hearing loss, the 
majority (eight) reported that conductive hearing loss occurred more often than sensorineural 
(three) and mixed hearing loss (zero) [16,17,27,30,31,40,44,45].  
Degree of hearing loss was described in six articles [17,27,28,33,39,45]. However, as one of 
the articles reported findings for the better ear only [39], it was excluded for further analysis. 
Of the five remaining studies, three reported that mild hearing loss occurred most often 
[17,33,45], while the remaining two reported that moderate hearing loss occurred most often.  
Of the 12 articles that reported on HIV-related factors associated with hearing loss; four did 
not include inferential statistics [16,28,31,42].  Of the remaining studies, three did not report 
significant associations [27,39,44].  Three found a significant association between hearing 
loss and current or previous ear infection [17,37,40] and three studies reported a significant 
association between hearing loss and antiretroviral therapy [37,40,41].  Furthermore, two 
studies found a significant association between hearing loss and stage of disease [17,46]. 
Nakku et al. [40] also reported significant associations between hearing loss and increasing 






This is the first systematic scoping review that we know of, that focusses exclusively on the 
extent and nature of hearing loss in HIV-infected children. Our search strategy (including 
pearling as a validation step) was sufficiently comprehensive to enable identification of the 
available relevant literature [17] pertaining to our research question. We were surprised at the 
number of studies that have been published on this topic. Overall in these studies, 
approximately 1:3 HIV-infected children had some form of hearing loss. This prevalence is 
higher than the pooled prevalence estimates (13.1%) reported in a review of 88 papers by 
Wang et al. [47]. The review included papers reporting on hearing loss in healthy children 
(aged 0 to 18 years), who were not at risk of having a disease associated with hearing loss. 
Only papers that reported on, were included. This difference in prevalence may be because 
Wang et al. [47] used bilateral hearing for the calculation of prevalence whereas the studies 
included in this review used both unilateral and bilateral hearing loss to determine 
prevalence. Prevalence varied considerably across studies. A similar finding was reported by 
Ensink et al. [6] in their systematic review of 21 studies on hearing loss in HIV-infected 
children and adults. The review included 12 studies related to children of which 11 are 
included in our review. A possible reason for this variation was methodological differences in 
assessment measures, assessment environments and cut-off criteria used for determining 
normal hearing [47,48].  
Conductive hearing loss occurred more frequently in HIV-infected children than either 
sensorineural hearing loss or mixed hearing loss. However, this finding is not specific to 
HIV-infected children as conductive hearing loss has been reported to account for more than 





Unilateral hearing loss seems to be more prevalent in HIV-infected children than bilateral 
hearing loss. Higher occurrence of unilateral hearing loss caused by chronic suppurative otitis 
media has also been reported in a population based study in rural Malawi [51]. Although this 
study did not specifically look at the HIV-infected population, the similarities between the 
findings of our review and the study by Hunt et al. [51] may in part be due to other factors, 
associated with conductive hearing loss (such as  passive smoking, allergies, nursery 
attendance, being the third or later sibling and poor nutrition) that may be similar [50].  
Although there was limited data on the degree of hearing loss, the most frequently occurring 
categories were “mild” and “moderate” hearing loss. Given that conductive hearing loss, 
probably due to opportunistic ear infection, was the most commonly occurring hearing loss, 
these categories correlate as mild to moderate hearing loss is associated with otitis media with 
effusion [52]. ART, especially HAART, has been reported to reduce the incidence of 
opportunistic diseases, however it has been found that the reduction of opportunistic disease 
due to HAART use is less pronounced in low to middle income countries where other factors 
(e.g. poverty and poor living conditions) may have an impact on the health status of the 
individual [53].  
ART, stage of disease and current or past ear infection appears to be prominent factors 
associated with HIV. A higher WHO or CDC stage reflects that the individual is immune 
compromised which places them at risk of opportunistic disease such as ear infections. As the 
disease progresses it may affect various body systems which could lead to disability, 
including hearing loss [54] 
Limitations: The review used a comprehensive search strategy to identify as much relevant 
literature as possible, and it highlights the scarcity of research on hearing loss in HIV-





have introduced bias toward countries from the Global North, however, we were surprised 
that only one study was based in this region and that the remaining studies were all based in 
the Global South. Although the exclusion of conference abstracts and other grey literature 
may have introduced publication bias; including this type of literature may not have provided 
sufficient detail for the purposes of this review.  
Conclusion 
The evidence suggests an association between pediatric chronic HIV and hearing loss, that is 
predominantly conductive in nature. Although hearing loss prevalence is greater in HIV-
infected children than in the general pediatric population, Itis difficult to determine the extent 
as hearing loss prevalence varies relative to the hearing test and cut-off criteria used.  There 
seems to be associates of hearing loss in HIV-infected children, however, the association 
between these variables and hearing loss is inconclusive. 
In order to improve the health and education services offered to HIV-infected children, a 
better understanding of the impact of the virus and subsequent treatment is needed. Carefully 
designed case control studies looking at the time-sequence and relationship between HIV, 
HIV-related variables and hearing loss in children should be considered. Furthermore, 
research needs to address issues of testing methodology, sampling rigour, sample size 
calculation, and sample heterogeneity, as well as exerting better controls for age as this may 
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Reflections on Findings 
The findings from the scoping review suggest that there is an association between 
paediatric HIV and hearing loss, that is predominantly conductive in nature. It appears that 
hearing loss prevalence is greater in CLHIV, than in the general paediatric population. 
However, it is difficult to determine the strength of the association or the extent of the 
differences between CLHIV and CNLHIV from this review, as there are several factors 
which should be considered. 
From the review, it is postulated that the probable cause for the higher occurrence of 
conductive hearing loss in CLHIV is middle ear infection due to a compromised immune 
system. However, Midgley et al. (2000) and Marriage, Brown and Austin (2017) have 
reported that age, as well as seasonal changes, is also associated with otitis media.  
Otitis media is common in young children, with more than 80% of four-year olds 
having had an episode of otitis media during their lifetime (Marriage et al., 2017). 
Considering that fourteen of the studies included in the review had children younger than six 
years old, age should be considered as a confounder. This has implications for the 
interpretation of the results and unless the study samples are stratified according to age, the 
association between HIV and conductive hearing loss remains inconclusive. 
Prevalence rates for otitis media fluctuate relative to the season, with higher rates 
typically noted during the winter months (Marriage et al., 2017). The studies included in the 
review did not report on when the hearing assessments took place. Thus, the impact of 
seasonal fluctuation on the prevalence of otitis media in CLHIV cannot be determined.   
In addition, the studies did not report on demographic and socio-economic factors that  
may have confounded the results. These factors include day care attendance, exposure to 
passive smoking, allergies and socio-economic status (Hunt et al., 2017; Marriage et al., 





Another important variable to consider when reviewing the literature is measures used 
to assess auditory functioning.  The findings from the review highlight the need for the use of 
comparable testing methodologies. Most studies used pure tone audiometry to measure 
hearing status, with reported cut-off criteria for normal hearing ranging from 15dB to 25dB. 
The studies using lower cut-off criteria did not necessarily report higher prevalence rates, as 
would be expected with a more stringent cut-off. However, a possible reason for the varying 
rates may be the environment in which testing took place. 
A further consideration is the inherent limitations of the audiological test used. The 
results obtained via conventional behavioural audiometry may not be accurate in “difficult-
to-test” or younger children as the test relies on executive functions such as attention. 
Children may habituate to the sound and fail to respond, or consistent responses may only be 
observed at levels that are above threshold (Jerger & Hayes, 1976). Age and executive 
function are, therefore, important factors to consider when selecting suitable tests, especially 
when considering that neurocognitive deficits have been reported in CLHIV (Phillips et al., 
2016).  
A few studies used auditory brainstem response testing, particularly for younger 
children. Although this test is considered to be objective, interpreting the results involves 
subjectivity. According to Gans (1987), ABR testing results should be interpreted with 
caution in children who have neurologic involvement. This implies that when interpreting the 
ABR testing results of CLHIV, cognisance should be taken of the possible effects of the well-
documented neurocognitive deficits (Phillips et al., 2016) in this population. 
In order to improve the health and education services offered to HIV-infected 
children, a better understanding of the impact of the virus and subsequent treatment is 
needed. The current evidence regarding the association between HIV and hearing loss is not 





well as the testing methodologies. Carefully designed case control studies examining the 
time-sequence and relationship between HIV, HIV-related variables and hearing loss in 
children, should be considered. Furthermore, research needs to address issues related to 
assessment methods, cut-off criteria, sampling rigour, sample size calculation, and sample 







HIV and Auditory Processing 
This chapter consists of a scoping review published in PLOS ONE (September 2019).  
The aim of the review was to explore the current body of evidence regarding the nature of 
auditory processing capacities in CLHIV. The review was undertaken to assist the primary 
investigator to set the scene for understanding what is known, and not known, about auditory 
processing in CLHIV. A secondary aim of the review was to explore current assessment 
measures used to measure auditory processing capacities. 






















Auditory processing disorders can negatively affect academic performance in children. They 
can result from a number of aetiologies, including the human immunodeficiency virus (HIV). 
Although studies in paediatrics are limited, research suggests that HIV-infected children 
display poorer auditory processing skills than uninfected children.  
Methods 
The aims of this study were to scan the peer-reviewed literature on auditory processing skills 
in HIV-infected children, to describe how auditory processing was tested, how auditory 
processing skills were reported, and to identify gaps in current evidence. This systematic 
scoping review was conducted using a modified version of Arksey and O’Malley’s 
framework. Key words comprised ‘HIV’, ‘auditory processing’, ‘hearing’ and ‘child’. 
Electronic databases were searched for relevant articles published from 1 January 2000 to 30 
April 2018, and reference lists of included studies were pearled. Two researchers reviewed 
the articles and extracted data on sample descriptors, auditory processing testing procedures, 
and auditory processing skills. A third author collated the results and resolved discrepancies. 
The American Speech-Language-Hearing Association description of auditory processing 
skills framed the analysis.  
Results 
Five articles were included in this review (three from Brazil, one each from Mexico and 
Tanzania). Samples, and methods of testing were heterogeneous.  Three studies reported on 
localization abilities, while gap detection thresholds, performance on dichotic tasks and 
speech discrimination scores were reported in one article each.   No one study tested all areas 
of auditory processing skills and there was limited information about the auditory processing 






This review highlighted the current sparse evidence-base for auditory processing in HIV-
infected children. It identified the need to standardise testing procedures, measures of 






Effective drug regimens have resulted in decreasing mortality rates from the human 
immunodeficiency virus (HIV) [1]. This has shifted attention to the impact of HIV on the 
developmental and educational outcomes of the approximately 1.8 million children, who are 
currently living with HIV [2]. HIV-infected children have been shown to perform poorer 
academically than their non-infected peers, with 40% of infected children aged between six 
and 12 years, being in a lower grade than is appropriate for their age [3]. It has therefore been 
suggested that HIV-infected children be recognised as a group with distinct educational needs 
[4].  However, in order to address their specific educational needs, research is required to 
describe the associated conditions affecting educational achievement.  
Research has shown an association between hearing loss and HIV in the paediatric population 
with prevalence rates ranging from 6% to 84.4% [3,5–13]. Hearing loss in this population 
may be caused by the virus itself, opportunistic diseases and associated treatment regimens 
[14]. Hearing loss, which leads to reduced access to auditory information, significantly 
impacts a child’s ability to listen and learn in a mainstream classroom environment [15]. 
However, listening difficulties may not only be associated with hearing loss but more subtly, 
a child can have normal hearing but an impaired ability to process auditory information [16].  
Auditory processing can be described as assigning meaning to what has been heard [17]. 
Discreet auditory processing skills form the foundation for listening [18]. These skills 
include: sound localization and lateralization, auditory discrimination, auditory temporal 
processing, auditory pattern processing, dichotic listening, auditory performance in 
competing acoustic signals, and auditory performance with degraded acoustic signals [19]. 





processing difficulties originate, for children with these deficits, the ability to function in a 
typical class environment is diminished [20].   
Overall, research within HIV-infected populations has primarily reported on peripheral 
hearing loss [21], with few studies reporting on auditory processing. Although findings 
suggestive of central auditory deficits have been reported [5,8,22,23], these studies looked at 
the integrity of the auditory pathway rather than specific auditory processing skills. Matas et 
al [24], however, found that HIV-infected children were poorer at localizing sound than 
uninfected children. These findings have important implications for the paediatric HIV 
population, as disorders affecting auditory processing, in the absence of hearing loss, have 
been associated with poorer educational outcomes [25]. 
Objective 
The aim of this review was to systematically scan the published literature to identify papers 
of any research design that reported on auditory processing skills in the HIV-infected 
paediatric population.   
Methods  
Study design  
A scoping review entails mapping key concepts and summarising available evidence of a 
particular research area [26,27]. A scoping review was the most appropriate design to address 
the objectives of this study, because so little is known about this area [28].  
Protocol registration 
No protocol was registered for this scoping review as it was part of a bigger study that 






Reporting standard  
This paper uses the PRISMA-ScR checklist [29] as a reporting standard. The review was 
conducted according to the framework proposed by Arksey and O’Malley [26], which was 
further developed by Levac, Colquhoun and O’Brien [27]. 
Eligibility criteria  
The search was conducted from 1 January 2000 until 30 April 2018. A PIO search framework 
was set, where P (patient) reflected children up to 18 years with HIV, I (intervention) was the 
assessment measure(s) for auditory processing skill(s), and O (outcome) was the auditory 
processing skill. Studies that included both adults and children were excluded. The inclusion 

















Table 1: Inclusion and exclusion criteria 
Inclusion  Exclusion 
Article reported on a specific auditory 
processing skill; namely sound localization 
and lateralization, auditory discrimination, 
auditory temporal processing, auditory 
pattern processing, dichotic listening, 
auditory performance in competing acoustic 
signals, and auditory performance with 
degraded acoustic signals [19] 
Article did not refer to a specific auditory 
processing skill 
Peer-reviewed journal articles Non peer-reviewed journal articles, 
conference presentations and other sources 
of grey literature 
Research/data driven articles only Literature reviews and commentaries 
Articles written in English Articles not written in English 
Study participants were HIV-infected 
children (18 years of age and under) 
Study participants were HIV-infected 
adults (>18 years of age) 
 
Information sources and search  
A comprehensive search strategy was designed in collaboration with a librarian from 
Stellenbosch University Library (Cape Town, South Africa). The databases searched included 
EBSCOhost research, Pubmed, Web of Science and Scopus. Within the EBSCOhost research 
database the following databases were accessed: Academic Search Premier, Africa Wide 
Information, CINAHL, Health Source: Nursing/Academic edition & MEDLINE. 
These databases were searched using a combination of keywords including HIV, auditory 
processing, hearing and child. The keywords or MeSH (Medical Subject Headings) terms 





AIDS in the literature, preliminary testing of the search strategy identified that the inclusion 
in the search of the term ‘AIDS’ identified many irrelevant articles (e.g. where aids referred 
to assistive devices). This term was then removed from the search on the understanding that 
its absence in connection with HIV would not diminish the search parameters.  
Study selection 
 Studies identified by the search were first screened for duplicates, then for relevance. A 
three-step process was followed: the title was first checked for articles that were clearly not 
relevant for the purposes of the review (e.g. Management of therapeutic hypothermia for 
neonatal hypoxic ischaemic encephalopathy in a tertiary centre in South Africa was 
excluded, as it was not relevant to the focus of the review). Of the retained articles after this 
step, the abstracts were then read and further exclusions were made in line with the exclusion 
criteria (e.g. Auditory Impairment in HIV-infected individuals in Tanzania was excluded as it 
related to the adult population and did not report on a specific auditory processing skill). 
Articles were then read in full text, and retained if they focused on measurements of auditory 
processing skills in children who were HIV positive (Fig 1). Reference lists of the retained 
articles were then searched for additional studies that may not have been identified by the 
primary search. As a final step, an international expert on auditory processing was consulted 
on whether the auditory skills identified from each article, were correctly identified.   
Data collection process  
A data extraction sheet (Table 2) was developed and used to extract data from included 
articles. The data collection sheet included: author, year, study design, level of evidence, 
study setting, description of the sample, assessment measures used in each study, auditory 
processing skill as described by the ASHA [19] and key findings. All stages of the review 





compared, and any discrepancies were discussed and resolved by EO and HE. A third author 
(GD), who also collated the results, was consulted when a discrepancy could not be resolved. 
Hierarchy of evidence  
Study design was classified according to the Joanna Briggs Institute (JBI) levels of evidence 
[30].  
Assessment of risk of bias  
Methodological quality of included studies was not evaluated due to the scoping nature of the 
review [29].  
Synthesis of results 
Data was summarized for currency, country of origin, method of assessing auditory 
processing skills and key outcome measures using tables, figures, numerical analysis and 
narrative synthesis, as recommended by Arksey and O’Malley [26]. 
Additional analyses 
By examining the scope of research described in each article, this enabled the authors to 
identify gaps in literature and areas for further research. 
Results 
Study Selection 
Fig 1 outlines the study selection process. A total of 678 articles were found in the selected 
databases. After titles were screened for relevance and duplicates were removed, 108 articles 
remained. Abstracts of these articles were then screened, according to the inclusion and 
exclusion criteria (Table 1) and resulted in 42 articles being included for full text review. 





exclusion criteria (Table 1). The remaining five articles [5,23,24,31,32] were retained for this 
review. Table 2 summarises key characteristics of each article. No additional articles were 
found during the search of relevant reference lists. 
 








The studies were all cross-sectional designs, whose subjects ranged in age from 1 month to 
16 years.  Although the study sample sizes ranged from 15 to 244 children, auditory 
processing skills were not measured in all the subjects. Three of the studies included control 
groups [23,24,32], while two studies reported case series [5,31]. The studies were all 
conducted in urban settings, in developing countries, with three of the studies based in Brazil 
(South America) and the other two studies based respectively in Tanzania (Africa) and 
Mexico (North America). Table 2 provides a summary of the included studies, and Table 3 






Table 2: Key characteristics of included articles as these relate to Auditory Processing Skills  











Auditory processing skill 






















aged 1 month 
to 30 months 
(HIV+ = 18, 
HEP = 34, 
HEU = 91) 
BOA (size of 
response, timing of 








Central auditory impairment 
observed more often in HIV+ group 
than in two control groups. In HIV+ 
group, findings suggestive of 
central auditory disorder observed 
more frequently than findings 






and acquisition of 
the ability to 
localize sound in 













aged 1 month 
to 30 months 
(HIV+ = 18, 
HEP = 34, 
HEU = 91) 
BOA (size of 
response, timing of 








Significant difference between 
HIV+ group and two control groups 
with regards to acquisition of ability 




























children aged 5 







Auditory discrimination Abnormalities in speech 
discrimination observed in 4 
children: 2 suggesting conductive 
involvement, 1 cochlear 
involvement and 1 central 


























than 18 years 
(HIV+ = 131, 
HIV- = 113) 
Gap detection (HIV+ 
= 48,     HIV- = 19)                  
sample size as 
reflected in Results 
section and not in 
Abstract 
Auditory temporal 
processing and patterning 
No significant difference in gap 
detection thresholds and ABR 
latencies between the HIV infected 
and control children. ABR latencies 
for HIV- group reflected in text 
0.1msec longer than latency 




























SSW, SAPT (sound 
localization in 5 
directions, memory 




(dichotic speech), binaural 
interaction (localisation) 
Auditory changes, related to 
auditory processing, observed. 
Difficulties observed related to 
deficits in attention, memory and 
auditory figure ground skills. 8-year 
olds performed poorer than 9-year 
olds suggesting a maturational 
effect. 
*Total number of children who underwent audiological assessment, not necessarily auditory processing assessment; HIV+ = children 
infected with HIV; HIV- = children who are HIV negative; HEU = children who have been exposed to the virus but are uninfected; HEP = 
children who have been exposed to the virus and are positive but their status has not been confirmed due to their age. 






Table 3: Reference population and sampling approach   
Study Nationality Reference 
population 
Source HIV diagnosis Age 
Palacios et 
al 2008 













HIV children (I), 
serum-reverted (SR) 






Brazil Children with 
HIV 
Not stated All infected 8 or 9 years 
Matas et 
al 2008 





HIV children (I), 
serum-reverted (SR) 




Maro et al 
2016 
Tanzania HIVP children < 




Disease Center  
HIV+ children and 
HIVN family members  
0.8 yrs-to 18 
yrs 
 
Synthesis of the results  
Sampling issues  
The five papers reported on four datasets, with Matas et al (2000, 2008) reporting on different 
aspects of the same sample. The study samples differed in selection criteria, age and health 
status.  Although four papers reported on the sampling location, information on how children 
were selected for study participation was notably absent in all studies.  Overall, the included 
papers report on 185 HIVP children (cases), of a total of 425 children.  All cases were on 
ART.  Within the 240 non-HIVP (control) children were 78 serum-reverted children and 30 
HIV exposed children, who were treated separately in subgroup analysis (Matas et al 2000, 
2008).  Maro et al (2016) recruited 113 HIVN (control) children who were family members 






conditions, Maro et al (2016) included 31 HIVP and 3 HIVN children with TB histories.   
The overall sample age ranged from one month to 18 years, however it was not possible from 
the available information to estimate an average sample age.  On the available data, it might 
be presumed that the majority of children were younger than 10 years.  Palacios et al (2008) 
reported on 23 Mexican cases (average age 4.5 years); Matas et al (2000, 2008) reported on a 
dataset of 143 children born to HIVP mothers (all children being younger than 2.5 years); 
Maro et al (2016) reported on 244 children (cases and controls) of average age 10.1 years, 
and Romero et al (2017) reported on 15 cases aged 8 or 9 years.   Sample heterogeneity 
potentially underpins the lack of consistency in the findings of this review.   
Auditory processing testing procedures  
The studies described different test procedures, namely Behavioural Observation Audiometry 
(size of response, timing of response, attention to sound, lateralization, localization in vertical 
plane, cochlea-palpebral reflex) (Matas et al 2000, 2008); speech discrimination (Palacios et 
al 2017); gap detection thresholds (Maro et al 2016); and Staggered Spondaic Words, 
Simplified Auditory Processing Test (sound localization in 5 directions, memory for verbal 
sounds, memory for nonverbal sounds) (Romero et al 2017).   
Auditory processing skills  
Moreover, the test procedures described in the studies assessed different auditory processing 
skills,  Four clusters of skills, described below, were identified during data extraction: (1) 
binaural interaction (Matas et al 2000, 2008, Romaro 2017); (2) auditory discrimination 
(Palacios et al 2017); (3) auditory temporal processing (Maro et al 2016) and (4) binaural 






• Binaural interaction: Localisation, as a measure of binaural interaction, was 
assessed in three studies [24,31,32]. A higher occurrence of abnormal findings in the 
HIV-infected group, compared to the two uninfected groups, was reported by Matas et 
al [24,32] while Romero et al [31] reported that localisation difficulties occurred in 
less than 30% of their participants. 
• Auditory discrimination: The only study that assessed auditory discrimination skills 
[5], reported that abnormal findings were observed in four children in a sample of 
nine. The origin of the deficits was attributed to conductive involvement (n = 2), 
cochlear involvement (n = 1) and central involvement (n = 1). 
• Auditory temporal processing: Maro et al [23] reported on gap detection thresholds 
as the outcome measure for auditory temporal processing. The authors reported that 
the mean and median gap detection thresholds, between children infected with HIV (n 
= 48) and uninfected children (n = 19) were not significantly different. 
• Binaural integration: One study assessed binaural integration by using the Staggered 
Spondiac Word Test (SSW) [31]. Although 87% (13 of the 15 participants) of 
children presented with difficulties, these difficulties were attributed to problems in 
the areas of attention, memory and auditory figure-ground skills rather than only 
problems with binaural integration.  
Discussion 
This is the first scoping review that we know of, that describes the volume and nature of 
research relating to auditory processing skills in HIV-infected children. We believe that our 
scoping review search strategy was sufficiently comprehensive that we identified all available 






independent researchers undertake the screening and extraction steps. Moreover, the scoping 
nature of the review enabled the identification of all available literature in this area without 
the restraints of seeking specific research designs or methodological quality. It thus provided 
a comprehensive overview of the literature currently available on the topic.  
From the limited available literature, there is consistent evidence of deficits in the auditory 
processing skills that were assessed in HIV-infected children [5,23,24,31,32]. The review 
highlights that the published research is limited in numbers of studies (five), study designs 
(cross-sectional), geographical settings (urban, developing countries).  
A possible reason for the limited research on auditory processing in the HIV-infected 
paediatric population, is the lack of consensus between researchers on definitions and/or 
descriptions of auditory processing [33]. Various definitions have been postulated with the 
definition by the American Speech-Language-Hearing Association [19]  being the most 
widely cited. According to this definition, (Central) Auditory Processing is “the perceptual 
processing of auditory information in the CNS and the neurobiologic activity that underlies 
that processing and gives rise to electrophysiologic auditory potentials”. More recently, the 
British  Society of Audiology [34]  has described auditory perception as being “the 
awareness of acoustic stimuli, forming the basis for subsequent action” and “results from 
both sensory activation (via the ear) and neural processing that integrates this ‘bottom up’ 
information with activity in other brain systems (e.g. vision, attention, memory)”.  
The literature identified in this review identified limitations in the scope of assessment 
measures for auditory processing skills. The use of assessment measures as a reflection of a 
specific skill, is complex. A gold standard for the assessment of auditory processing disorders 






approach be used and that an auditory processing deficit cannot be diagnosed on the basis of 
one test, measuring a single auditory processing skill [19,35–38]. The American Speech-
Language-Hearing Association [19] lists various categories of central auditory tests that may 
be considered for the assessment of central auditory processing including: auditory 
discrimination tests, auditory temporal processing, dichotic speech tests, monaural low-
redundancy speech test, binaural interaction tests, electroacoustic measures and 
electrophysiologic measures. Despite the variety of assessment measures available, four of 
the five studies included in the review, only reported on measures that were easily 
quantifiable and not language-dependant, such as auditory discrimination, localization and 
gap detection thresholds.  
Auditory temporal processing do not appear to be affected by HIV [23]. Maro et al. [23] did 
not report significant differences in gap detection thresholds between HIV-infected and 
uninfected children. Furthermore, similar performances were reported for HIV-infected 
children regardless of the type of ART being used or the time delay before initiation of 
treatment [23]. A possible reason for the lack of statistically significant results was the small 
sample size [39] as very few children could complete the task due to the complexity of the 
instructions. Despite similar results being reported for adults when HIV-infected and 
uninfected individuals were compared [40], within the group of HIV-infected adults, persons 
using antiretroviral therapy (ART) performed significantly poorer than persons not using 
medication [40]. Based on the findings of this adult study, a possible explanation for deficits 
in gap detection is the use of ART, rather than the virus itself. However, the two groups that 
were compared in the adult study also differed in term of mean age and history of 







Research suggests that HIV may affect auditory discrimination. The only study that used this 
skill as an outcome measure, reported that 44% of the sample presented with deficits [5]. 
However, this study was a case series with a small sample size (nine participants).  Although 
the authors differentiated between conductive, cochlear and central impairment; the inclusion 
of children with hearing loss may have increased the prevalence of abnormal findings as 
hearing loss has been associated with impaired speech perception abilities [43].  
Binaural interaction skills appear to be impaired in HIV-infected children. This can be seen in 
deficits in localizing abilities [24,31,32]. However, the extent to which these abilities are 
affected is not known as one of the studies was a case series [31] which provides limited 
information about causality and the pattern of the auditory processing deficits [39]. The other 
studies  were case-control studies [24,32] that did not report on the statistical significance of 
the observed differences. A factor that may have contributed to the prevalence of impaired 
localizing skills is age, as two of the studies [24,32] assessed babies and infants (interrogating 
the same sample of children born to HIVP mothers). Muir et al. [44] reported that the 
development of localizing skills followed a u-shaped trajectory. According to this trajectory, 
a neonate’s response to sound decreases between the ages of one and three months with a 
greater, more accurate response being seen from four to five months of age [44].   
Binaural integration is reported to be abnormal in HIV-infected children. The findings 
reported by the one study that assessed performance on a dichotic speech test [31] are 
consistent with the findings reported for a study conducted in HIV-infected adults [45]. 
However, when considering the well-documented neurocognitive effects of HIV [46,47], it is 
difficult to comment on whether it is a pure  binaural integration deficit as this skill is so 






The biologic sequelae of HIV have been well-documented in children, and the studies 
included in this review provide insights into a few auditory processing skills that are affected 
in HIV-infected children. These studies use methodologies that answer questions related to 
the organic nature of HIV and provide information on the deficits that may be associated with 
HIV. However, when one considers the chronic nature of the virus, these methodologies may 
need to be supplemented with measures to answer questions related to functional outcomes of 
HIV. In order to provide appropriate educational services, identifying deficits that may affect 
learning is not enough, as understanding how these deficits affect the way the individual 
functions in their learning environment, is also needed. 
Limitations  
The review findings highlight the scarcity of research in this area. We were concerned that 
the inclusion of only English language studies may have introduced bias toward countries 
from Europe and North America, however, all the articles were from countries whose official 
languages were not English. The exclusion of conference abstracts and other grey literature 
may have also introduced publication bias; however, this literature may not have provided the 
detail that we required in order to describe research in the area.  
Conclusion 
This systematic scoping review identified only five studies on auditory processing skills in 
HIV-infected children and highlights the paucity of research in the area. This evidence-base 
is inconclusive regarding the association between HIV and auditory processing difficulties as 
the studies did not necessarily assess the same auditory processing skill and findings were, 
therefore not comparable. In order to better understand the impact of the virus on learning 






educational services offered to children infected with HIV, further research of all auditory 
processing skills is needed. Carefully designed case control studies looking at the time-
sequence and relationship between HIV, auditory processing and learning in children should 
be considered. As the organic consequences of HIV have frequently been demonstrated, it is 
imperative that future studies include functional outcomes so as to develop a more 
comprehensive picture of the auditory abilities of this population. Furthermore, research 
needs to address issues of sampling, sample size calculation and heterogeneity of the 
population, as well as exerting better controls for maturational aspects of auditory processing, 
by carefully considering the age of both participants and controls. 
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Reflections on Findings 
This systematic scoping review highlights the paucity of research into auditory 
processing capacities in CLHIV. The evidence-base is inconclusive regarding the association 
between HIV and auditory processing difficulties because the studies did not necessarily 
assess the same auditory processing capacity or use similar assessment measures. The 
findings of the various studies were, therefore, not comparable.  
The assessment of auditory processing capacities is a perplexing area with a range of 
available position statements, guidelines, and reports recommended for assessment and 
management of this disorder.  Despite these clinical documents, there is still no universally-
accepted test battery that is considered to be the gold standard for diagnosing auditory 
processing disorders (British Society of Audiology, 2018).  
The reviewed studies aimed to describe specific auditory processes in CLHIV and not 
diagnose an auditory processing disorder. A holistic picture of auditory processing in CLHIV 
could not be gained as the studies assessed a limited number of auditory processing 
capacities. The studies varied on how these capacities were measured and included: 
behavioural observation audiometry (BOA), speech discrimination test, gap detection test, 
sound localization test, and staggered spondee words.  
Although BOA is widely used to assess infants, results obtained by this method may 
not be accurate (Jerger & Hayes, 1976). Young children may fail to respond or may not 
respond consistently despite normal hearing (Jerger & Hayes, 1976). In addition, responses 
may be difficult to observe, and observer bias may affect interpretation of the results (Gans, 
1987).  
The included studies reported on children as young as one month. However, auditory 






Cowan, Riley, et al., 2011). Various position statements and guideline have indicated that 
behavioural tests of auditory processing capacities may not be valid or reliable for children 
younger than 7 years (American Academy of Audiology, 2010; British Society of Audiology, 
2018; Canadian Interorganizational Steering Group for Speech-Language Pathology and 
Audiology, 2012). Administering these tests to young children is, therefore, not 
recommended, as poor performance may be an indication of typical neurodevelopment, rather 
than the effect of HIV.  
Further research of a range of auditory processing capacities is needed to understand 
the impact of the virus on learning, and to justify the inclusion of auditory processing 
assessments in the basic health and educational services offered to CLHIV. Carefully 
designed case-control studies investigating the time-sequence and relationship between HIV, 
auditory processing, and learning in children, should be considered. As the organic 
consequences of HIV have frequently been demonstrated, future studies must include 
functional outcomes to develop a more comprehensive picture of the auditory processing 
capacities of this population.  
 Furthermore, research needs to address issues of sampling, sample size calculation, 
and heterogeneity of the population, as well as exert better controls for maturational aspects 











This chapter presents the aim and objectives of the study. Furthermore, it outlines the 
research design, participant selection procedures, ethical considerations, data collection 
procedures, and data analysis methods used to collect primary data to address the research 
aim and objectives. 
Study Aim 
The research aim of this study was to analyse auditory functioning (hearing and 
auditory processing capacities) and learning capacities (namely NVIQ, STM and WM) of 
pre-teen CLHIV and to compare these to CNLHIV of a similar age and social circumstances.  
Study Objectives 
The study objectives were to: 
1. Describe a profile of hearing in CLHIV and CNLHIV; 
2. Describe a profile of auditory processing in CLHIV and CNLHIV; 
3. Investigate the predictor variables associated with hearing loss in CLHIV; 
4. Test the association between auditory functioning (hearing and auditory processing 
capacities) and learning capacities (NVIQ, STM, WM) in CLHIV and CNLHIV. 
Study Design 
A descriptive cross-sectional research design was utilized for the primary research 
reported in this dissertation. Descriptive research entails gathering data to obtain a detailed 
representation of the person, situation, or social setting under investigation (Neuman, 2000). 
This study is situated within descriptive research, as it aims to describe hearing loss and 






Cross-sectional research was appropriate for this enquiry, which aimed to investigate 
differences between groups of children at a point in time (de Vos, Strydom, Fouche, & 
Delport, 2011; Neuman, 2000). In this case, the key focus was to describe overall auditory 
functioning (hearing and auditory processing) and learning capacities in CLHIV compared to 
CNLHIV. The advantage of using this design was that data could be collected over a short 
time while still supporting the analysis of different combinations of Exposures and Outcomes 
(Neuman, 2000).  
Participant Selection 
Setting 
One large tertiary metropolitan hospital in Cape Town provided access to CLHIV 
attending its Infectious Diseases Clinic (IDC). This hospital provided services for over 3.4 
million people in surrounding socioeconomically disadvantaged suburbs, most of whom 
relied on public health care. In South Africa, only 17% of citizens are estimated to have 
medical insurance, resulting in the majority attending public health facilities (Statistics South 
Africa, 2018a). Although a tertiary hospital is a public hospital to which more complicated 
cases are referred, in this instance, the participating hospital also provided an ART clinic 
(Infectious Diseases Clinic) to patients who were unwilling to be transferred to the local 
community-level health facilities.  
Sample and Sampling Method  
Sample. This study investigated school learners aged 9-12 years who had confirmed 
HIV-positive status (CLHIV) or had documented evidence of HIV-negative status 
(CNLHIV). The sample was not age- or gender-matched because of recruitment issues. 
Sampling: A nonprobability, purposive sampling approach was used to select the 






children’s HIV status was known) were recruited. Purposive sampling of places of 
recruitment was the most suitable sampling procedure for this study in this sociodemographic 
area as it allowed the primary researcher to efficiently identify the subjects required to 
address the aims and objectives of the study (Daniels, 2012). Comprehensive sampling was 
then undertaken at each site, by inviting all eligible CLHIV attending the hospital IDC, and 
all eligible CNLHIV attending the primary school, to enter the study.  This sampling 
procedure enabled the researcher to ensure that all potentially relevant participants were 
offered the opportunity to join the study (Table 1). 
Inclusion and Exclusion Criteria. Table 1 describes the eligibility criteria used for the 






















Age Aged 9-12 years This age group was selected to ensure that the participants 
were not too young to complete the auditory processing test 
battery. Literature indicates that auditory processing test 
batteries may not be appropriate for younger children, as 
auditory processing skills are acquired developmentally 
(Moore, Cowan, Riley, et al., 2011; Moore, Ferguson, 
Edmondson-Jones et al., 2010). The maximum age of 12 
years was selected as this age corresponds to the widely 
accepted definition of a school-aged child (i.e. 5-12 years) 
(Erikson, 1959 cited in McLeod, 2008). The inclusion of 
participants in this relatively small age range limited the 




Participants from any 
population group  
No limitations were prescribed for this criterion in order to 
obtain a representative sample. 
 
Gender Male and female No limitations were prescribed for this criterion in order to 




Proficient in Afrikaans, 
English, or isiXhosa. 
The inclusion of these three official provincial languages 
(Western Cape Government: Department of Cultural Affairs 
and Sport, 2019) allowed for a more representative sample 
and reduced the risk of discriminating based on language. 
 
HIV status CLHIV were included if they 
had been diagnosed as HIV 
positive. 
CNLHIV were included 
based on reported negative 
status. 
 
The aim of the study was comparisons of CLHIV and 
CNLHIV 
Schooling Participants were required to 
be enrolled in primary 
school, at least in Grade 3, at 
the commencement of the 
study. 
The study aims to investigate “learning”. Primary school 
children typically have one educator who is responsible for 
teaching the bulk of the curriculum. As one of the data 
collection procedures involves the completion of a 
questionnaire by the educator, this measure was included to 
facilitate the data collection procedure as only this one 
educator would be included in the study. 
 
Comorbidity Participants who presented 
with diagnosed comorbid 
medical conditions affecting 
cognitive abilities were 
excluded. 
The study aimed to investigate the capacity for learning, as 
observed by NVIQ, STM, and WM. The exclusion of these 
conditions facilitated interpretation of the findings, as 






Males and females were included if they had: (1) documented HIV-positive status or 
reported HIV-negative status; (2) were aged between 9 – 12 years; (3) had verbal proficiency 
in at least one of English, Afrikaans or isiXhosa (African) language; (4) were enrolled in at 
least Grade 3 in a mainstream primary school and (5) could understand and complete an 
assent form. Exclusion criteria were: (1) HIV status not documented/reported; (2) comorbid 
conditions causing cognitive impairment (e.g., neurological conditions) that could affect the 
understanding of, and performance in, the assessment batteries; (3) cognitive impairment 
(e.g. intellectual disability) that could affect understanding of and performance on the 
assessment test batteries; or (4) on a waiting list for, or enrolled in, a school for learners with 
special education needs. 
Recruiting CLHIV. The IDC at the participating tertiary hospital had records of 836 
patients on ART at the end of February 2017. This included 412 children (aged 0 to 18 
years), of which 110 fitted the age criteria for the study. Attempts were made to recruit all 
110 children on the register attending the IDC for their medical follow-up appointments, 
between June 2017 and November 2018. The recruitment process involved the primary 
investigator regularly attending the IDC and physically identifying and recruiting age-eligible 
children on each clinic day. The IDC operated from Monday to Wednesday (8h00–13h00), 
with the majority of paediatric appointments available on Tuesdays. Each morning, the 
medical records (folders) of all children with appointments for the day were accessed by the 
primary investigator at the IDC, and she identified all potential candidates based on their date 
of birth. Caregivers accompanying children to their appointments were approached and 
informed of the study. Caregivers who were interested in the study, were asked questions 
related to the eligibility criteria (e.g. Which school does your child attend?) (Table 1). If all 






in the study. A small reimbursement for travelling costs was offered to each family to assist 
them to return for the study appointment.  
Recruiting CNLHIV. Participants were recruited from one local primary school in the 
same area as the participating hospital. Information pamphlets (addressed to the caregivers) 
were distributed to 162 children aged 9-12 years in the school, together with informed 
consent forms and the primary investigator’s contact telephone number. The school was 
classified as a Full-service school, which is defined in the Education White Paper 6 as 
“schools and colleges that will be equipped and supported to provide the full range of 
learning needs among all learners” (Department of Education: ELSEN Directorate, 2001, p. 
22). The children’s HIV status was thus known to school management. The school principal 
assisted the primary investigator in distributing research information only to children who 
were known not to be HIV positive.   
Sample Size Calculation. Sample size calculation was undertaken using EpiInfo 
Version 7.2.2.6 (Dean et al., 2011). Based on an estimated prevalence of hearing loss in 
CLHIV (33%), estimated prevalence of hearing loss in CNLHIV in low socio-economic 
conditions (15%), 80% power, and 95% Confidence, 174 children were required in total. The 
estimated prevalence of hearing loss reflected the prevalence most often reported in the 
systematic review of 21 studies, which included 11 paediatric studies, conducted by Ensink & 
Kuper (2017).  
Sample. Two hundred and seventy-two children were identified as potential study 
participants. 
CLHIV. One hundred and ten potential participants were identified at the IDC. All 
were individually invited to participate, in person, by the primary investigator, by speaking to 






participate, 12 children agreed to participate but did not meet the inclusion criteria and 22 
children whose caregivers agreed for them to participate, did not attend their study 
appointment (even after reminders were sent or appointments were rescheduled). This left 23 
eligible CLHIV whose caregivers consented for them to participate and who did so.   
CNLHIV. Thirty-seven consent forms were returned out of the 162 information 
pamphlets and consent forms distributed at the participating school (to preteen children 
known to be HIV negative). Out of these, three parents declined their child’s participation. 
On scrutinising the potential participants’ information, it also became clear that two CNLHIV 
had been exposed to HIV, although they were not HIV positive (5.4% of the sample). Their 
data were excluded from analysis as the numbers were too small for separate subgroup 
consideration. However, these children were tested to ensure equity in access to health 
assessments. This left 32 eligible CNLHIV whose caregivers consented to their participation. 
Thus, the study dataset consisted of 55 participants (23 CLHIV (42.8%) and 32 


































Figure 3. Flow Diagram Depicting Study Inclusion and Exclusion 
Demographics 
Age. The average age of the overall sample was 11.2 years (SD 0.9). The small 
standard deviation reflected the study inclusion criteria of 9-12-year olds. There was no 
significant age difference between CLHIV (mean age 11.4 years (SD 0.8)) and CNLHIV 




CNLHIV (n=32) Allocation 
Analysis 
Enrolment 
Assessed for eligibility (CLHIV n=110)                   
(CNLHIV n=162) 
Excluded  
CLHIV n=87  
• Declined to participate (n=52) 
• Not meeting inclusion criteria (n=13) 
• Did not attend study appointment 
(n=22)  
CNLHIV n=130 
• Did not return consent form (n=127) 
• Declined permission (n=3)  
HEU n=2 






Gender. Of the 55 participants, 30 were males (54.5%) and the remaining 25 (45.5%) 
were female. There were no significant differences in gender proportions in the overall 
sample, or between CLHIV and CNLHIV (p>0.05). Sixteen of the 30 males (53.3%) and 16 
of the 25 females (64.0%) were CNLHIV.  
Population group. Population groups were identified from hospital or school records 
or by their parents on the case history forms, as Coloured (which predominated (79.8%)), 
with smaller percentages of children identified as Black (19.1%) or White (1.1%).  
Language. For this study, participants were described by the languages they spoke at 
home and school, rather than by population group, which is a contentious issue in South 
Africa (Khalfani & Zuberi, 2001).  
English was the primary home language of 28.9% of participants, while Afrikaans 
was the primary home language of 46.7% of participants. The remainder (24.4%) spoke an 
African Indigenous language. The language distribution for the sample followed a similar 
trend to the provincial language distribution reported for the Western Cape in the South 
African Census 2011 (Statistics South Africa, 2011), where 20.2% of the provincial 
population spoke English, 49.7% of the population spoke Afrikaans, and approximately 
27.5% of the population spoke an African Indigenous language. By considering the primary 
language spoken at school, 44.4% spoke English, 46.7% spoke Afrikaans, and 8.9% spoke 
isiXhosa (an African Indigenous language). Most participants spoke the same language at 
home and school (87.5%). However, approximately 1 in 6 participants spoke a different 
language at home and at school. The majority (81.2%) of these spoke an African Indigenous 
language at home.  
English as a primary language was spoken both at home and school by 31.7% of the 






sample; and IsiXhosa (an African Indigenous language) was spoken as primary language both 
at home and school by 7.9% of the participants. No English-speaking participants reported a 
difference between home and school language. Home-school language difference was 
reported by one of the 21 participants whose home language was Afrikaans (4.8%), and seven 
of the 11 participants who spoke an African Indigenous language (63.6%). 
Antiretroviral Therapy (ART). All CLHIV had been treated with ART at some stage 
in their lives, although not all had been treated since birth, or since diagnosis (whichever 
came first). Six participants (28.6%) had a history of defaulting on ART, which potentially 
reduced their capacity to avoid opportunistic infections. Out of the 22 CLHIV for whom 
information on ART was available from hospital records, the mean percentage of lifetime 
exposure to ART was 78.5% (SD 20.7%) (range 23-6% - 100%), with N=10 (43.5%) 
participants having a lifetime exposure of less than 75%. All participants were on HAART 
which meant that they were using a combination of ARVs. Twenty-two of the participants 
(95.6%) were taking Lamivudine (3TC); 21 (91.3%) were taking Abacavir (ABC); 16 were 
taking Aluvia (69.5%); 7 (30.4%) were taking Efavirenz (EFV); and one each were taking 
Tenofovir Disoproxil Fumarate (TDF) and Zidovudine (AZT).  
Ethical Considerations  
Ethical approval (S15/10/220) was obtained from the Health Research Ethics 
Committee, Stellenbosch University (Appendix E). 
Permission was also obtained from:  
• Western Cape Department of Health (WC_2016RP50_968) (Appendix F) 
• Western Cape Department of Education (Appendix G)  
• Relevant tertiary hospital (Appendix H) 






The study followed the research ethics guidelines as required by the HREC 
(Stellenbosch University) and in the document “Ethics in Health Research: Principles, 
Processes, and Structures” (Department of Health, 2015).  
Informed Consent: Informed consent was obtained before inclusion in the study. For 
CLHIV, the relevant information was explained to the caregiver of the participant in the 
language of their choice. As the primary investigator was only proficient in English and 
Afrikaans, a translator was available for all participants who spoke an African Indigenous 
language. However, none of the caregivers made use of the translator as they all reported that 
they were proficient in English. The caregivers were provided with copies of the relevant 
documentation after the consent form was signed (Appendix I). For CNLHIV, a contact 
number was provided for the caregivers to contact the primary investigator if they were 
uncertain about any of the information provided in the information document (Appendix J). 
This measure was also taken for the teachers. The explanation of the study sent to teachers, 
excluded the term HIV to prevent unintentional disclosure of the participant’s status. 
Although the letters to the teachers were sent via caregivers, the caregiver could decide if 
they were willing to allow teacher participation. 
Assent was obtained from all participants. The explanation of the study excluded the 
term HIV to prevent accidental disclosure of the participant’s status.  
All participants were provided with the opportunity to ask for clarification if they did 
not understand the information provided (Appendix K).  
Autonomy: Participants were informed that participation was voluntary, that they 
could refuse to participate, and that refusal to participate would not negatively affect them. 







Confidentiality: Participants were informed that all information obtained during the 
study would be managed confidentially. Participant numbers were used, thus protecting the 
identities of the participants. All the information was stored relative to the participant 
number, and any identifying information was excluded from the dataset. This measure was 
taken to ensure that the identifying information of the individual participants could not be 
matched with their HIV status. Although anonymity was strived for by redacting all 
identifying information of both the participants and research sites, and excluding identifying 
information in all articles published and during all presentations of the research findings (e.g., 
scientific conferences), it is acknowledged that the primary investigator was aware of the 
identity of the participants. 
All documentation was stored in a secure place, and all electronic files were password 
protected. Access to these documents was strictly limited to the primary investigator. 
HIV status was not mentioned on information pamphlets and consent forms for 
teachers, as well as on participant assent forms to prevent unplanned disclosure. 
Distributive justice: The primary investigator did not foresee any risks of physical 
harm to any of the participants, or anyone in the research team, and none occurred.  
Participants benefitted from participating in the research as all those who were 
identified as having a hearing disorder were referred for appropriate management (medical or 
audiological intervention). Although the direct benefit to the individual participant was 
minimal (knowing their hearing status and being referred for appropriate intervention), the 
population of CLHIV will benefit from the information generated by this research. This 







The assessment procedures included assessments of auditory functioning, NVIQ, 
STM, and WM. The study pathways for the participants are depicted in Figure 4 (CLHIV) 
and 5 (CNLHIV). 
 



















The selection of assessment procedures for auditory functioning was informed by the 
literature review findings. Auditory functioning was defined as consisting of hearing and 
auditory processing. Hearing (loss) was primarily assessed by using pure tone audiometry 
and immittance measures. Auditory processing capacities were assessed using subtests of the 
SCAN 3C (Keith, 2009a) and the TAPS 3 (Martin & Brownell, 2005). These subtests 
reflected the discrete auditory processing capacities that are listed in the Technical Report by 
the American Speech-Language-Hearing Association (2005a). 
Three audiologists (GD, HE, EN), who received training in the study procedures 
before the commencement of the study, conducted all tests.  
Audiologic Test Battery. The audiologic test battery was conducted on all 
participants, irrespective of HIV status. All testing was conducted after informed consent 
from caregivers, and assent from participants had been obtained (Appendices I - K). 
Audiologic data was collected using a test battery approach. Within the field of Audiology, 
this approach is considered as standard practice as it allows for the inclusion of various test 
procedures to gain detailed information regarding an individual’s hearing (Cole & Flexer, 
2011). Cole and Flexer (2011) further assert that using this approach is advantageous for the 
following reasons: (1) conclusions about auditory capabilities are not based solely on one 
test; (2) pathologies can be identified at each of the levels of the auditory system; and, (3) 
auditory behaviour and functioning can be observed. One of the disadvantages of including 
many tests within a test battery is that the person being tested may become fatigued during 
testing, which would affect the reliability and validity of the findings. In order to minimise 






The test battery consisted of a case history questionnaire, otoscopy, pure tone 
audiometry (PTA), and immittance audiometry. Additional tests that were included for 
CLHIV were: speech audiometry, otoacoustic emissions (OAEs), and auditory brainstem 
response testing (ABR). These tests were not included for CNLHIV as the equipment was not 
available at school. 
Case History Interview / Questionnaire. The case history is considered to be the 
initial step in the audiology test battery. Case history for a child typically provides essential 
information regarding the nature of the auditory complaint, possible contributing factors, 
developmental progress, communication abilities, and academic achievement (Stach, 2010). 
The case history interview was conducted within the scope of the study to obtain the relevant 
health and medical information from the primary caregiver, as well as information on the 
participant’s academic progress and auditory functioning. The information obtained was used 
to identify potential clinical (such as opportunistic disease) and social risk (such as socio-
economic status) factors that would be used during the data analysis phase of the study.   
CLHIV. Caregivers were required to complete a written case history questionnaire 
(Appendix L) while the participants were seen for the basic audiologic test battery. If the 
caregiver preferred, the complete set of questions was administered verbally in their chosen 
language (i.e., English, Afrikaans, or isiXhosa). The interview format allowed the primary 
investigator to probe for answers where necessary, and to clarify any questions that were not 
understood (Babbie, 2010), although this was only done where the caregiver was non-
responsive. The option of verbal administration of the questionnaire ensured that caregivers 
were not excluded based on literacy levels. The wording of the questions, as it appeared on 






preferred, they could complete the questionnaire at home and return it at the participant’s 
medical follow-up.  
CNLHIV. The case history questionnaires were sent home with participants as the 
caregivers were not present during testing. Caregivers were requested to complete the 
questionnaire and return it to school in a sealed envelope where the primary investigator 
collected it. Although the primary researcher provided her contact details to the caregivers for 
any queries or questions, it was assumed that caregivers who were not literate would have 
access to a literate family member or neighbour. 
Otoscopic Examination. The otoscopic examination was conducted to investigate the 
condition of the outer ear and tympanic membrane (Stach, 2010). This part of the assessment 
was included in the test battery as abnormalities of the outer ear, and the tympanic membrane 
have been reported in CLHIV (Hrapcak et al., 2016; Ianacone et al., 2017; Smith et al., 
2017). 
After the procedure was explained to the participant, one of the three audiologists 
(GD, HE, and EN) who were available at the time, performed the otoscopic examination. A 
form (Appendix M) was used as a reference to ensure consistency. All relevant structures 
were examined using a Welch Allyn pocket otoscope. Any abnormalities such as 
inflammation, growths, foreign objects, excessive wax, or perforations of the tympanic 
membrane were recorded on the audiogram. If any abnormality was noted, CLHIV were 
referred to their treating doctor for medical management, while CNLHIV were referred to 
their closest clinic or private general practitioner via a referral letter.  
Pure Tone Audiometry. PTA was conducted to determine the behavioural hearing 






component of the test battery was included as research reports that hearing loss is associated 
with HIV (Ensink & Kuper, 2017).  
CLHIV: After the audiologist (HE) explained the procedure, pure tone audiometry 
was performed in a soundproof audiometric booth, using a GSI 61 audiometer (calibrated as 
per legislated standards, SANS 10154-2:2012). Circum-aural earphones (TDH-39P) were 
used, and air conduction thresholds were obtained at 250Hz, 500 Hz, 1000 Hz, 2000Hz, 
4000Hz, 8000 Hz as per the Guidelines for Manual Pure Tone Threshold Audiometry 
(American Speech-Language-Hearing Association, 2005b), for the left and right ears 
separately. All thresholds were plotted on the participant’s audiogram. A participant, who 
was tested in the audiometric booth, was considered to have a hearing loss if a pure tone 
average (PTA) of >15dbHL was obtained (Northern & Downs, 2002). Bone conduction 
threshold testing, using a B71 bone vibrator, was only conducted at frequencies where the air 
conduction threshold was >10dBHL (Stach, 2010). The bone conduction thresholds were 
obtained in order to describe the type of hearing loss, i.e. conductive, sensorineural, or mixed 
hearing loss. The bone vibrator was placed on the mastoid-bone prominence for all 
participants. The advantages of mastoid placement include slightly improved thresholds, less 
need for masking and less complicated masking processes (Stach, 2010). Any participant 
presenting with a sensorineural hearing loss was referred to the Audiology Department at the 
tertiary hospital for diagnostic testing and further management. Any participant presenting 
with a conductive or mixed hearing loss was referred to their treating doctor at the IDC, for 
medical management.   
CNLHIV: After the audiologist (EN) explained the procedure, pure tone audiometry 
was performed in a quiet venue, as provided by the school, and testing was completed using 






10154-2:2012). Circum-aural earphones (Amplivox Audiocups) were used, and air 
conduction thresholds were obtained at 250Hz, 500 Hz, 1000 Hz, 2000Hz, 4000Hz, 8000 Hz 
as per conventional audiometry (Stach, 2010), for the left and right ears separately. All 
thresholds were plotted on an audiogram. A participant, who was tested in a quite 
environment, was considered to have a hearing loss if a pure tone average (PTA) of >25dbHL 
was obtained (Northern & Downs, 2002). Bone conduction was not conducted.  
Tympanometry. Tympanometry was conducted to assess the transmission of sound 
through the middle ear (Stach, 2010). This component of the test battery was included, as 
research has reported an increase in abnormal middle ear function in persons with HIV 
(Ianacone et al., 2017). 
After the audiologist explained the procedure, tympanograms were obtained using a 
GSI Tympstar (CLHIV) (HE) and Interacoustics MT10 (CNLHIV) (EN) with a 226 Hz probe 
tone. Both machines adhered to legislated calibration standards (SANS 10154-2:2012). The 
results were recorded on the participant’s audiogram, and the following parameters were used 
to indicate normal middle-ear function: Type A tympanogram with a middle ear pressure of -
100 to 100 daPa; acoustic compliance of 0.3 to 1.7 ml; and ear canal volume of 0.4 – 1.5 ml 
(Stach, 2010). Participants presenting with abnormal tympanograms were referred to the 
treating doctor (IDC) or their closest clinic for medical management. 
Acoustic Reflex Threshold Testing. Acoustic reflex threshold testing was only 
available for the CLHIV as the equipment was not available at the school. This test was 
conducted because it provides useful information regarding the possible site of the lesion, i.e., 
whether the hearing loss is due to a cochlear or retro-cochlear pathology (Northern & Downs, 






cochlear (Khoza-Shangase, 2010), and acoustic reflex thresholds are a sensitive indicator of 
cochlear pathology (Northern & Downs, 2002). 
After the audiologist (HE) explained the procedure, the acoustic reflex thresholds 
were obtained for each ear at 500 Hz, 1000 Hz, and 2000 Hz and recorded on the audiogram, 
using the GSI Tympstar (calibrated as per legislated standard, SANS 10154-2:2012).  For this 
study, 4000Hz was not included as responses at this frequency are often absent in normal-
hearing persons, and the absence of a response is thus not informative (Northern & Downs, 
2002).  
Otoacoustic Emission measurements (OAE). Distortion Product Otoacoustic 
Emission (DPOAE) screening measures were only obtained for CLHIV as the equipment was 
not available at the school. DPOAE provides information regarding the functioning of the 
cochlear, specifically the outer hair cells (Stach, 2010). This component of the test battery 
was included as OAEs are considered useful in ototoxicity monitoring (Khoza-Shangase, 
2010). After the audiologist (HE) explained the procedure to the participant, the DPOAE 
measurements were obtained in both ears (at 2000Hz, 3000Hz, and 4000Hz) using the GSI 70 
(calibrated as per legislated standard, SANS 10154-2:2012). The measurements were 
automated, using the GSI default 4 protocol (Grason-Stadler, 2009). Test results were scored 
as “PASS”, “REFER” or “NOISE” (Appendix N). The results were recorded on the 
audiogram. Participants presenting with abnormal findings were referred to the Audiology 
Department for diagnostic testing and further management.  
Speech Recognition Thresholds (SRT). SRTs were included to assess the reliability 
of the pure tone thresholds (Stach, 2010). The speech recognition threshold (SRT) was 
determined for CLHIV only, as their testing set-up allowed for Speech Audiometry to be 






using live voice on the GSI 61 audiometer (calibrated as per legislated standards, SANS 
10154-2:2012) and recorded on the audiogram. SRT testing required that bisyllabic words 
were presented to the participants. The SRT is thus the lowest intensity level, at which 50% 
of these words are identified (Stach, 2010). For this study, paired digits (e.g.one-ten) were 
used instead of bisyllabic words when the participants were not familiar with the vocabulary 
on the South African Spondee word list (Hanekom, Soer & Pottas, 2015). The digits were 
presented to the participants speaking an African Indigenous language, in English, as they 
were familiar with numbers spoken in English. The SRT and PTA had to be within 10dB of 
each other for the pure tone thresholds to be considered reliable. 
Auditory brainstem response testing (ABR). Auditory brainstem responses are 
considered to reflect neural activity from cranial nerve VIII to the midbrain. ABR testing was 
only available for CLHIV, as the equipment was not available at the school. This test was 
included in the test battery as the evidence suggests that hearing loss associated with HIV 
may be neural in origin (Matas et al., 2000). After the audiologist (HE) explained the 
procedure to the participant, the ABR testing commenced. ABR data were obtained 
bilaterally using the GSI Audera. The participant was instructed to remain quiet and still. 
Surface electrodes were placed on both earlobes, and at high (vertex) and middle (ground) 
forehead positions. A click stimulus was presented at a rate of 11.1/sec at 75dBnHL, and both 
rarefaction and condensation tracings were recorded. Peak latencies for Wave I, III, and V 
were identified and compared to the clinical norms for the Audera system (Appendix O) (G. 
Kerr, personal communication, 29 April 2020). 
 The results were recorded on the audiogram. Any participant that presented with 







Auditory Processing Test Battery. In clinical practice, auditory processing test 
batteries are individualized for the client; thus, all categories of tests may not be included for 
each client (American Speech-Language-Hearing Association, 2005a). However, as the 
objective of the study was to describe the auditory processing capacities of CLHIV, rather 
than to make a diagnosis of auditory processing disorder, the investigative team endeavoured 
to include tests measuring each auditory processing capacity as listed by the American 
Speech-Language-Hearing Association (2005a).  
During 2016, a review of clinically relevant documents was undertaken to collate 
recommendations regarding the assessment of auditory processing disorders. These 
recommendations were used to inform the assessment measures used in the study. 
A data extraction sheet (Table 2) was developed to extract information in a standard 
manner from the included documents. The following data were recorded: (1) organisation, (2) 
auditory processing area to be assessed, and (3) additional assessment measures. The content 
of each document was analysed concerning assessment of auditory processing, and relevant 
information was recorded on the data extraction sheet. Although this review did not follow 
the methodology of a scoping review, the data was collated and summarized systematically 
using tables, figures, numerical analysis, and narrative synthesis, as recommended by 
(Arksey & O’Malley, 2005) for systematic literature scoping reviews. 
At the time of the review, Heine and O’ Halloran (2015) had recently evaluated 
clinical practice guidelines. It was, therefore, decided to review the documents included in 
their evaluation individually. The database search, which is typically one of the initial steps in 
a review (Arksey & O’Malley, 2005; Levac et al., 2010), was therefore not undertaken as 
these authors had already completed a comprehensive search of the literature. Thus, the 






• ASHA Technical Report: (Central) Auditory Processing Disorders (American 
Speech-Language-Hearing Association, 2005a),  
• American Academy of Audiology Clinical Practice Guidelines: Diagnosis, Treatment, 
and Management of Children and Adults with Central Auditory Processing Disorder 
(American Academy of Audiology, 2010),  
• Practice Guidance: An overview of current management of auditory processing 
disorder (APD) (British Society of Audiology, 2011b) and  
• Canadian guidelines on auditory processing disorder in children and adults: 
Assessment and intervention (Canadian Interorganizational Steering Group for 
Speech-Language Pathology and Audiology, 2012).  
Although Heine and O’Halloran (2015) evaluated six documents, it was decided not to 
include: 
• Position Statement: Auditory processing disorder (British Society of Audiology, 
2011a) as it did not describe the specific areas to assess; and  
• Colorado Department of Education Auditory Processing Disorders: A team approach 
to screening, assessment & intervention practices (Colorado Department of 
Education, 2008) as it is based on the ASHA Technical Report (2005) that is included 
in this review.  
The five documents consisted of one technical report, three practice guidelines, and one 
position statement. These documents were from three countries, namely the United States of 
America, Britain, and Canada. As can be seen in Table 2, all the documents listed similar 
auditory processing areas for assessment. The British Society of Audiology (2011b) referred 
to the assessment areas as listed by the American Speech-Language-Hearing Association 






Interorganizational Steering Group for Speech-Language Pathology and Audiology (2012) 
also listed memory as an area to be included. However, memory is considered as a domain 
that may or may not affect auditory processing as it is not necessarily an auditory process. All 
documents also recommended that cognitive skills be considered when deciding on the 
assessment, and when interpreting the results. The review of the clinical documents revealed 
similar recommendations and all the documents that were published after 2005, referred to 
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The clinical practice guidelines typically listed similar areas of assessment, namely 
auditory discrimination, auditory temporal processing, dichotic speech, low redundancy 
speech, binaural processing, and electrophysiology assessment when required. For this study, 
it was thus decided to include tests that assessed all the areas mentioned in the clinical 
documents. As South African tests were not available, the following subtests from 
commercially available tests were included in the auditory processing test battery:  
- Auditory discrimination: Word Discrimination (WD) subtest from TAPS 3 (Martin 
and Brownell, 2005); 
- Auditory temporal processing: Gap detection subtest (GP) from SCAN 3C (Keith, 
2009a); 
- Dichotic speech: Competing words-free recall (CWFR) from SCAN 3C (Keith, 
2009a); 
- Low redundancy speech/understand speech in background noise: Auditory 
Figure-Ground (+8 dB signal to noise ratio) (AFG) from SCAN 3C (Keith, 2009a); 
- Binaural processing: Laterality (binaural interaction) as measured by correct 
identification of ear that the stimulus was presented to during the AFG subtest from 
SCAN-3C (Keith, 2009a) 
Although cognisance was taken of the impact of language on test performance, the purpose of 
the study was not to diagnose an auditory processing disorder, but rather to compare CLHIV 
to CNLHIV, with similar language exposure. It was assumed that due to similar language 









Document Review and Survey. When this study was conceptualised, it was planned 
that additional information on the child’s academic performance would be provided through a 
review of academic documents (Academic report), and the use of a teacher questionnaire 
(The Screening Instrument for Targeting Educational Risk (SIFTER) (Anderson, 1989)). This 
could have been used to obtain information regarding five important areas for successful 
learning within an educational environment (academics, attention, communication, classroom 
participation, and school behaviour). The advantage of using the SIFTER would have been 
that the participants would be rated by a teacher who was familiar with both the curriculum 
and child, relative to the performance of their class peers, rather than norms. However, 
teachers were reluctant to engage with this study for a variety of reasons (for instance, lack of 
interest, lack of time, difficulty in actually providing information on the child because of 
classroom workload), and thus collating this information for cases or controls was not 
possible.  Furthermore, some parents were reluctant to give the questionnaire to the teacher 
for fear of inadvertently disclosing their child’s HIV status. 
Retrospective Medical File Review. The retrospective medical file review was 
undertaken to gather further medical information on documented clinical risk factors, 
including WHO status, CD4 count, ART medication being used, TB history, opportunistic 
disease, other medication administered and history of middle ear pathologies. Patient records 
were available for review on medical appointment dates. The primary researcher perused the 
records and recorded all relevant available information on the data capturing form (Appendix 
P). Where the physical record was not available, the electronic patient record was accessed 
via the electronic patient management system of the hospital. 
Categorical data were summarised by using graphs, cross-tabulations, frequency 






five-number summary), standard deviations, or 95% Confidence Intervals (CI) (Rumsey, 
2010).  
Data were reported descriptively using means (Standard Deviations) or percentages, 
as dictated by the form of the measurement. Odds ratios (95%CI) were applied to binary 
forms of continuous/ integer variables, and relevant categories of the categorical variables to 
consider associations. Significant associations were identified as those whose 95%CI did not 
encompass the value 1.  
Reliability and Validity 
Reliability reflects whether a measuring instrument or technique yields the same 
result each time it is applied (Babbie, 2010). The following section describes the measures 
taken to ensure that data collection was reliable. 
The audiologists on the research team were trained on the study protocol and 
procedures before the study commenced to ensure that the data were collected consistently 
and reliably. The audiologist who completed the assessment recorded a diagnosis on the 
audiogram, and the primary researcher cross-checked the diagnosis before entering the data 
into the database.  Furthermore, the medical record review was undertaken by the primary 
researcher to ensure that the data were collected and recorded consistently. The data were 
entered into a spreadsheet created in Microsoft Excel (Version 16.20.0), with data validation 
rules set for the cells. This reduced the likelihood of entering incorrect data. The primary 
researcher (GD) manually checked the accuracy of data entry into the spreadsheet as per the 
source document.  
All audiological equipment used was calibrated per legislated standards (SANS 
10154-2:2012) and a biologic check was done before testing commenced to ensure that the 






A standard set of questions was used for all the participants to ensure reliability 
during the case history interview.  However, some caregivers preferred to complete the case 
history questionnaire at home, which limited the opportunity to ask for clarity. 
Validity refers to the extent to which a measurement measures what it is intended to 
measure (Babbie, 2010). In this study, experimenter bias was minimised by having a standard 
set of questions for the case history and using a test battery approach for assessment of 
auditory functioning. The study testing procedures were routine clinically accepted 
procedures and followed the ASHA guidelines (2005b). Although the assessments for 
auditory processing capacities included subtests of validated assessment instruments, these 
tests were not validated on the South African population. However, there are currently no 
validated South African tests that target these processes. The aim of the study was to compare 
two groups of children from similar socio-economic backgrounds to each other, not to the 
norms. Thus, it was decided to include the test despite the lack of South African normative 
data. The inclusion of the NMF and NMR rather than the memory for word subtests 
eliminated the effect of language on memory. Triangulation of measures was intended as 
multiple data sources and data collection methods were incorporated into the study. However, 
the planned triangulation was not possible due to reduced return rates for questionnaires. 
Using more than one test allowed the investigator to compare the results to see whether they 
correlated with each other.  
Data Analysis  
Overview  
The data was described by CLHIV and CNLHIV for demographic variables and 







Data Management   
Objective 1. Describe a profile of hearing in CLHIV and CNLHIV 
Objective 3. Investigate the predictor variables associated with hearing loss 
a. Lifetime exposure to ARVs; 
b. CDC4 count and viral load;  
c. Gestational age 
d. History of repeating school grades, or absence from school; 
e. History of meningitis, TB or malaria; and  
f. Family circumstances (person in a caregiver role, level of caregiver education, 
family income).  
Data Management. HL was determined by a pure tone average (PTA) of >15dBHL 
for CLHIV and >25dBHL for CNLHIV (Northern and Downs, 2002). The severity of hearing 
loss was assessed using the degree of loss (0=none, 1=mild, 2=moderate, 3=unspecified), and 
calculated as an integer score for both ears.  
The relevant continuous predictor variables were divided into binary form for entry 
into logistic regression models (the value 1 indicating hypothesised high risk).  
• Lifetime exposure to ARVs was calculated as the percentage of total years lived on 
ARV (calculated as the difference between age and age at which ARV commenced, 
divided by age, and expressed as a percentage). It was hypothesized that >50% 
lifetime exposure to ARVs was protective of HL because it reduced opportunistic 
infections;    
• CD4 counts less than the median were considered to be high risk for HL;   
• Children who were older than usual for their grades were identified as old-for-grade 






and grade 6 older than 13 years). Children older than expected in their grade were 
likely to have repeated a grade at school, usually because of regular absence for 
illness, living with an HIV-positive adult, or being orphaned (Bandason et al., 2013; 
Pufall, Nyamukapa, Eaton, et al., 2014); 
• Family income lower than R26 256 for a family of four based on the value of the food 
poverty level of R547 per person per month (Statistics South Africa, 2018b). 
 
Categorical predictor variables were categorized as:  
• Viral load (not controlled, versus low or undetectable levels);  
• History of defaulting on ARV medications; 
• WHO HIV staging (stages 3 or 4 (progressed disease) versus stages 1 or 2); 
• History of repeating school grades (Yes/ No), or regular absence from school (Yes/ 
No);  
• History of meningitis, TB or malaria (Yes for any);    
• A person in caregiver role (parent, other blood relatives, non-blood relative);  
• Level of caregiver education (less than year 9; year 9-10; year 11-12; tertiary). 
 
Objective 1. Describe a profile of hearing in CLHIV and CNLHIV 
Objective 4. Test the association between hearing and NVIQ, STM and WM in the CLHIV 
and CNLHIV. 
a. HIV status and HL; 
b. HIV status and learning capacities; and 






Data Management. The hearing loss was considered as none (0) or as three different 
types (conductive hearing loss (CHL), sensorineural hearing loss (SNHL), or unspecified) (all 
coded as 1) in the left or right ear. “Unspecified” referred to hearing loss where the type of 
hearing loss could not be determined as bone conduction thresholds were not available. 
The degree of hearing loss in each ear was recorded as mild (PTA = 25 to 40dBHL), 
moderate (PTA = 41 to 55dbHL) or severe (PTA = 71 to 90dBHL) (Clark,1981 in Welling & 
Ukstins, 2015). The category “unspecified” was used when the hearing testing had not been 
conducted in a soundproof booth. 
A cumulative integer score was determined for hearing loss as the per-child sum of 
severity scores (hearing loss (yes, no) in either ear multiplied by the numeric code given to 
the severity of a loss. Hearing loss was then applied to models as a three-level variable (no 
hearing loss, hearing loss in only one ear, or hearing loss in both ears). A total severity score 
was calculated per child and reported as an integer variable for the analysis of variance 
models. The higher the severity score, the more severe the hearing loss. For logistic 
regression modelling purposes, the severity score was split into three independent variables 
(0 for children without hearing loss), and then at the median value of severity for children 
with hearing loss (>0 to 2 (mild hearing loss), >2 (moderate or severe loss)). In the analysis, 
the TONI 4 score was expressed as a percent of the possible total score, which was also split 
at the median value for modelling purposes.  
Data analysis. Linear regression models were initially constructed to test the 
association between severity of hearing loss and learning performance scores to gain the most 
leverage from the sensitivity of the integer variables, using the Pearson r2 statistic as an 






identified in initial testing were individually applied to this model with differences in impact 
being determined as a significant change in the r2 statistic.  
Univariate logistic regression models were constructed to test the association between 
binary forms of all variables. HIV status was tested with hearing loss (model 1), learning 
performance (model 2), and hearing loss and learning performance (model 3). Potential 
confounders were added to these models in a stepwise manner applying the strongest 
predictor variable first. Predictor variables were retained in the model if they significantly 
changed the amount of variance, determined from the chi-square value associated with the 
Likelihood Ratio, assessed against the critical chi-square value for the degree of freedom 
associated with the model. 
(https://web.ma.utexas.edu/users/davis/375/popecol/tables/chisq.html). 
For regression purposes, changes in chi2 values were determined at p<0.05.  For one 
degree of freedom, the critical chi2 value is 3.8; for two degrees of freedom, it is 5.9, and for 
three degrees of freedom, it is 7.8.   
 
Objective 2. Describe auditory processing capacities in CLHIV and CNLHIV  
Objective 4. Test the association between auditory processing and NVIQ, STM and WM in 
CLHIV and CNLHIV. 
a. HIV status and AP, 
b. AP and learning capacities  
Data Management. Only those children with no hearing deficits were retained for the 
analysis. The percentage of total scores for the auditory processing capacities and learning 
capacities (AFG, CWFR, WD, GD, NMF, NMR, TONI 4) were converted into binary form 






recorded for testing purposes as English, Afrikaans or African Indigenous languages (these 
being combined because of small numbers).  
Data Analysis. Factor analysis was first applied to the auditory processing measures 
(AFG, CWFR, WD, GD, laterality) and the learning capacities (TONI 4, NMF, NMR), to 
identify underlying composite latent variables. These variables were first tested for normality 
of distribution to ensure that they were appropriate for inclusion in factor analysis models. 
Spearman (1904) first developed the notion of factor analysis. Its key concept is that a latent 
(not measured) variable will underpin several observed (potentially correlated) variables 
because research participants may express similar patterns of responses in the observed 
variables. In most instances, the latent factor is abstract, and therefore not readily measured. 
However, the abstract notion underpinning the latent factor may have multiple measurable 
elements, which, when combined, can provide a single estimate of the new (latent) variable. 
Thus, the purpose of factor analysis is to analyse these patterns of responses, identify 
underlying latent factors, and use each latent factor as a single measure, expressing a 
combination of observed variables. Factor analysis also weights item responses within each 
latent factor (called factor loadings). These can be combined and then expressed as an 
individual score for each person, as an estimate of the latent variable. Factor loadings can be 
interpreted in the same ways as standardized regression coefficients. If an observed variable 
has a factor loading of about 0.7, then it can be assumed that that observed variable has a 
correlation of 70% with the latent factor (a strong relationship). Conversely, if the loading is 
0.2, the correlation of 20% with the latent factor is considered to be weak. On this 
assumption, the rules of correlation are applied when considering the factor loadings, as 
usually only those variables with loadings over 0.3 are considered as vital within a latent 






Each factor captures an amount of the overall variance in the observed variables, and 
statistical programmes that calculate factor analysis usually list factors in order of the amount 
of variation that each factor explains of the overall variance. The eigenvalue is a measure of 
how much variance in the observed variables is explained by one factor. As a rule of thumb, 
any factor with an eigenvalue greater than one explains more variance than a single observed 
variable.  
The weighted auditory processing scores were combined into a new latent variable of 
per-child overall auditory processing performance, and the weighted learning capacities 
scores were combined into a new latent variable of per-child overall learning capacities. This 
was calculated as the cumulative sum of the binary value (1,0) for each variable multiplied by 
the relevant weighing.  Given that scores of 1 indicated poor performance, the higher the 
composite score, the poorer the child performed overall.  
Influence of Predictor Variables. The influence of potential predictor variables 
(HIV status, gender, and primary language spoken at home or school) on the new (continuous 
measure) latent variables of auditory processing performance and learning capacities was 
assessed using Analysis of Variance models, with significance reported at p<0.05. The 
association between the new latent variables of auditory processing performance and learning 
capacities was assessed using a univariate linear regression model, with the strength of the 
association reported as r2 value (significance p<0.05). 
Univariate logistic regression models were also constructed to test the association 
between binary forms of the new (composite) latent variables of auditory processing and 
learning capacities (reported as Odds Ratios (OR), 95% Confidence Intervals (95%CI). If a 
potential predictor variable was found to significantly influence the mean values of the 






adding it to logistic regression models, and testing whether the Likelihood ratio chi2 value 
changed significantly. This was an expression of the amount of variance in the model 
explained by the component variables. The significance of the change was determined by 
whether the amount exceeded the critical amount of change in the chi2 value for the number 











This chapter reports the findings of the study with regards to auditory functioning 
(hearing and auditory processing capacities), HIV status, and learning capacities (NVIQ, 
STM, and WM) in South African preteens. The results are presented according to the 
objectives listed below (also see Chapter 5): 
1. Describe a profile of hearing in CLHIV and CNLHIV; 
2. Describe a profile of auditory processing in CLHIV and CNLHIV; 
3. Investigate the predictor variables associated with hearing loss in CLHIV; 
4. Test the association between auditory functioning (hearing and auditory processing 
capacities) and learning capacities (NVIQ, STM, WM)) in CLHIV and CNLHIV. 
 
The findings have been reported in the following submitted papers: 
Appendix A: 
Dawood, G., Klop, D., Pillay, M., & Grimmer, K. (submitted: 17 September 2019). Hearing 
loss in a group of HAART-treated 9-12-year-old children from Cape Town, South 
Africa: A cross-sectional study. Brazilian Journal of Otorhinolaryngology. 
Appendix B: 
Dawood, G., Klop, D., Pillay, M., & Grimmer, K. (submitted: 19 August 2019). HIV, hearing 
loss, and learning capacity in Cape Metropole pre-teens, South Africa: A cross-










Dawood, G., Klop, D., Pillay, M., & Grimmer, K. (submitted: 17 October 2019). Auditory 
processing and learning capacity in 9 to 12-year-old children from Cape Town, South 

























Objective 1. Hearing profile of CLHIV and CNLHIV 
The first objective was to describe the hearing profile of CLHIV and CNLHIV.  
Pure Tone Audiometry 
Failed Tests. The percentage of children who failed each frequency tested is 
described in Table 3, for CLHIV and CNLHIV, and the difference between CLHIV and 
CNLHIV is reported as p values from chi2 tests. For each test, the same threshold pass/fail 
was set, but this differed between CLHIV and CNLHIV because of test circumstances. For 
CLHIV, the fail threshold was >15dBHL, whilst for CNLHIV it was >25dBHL. 
Table 3: Pure Tone Audiometry - Fail Results per Frequency  
Frequency Ear CLHIV CNLHIV Significance 
250Hz Right  0% 6.3% 0.21 
250Hz Left 25% 6.3% 0.05 
500Hz Right 29.2% 6.3% 0.02* 
500Hz Left 16.7% 6.3% 0.21 
1000Hz Right 29.2% 3.1% 0.005* 
1000Hz Left 16.7% 9.4% 0.41 
2000Hz Right 20.8% 0% 0.01* 
2000Hz Left 12.5% 0% 0.05 
4000Hz Right 16.7% 6.3% 0.21 
4000Hz Left 16.7% 6.3% 0.21 
8000Hz Right 29.2% 6.3% 0.03* 
8000Hz Left 29.2% 9.4% 0.06 
 
Hearing Loss. Eleven children overall (19.6% sample) were diagnosed with hearing 






However, there were significantly more CLHIV with hearing loss in both ears (N=6 
(25%)) than CNLHIV (N=1 (3.1%)). In children with hearing loss, there were eight CLHIV 
(66.7%) and four CNLHIV (33.3%) who reported hearing loss in either or both ears.   
In the eight CLHIV with hearing loss in one or both ears (34.8% total CLHIV), there 
were 14 ears with hearing loss. Six participants had bilateral hearing loss, and the remaining 
two participants had unilateral hearing loss. In both cases of unilateral hearing loss, the right 
ear was affected. In the 14 involved ears, nine ears (64.2%) presented with conductive 
hearing loss and five ears presented with sensorineural hearing loss.  
The mean PTA-Right was 15.2 (12.7), and PTA-Left was 12.6 (9.9). The mean 
overall severity score of hearing loss in the left ear was 0.4 (SD 0.8), and in the right ear, it 
was 0.6 (SD 0.9). For hearing loss in both ears, the severity score was 1.0 (SD 1.7). 
ART and Hearing Loss. Hearing loss in one or both ears was significantly associated 
with low lifetime exposure to ART (3.7 (95%CI 1.0-14.5)). 
Type of Hearing Loss. Hearing loss was determined as conductive, sensorineural, or 
unspecified (where bone conduction testing was not done). Table 4 reports on the type of 














Table 4: Type of Hearing Loss 





No hearing loss Right 16 (66.7%) 30 (93.7%) <0.05* 
No hearing loss Left 18 (75.0%) 29 (90.6%) <0.05* 
Conductive hearing loss Right 4 (16.7%) 0 (0%) <0.05* 
Conductive hearing loss Left 4 (16.7%) 0 (0%) <0.05* 
Sensorineural hearing loss Right 2 (8.3%) 0 (0%) >0.05 
Sensorineural hearing loss Left 1 (4.2%) 0 (0%) >0.05 
Unspecified hearing loss Right 2 (8.3%) 2 (6.3%) >0.05 
Unspecified hearing loss Left 1 (4.2%) 3 (9.4%) >0.05 
Significant difference Right 0.04*  
Significant difference Left 0.06*  
 
The Severity of Hearing Loss. Considering the entire sample (children with, and 
without hearing loss), the overall severity of hearing loss score for either ear ranged from 0-3 
(mean 0.3, SD 0.7), and the overall both-ear score ranged from 0-6 (mean 0.6, SD 1.4). 
Among only those children with hearing loss (all with severity ranges from 1-3), for children 
with Right ear loss only, the severity score was 2.1 (SD 0.9), and for children with Left ear 
loss only, the severity score was 1.6 (SD 1.1). The overall severity score for the seven 
children with hearing loss in both ears was 3.7 (SD 1.8). The mean severity of hearing loss 
scores (SD) for CLHIV and CNLHIV is reported in Table 5, along with significant 








Table 5: Severity of Hearing Loss – Mean (SD) 
Ear CLHIV CNLHIV Significance  
Severity Right  1.8 (0.9) 3.0 (0) 0.09 
Severity Left 1.5 (0.8) 3.0 (0) 0.05 
Severity both ears 3.3 (1.6) 6.0 (0) 0.2 
 
Electroacoustic Measures 






Right ear     
A 18 (75%) 25 (83.3%) >0.05 
As 2 (8.3%) 3 (10%) 
B 2 (8.3%) 1 (3.3%) 
C 2 (8.3%) 1 (3.3%) 
Left ear     
A 18 (75%) 28 (93.3%) >0.05 
As 2 (8.3%) 0 (0) 
B 2 (8.3%) 1 (3.3%) 
C 2 (8.3%) 1 (3.3%) 
 
Tympanometry. There was no significant difference between the tympanograms 
obtained for the CLHIV compared to CNLHIV. Tympanometry results are reported in Table 
6. 
OAE. Only the CLHIV were tested, as the equipment was only available at the 
tertiary hospital. Moreover, only 29% of CLHIV could be tested. This was due to various 
reasons, including children refusing to be tested, high levels of ambient noise, and equipment 






results were recorded in the Right ear for two of the 15 CLHIV (13.3%) and in the left ear for 
three of the CLHIV (18.8%).  
Acoustic Reflex Testing. For all ipsilateral reflex tests, data were missing on five 
CLHIV children. At 500Hz for the Right and Left ears, significantly more CLHIV than 
CNLHIV children had present reflexes (Right ear N=19 (90.5%); N=17 (56.7%) respectively) 
(p<0.05); Left ear N=20 (95.2%); N=13 (43.2%) respectively) (p<0.05)).  However, this was 
not the case at 1000Hz (Right ear CLHIV N=19 (90.5%); N=17 CNLHIV (56.7%) 
respectively) (p<0.05); Left ear N=20 (95.2%); N=13 (43.2%) respectively) (p<0.05)); and at 
2000Hz (Right ear CLHIV N=17 (80.9%); CNLHIV N=20 (66.7%) respectively) (p<0.05); 
Left ear CLHIV N=20 (95.2%); CNLHIV N=15 (50.0%) respectively) (p<0.05)).    
For all contralateral reflex tests, the data is reported only for CLHIV because the 
equipment was not available for testing in schools.  Right contralateral acoustic reflex 
thresholds were present at 500Hz for 18 of 20 children tested (90.0%), 1000Hz for all 20 
children (100%) and 2000Hz for 19 of 20 children tested (95.0%). Left contralateral 
responses were present at 500Hz for 19 of 20 children (95.0%), 1000Hz for 19 of 20 (95.0%) 
and 2000Hz for 18 of 20 children (90.0%).  
Objective 2. Auditory processing capacities in CLHIV and CNLHIV 
The second objective of the study was to describe auditory processing capacities in 
CLHIV and CNLHIV  
This section reports auditory processing in two ways; firstly, as four individual 
measures, and secondly as a combined measure. It is not usual practice to report a combined 
measure for discrete skills, however, there is no agreement on the best way of reporting 
auditory processing. As auditory processing is an area that required significantly more 






understanding the data will be helpful for future researchers. The use of factor weighting, 
albeit on a small sample provides a better indication of the relative importance of the 
individual components than simply combining binary (1,0) forms of each measure into a 
composite score. Providing the data in two separate ways gives readers the opportunity to 
consider individual auditory processing measures or one composite measure. 
Auditory processing capacities were assessed only in children with no hearing loss 
(N=44 [16 CLHIV, 28 CNLHIV]). However, not all the children were able to complete all 
auditory processing measures (Table 7). 
 
Table 7: Auditory Processing Capacities 
Measure  Mean (SD) Range (Percentile) 
 
N meeting pass 
criteria (%) 
GD   22 (50) 
AFG 6.7 (9.1) 0.1-50 2 (4.6) 
CWFR 14.6 (19.3) 0.1-63 13 (29.5) 
WD 42 (23.2) 2-84  
    
Table 8: Auditory Processing Capacity - Gender, HIV-status, Home Language (p<0.05) 
Measure  Gender HIV status Home language 
GD 0.79 0.24 0.40 
AFG 0.02* 0.06 0.09 
CWFR 0.06 0.01* 0.37 










Of the 22 who met the pass criteria, N=5 (33.3%) CLHIV and N=17 (60.7%) 
CNLHIV (trend towards a significant difference in case-control proportions) (p=0.06) met the 
pass criteria (Keith, 2009a).  
Auditory Figure-Ground 8+ 
  Of the 2 who met the pass criteria N=0 (0%) CLHIV and N=2 (7.1%) CNLHIV (no 
significant difference in case-control proportions) met the pass criteria (Keith, 2009a). 
Applying a descriptive rating to the AFG results (Keith, 2009b), for CLHIV, one participant 
(6.3%) was rated as normal, N=11 (68.8%) were disordered, and N=4 (25%) were borderline, 
while for CNLHIV children, N=8 (28.6%) were rated as normal, N=7 (25%) were disordered, 
and N=13 (46.4%) were borderline.  Considering the mean standardized AFG scores, the 
CLHIV had significantly lower mean scores (2.8 (SD 1.9)) than CNLHIV (5.2 (SD 2.2)) 
(p<0.05). The same significant finding occurred for the percentile scores (CLHIV mean 2.4 
(SD 4.3), CNLHIV mean 9.6 (SD 10.2) p<0.05)). When considering ear advantage ratings 
(typical and atypical) for the AFG, there was no significant difference between CLHIV and 
CNLHIV scores. For CLHIV, 11 of 16 participants tested were atypical (68.7%), and for 
CNLHIV, 17 of 28 participants tested were atypical (60.7%) (p>0.05). 
Competing Words- Free Recall 
Significantly fewer CLHIV N=2 (12.5%) met the pass criteria (Keith, 2009a), 
compared with CNLHIV (N=11 (39.3%)) (p<0.05). Applying a three-level rating to CWFR 
scores (Keith, 2009a), for CLHIV, three participants (18.8%) were rated as normal, N=7 
(43.8%) were disordered, and N=6 (37.5%) were borderline, while for CNLHIV, N=13 
(36.4%) were rated as normal, N=6 (21.4%) were disordered, and N=9 (32.1%) were 






mean standardized CWFR scores, the CLHIV had significantly lower mean scores (4.1 (SD 
2.3)) than CNLHIV (6.4 (SD 3.1)) (p<0.05). The same significant finding occurred for the 
mean CWFR percentile scores (CLHIV mean 6.3 (SD 10.6), CNLHIV mean 20.4 (SD 21.7) 
p<0.05)). Similar to the finding for AFG, when considering ear advantage ratings for the 
CWFR, there was no significant difference between CLHIV and CNLHIV percentage mean 
scores (CLHIV mean 8.0 (SD 4.5); CNLHIV mean 7.3 (SD 5.4)). Supporting this finding, for 
CLHIV, five of 16 participants tested were considered to be atypical (31.2%), and for 
CNLHIV, 12 of 28 participants tested were atypical (42.9%) (p>0.05).   
Word Discrimination 
Mean word discrimination test differences between CLHIV and CNLHIV are reported 
in Table 9. There were no significant differences between CLHIV and CNLHIV for any test. 
 
Table 9: Word Discrimination - Mean (SD) 
 CLHIV CNLHIV Significance 
Word discrimination 
rank scores 
29.7 (2.2) 30.0 (1.6) >0.05 
Word discrimination 
standardized scores 
9.3 (2.8) 9.2 (1.9) >0.05 
Word discrimination 
percentile scores 









Objective 3. Predictor variables associated with hearing loss in CLHIV 
The third objective of the study was to investigate the predictor variables associated 
with hearing loss in CLHIV. 
Hearing Loss 
 There were eight CLHIV (66.7%) who reported hearing loss in either or both ears (a 
non-significant difference of proportions within CLHIV), and there was a non-significant 
association between HIV and hearing loss (OR 3.7 (95%CI 0.8-14.5)). This finding persisted 
when further considering the severity of hearing loss. Compared with participants with no 
hearing loss (severity=0), the association between HIV status and minimal/ mild severity of 
hearing loss was OR 8.2 (95%CI 0.9-79.4), and for moderate/ high severity of hearing loss, 
the association with HIV status was OR 2.1 (95%CI 0.4-11.3). 
Factors Associated with Hearing Loss in CLHIV. ART lifetime exposure, history 
of defaulting on ARV, WHO staging of HIV, viral load, disease history, prematurity, 
developmental delay, history of absence from school, history of repeating a grade, age-for-
grade, family income, parent/caregiver status, and caregiver education were tested for 
associations with HL, using univariate logistic regression modelling. CD4 count was only 
available from the case-notes of 11 participants, precluding analysis of associations with HL. 
Table 10 reports the cut point for each variable, and the strength of association using odds 
ratios (95%CI).  Only ART lifetime exposure less than the median (80.6%) provided 










Table 10: Association between Hearing Loss (either ear) and Predictor Variables 
Variable Cut-off point Odds ratio (95%CI) 
ART lifetime exposure  <75%  4.4 (1.1-18.5) * 
History of defaulting on 
ARV 
Yes 1.0 (0.2-7.4) 
WHO staging Stages 3 or 4  1.9 (0.5-7.9) 
Viral load LDL 1.7 (0.3-9.1) 
Disease history TB, malaria, meningitis 2.6 (0.7-11.5) 
Prematurity  <38 weeks gestation 0.6 (0.2-3.7) 
Developmental delay Any  1.7 (0.1-36.7) 
History of absence from 
school 
Yes 0.4 (0.1-3.4) 
History of repeating a grade Yes 0.7 (0.2-3.6) 
Age-for-grade Grade 3 ≥10 years or Grade 4 ≥11 years 
or Grade 5 ≥12 years or 6 ≥13 years 
2.6 (0.6-10.9) 
Family income < R28320 / year 1.7 (0.3-8.8) 
Parent caregiver No 1.6 (0.3-9.2) 
Caregiver education Completed Grade 10 or lower 0.4 (0.1-1.6) 
 
Objective 4. Association between auditory functioning and learning capacities  
The fourth objective was to test the association between auditory functioning (hearing 
and auditory processing) and learning capacities (NVIQ, STM and WM) in the CLHIV and 
CNLHIV. Before the results can be presented relative to the objective, results pertaining to 
NVIQ, STM, and WM are presented. 









Table 11: Learning Capacity - Mean (SD) 
Measure Mean (SD) Range 
NMF 39.1 (27.1) 1-98 
NMR 27.4 (24.2) 1-90 
TONI 32.0 (17.6) 6-84 
 
The mean TONI 4 percent score was 32 (SD 17.6), ranging from 6-84.  (Table 11) 
STM, WM, and NVIQ. Number memory forward, number memory reversed, and 
TONI 4 scores, each considered as rank, standardized and percentile mean scores, and an 
overall TONI 4 score reported as an integer (average or above average, and below-average). 
All children (irrespective of hearing loss) provided information on attributes using the TONI 
4 score, which did not require intact hearing. Working memory, however, required intact 
hearing and thus could only be tested on such children.   
CNLHIV had significantly higher TONI 4 percentile scores compared with CLHIV 
(39.9 (SD 17.9) compared with 21.4 (SD 10.1), respectively) (p<0.05). For CLHIV, 14 
participants (58.3%) TONI 4 scores were rated as being below-average, which was 
significantly higher than for CNLHIV (5 children, 15.6%) (p<0.05). Using this measure, 
CLHIV were 7.6 times more likely (95%CI 2.2-26.5) to have below-average TONI 4 scores 
than CNLHIV. There were significant differences between CLHIV and CNLHIV for mean 
NMR ranked scores, and all the TONI 4 mean scores.  
Table 12 reports mean scores for the integer learning capacities measures for CLHIV 









Table 12: Learning Capacity for CLHIV and CNLHIV - Mean (SD) 
Learning capacity score CLHIV CNLHIV Significance 
NMF ranked score 17.6 (4.3) 17.6 (4.2) >0.05 
NMF standardized scores 9.2 (2.8) 8.9 (2.8) >0.05 
NMF percentage scores 40.3 (28.6) 38.4 (26.7) >0.05 
NMR ranked score 8.0 (2.4) 9.7 (2.1) <0.05* 
NMR standardized scores 6.5 (2.3) 7.9 (2.2) >0.05 
NMR percentile scores 18.9 (23.1) 31.9 (23.9) >0.05 
TONI 4 ranked score 20.1 (4.3) 27.9 (5.8) <0.05* 
TONI 4 standardized score 87.3 (5.5) 95.8 (7.8) <0.05* 
TONI 4 percentile score  21.4 (10.1) 39.9 (17.9) <0.05* 
 
Determining Latent Composite Learning Capacities 
In children with no hearing deficits, factor analysis was employed to identify the 
latent variable underpinned by the inter-relationships between the three learning capacities. 
One factor was identified with the NMR ranked percent weighting = 0.82; NMF ranked 
percent weighting = 0.57; and TONI 4 ranked percent weighting = 0.60. The mean per-child 
overall latent learning capacity score was 1.17 (SD 0.8); (range 0 to 1.99) by applying these 
factor weightings to the per-child test scores. There was a significant difference between 
CLHIV and CNLHIV mean scores (case mean 1.51 (SD 0.58); control mean 0.92 (SD 0.68)) 








Table 13: Learning Capacity - Gender, HIV-status and Home Language (p<0.05) 
Measure Gender HIV status Home language 
NMF 0.97 0.82 0.22 
NMR 0.27 0.09 0.46 
TONI 4 0.32 0.001* 0.009* 
 
Demographics as a Predictor of HIV. Gender was not associated with HIV status 
(OR 0.7, 95%CI 0.2-1.9) (Table 13). 
Demographics as a Predictor of Learning Capacity. There was no influence of 
gender on NVIQ (TONI 4 percentile scores (females mean 33.0 (SD 18.1) and males (36.1 
(SD 21.2 (F value 0.4 (df=1) p>005). There was a significant effect of speaking English at 
home on language performance scores (mean TONI 4 percentile rank score 47.7 (SD 21.0), 
compared with Afrikaans language (mean 28.8 SD 14.1) and African languages (mean 27.5, 
SD 18.3) (F value 8.3 (df=2) p<0.01)). There were similar significant findings for languages 
spoken at school, with English school-language TONI 4 percentile rank scores being 
significantly higher than for the other school languages (English mean TONI 4 score 42.8 
(SD 21.0), Afrikaans mean 28.6 (SD 13.9) and African languages mean 14.8 (SD 8.7) (F 
value 8.1 (df=2) p<0.01)). Moreover, there was no influence of experiencing a difference in 
languages spoken at home and school on TONI 4 percentile rank scores (the same language 
mean 34.7% (SD 20.3%), different language mean 33.5% (SD 17.9%) (F value 0.04 (df=1) 
p>0.05). 
HIV as a Predictor of Hearing Loss and NVIQ. NVIQ was significantly different 
between HIV groups, with the CNLHIV having a significantly higher TONI 4 score (mean 






the median division in TONI 4 scores (30%), HIV status was significantly associated with the 
risk of low TONI 4 scores (OR 15.4 (95%CI 3.7-63.8)) (Table 13).   
Hearing Loss and NVIQ. The association between hearing loss and NVIQ was 
considered in two ways, with neither demonstrating a significant association. There was a 
minimal association (r2=1.0%, p>0.05) when using both hearing loss and learning NVIQ as 
integer variables in a linear regression model. There was no significant association for one 
ear (either Left or Right) OR 0.8 (95%CL 0.1-6.2), or both ears affected OR 1.3 (95%CI 0.1-
15.7)) when using categories of hearing loss of none (default comparator), one ear or both 
ears, and testing against learning capacity divided at the median value. There were 
insufficient numbers of children with mild-moderate hearing loss to resolve a logistic 
regression model, which considered three independent levels of hearing loss severity (none 
(default), mild-moderate, or severe). Thus, a binary form of hearing loss severity data was 
developed, as none, or combined categories of mild, moderate, and severe. There was no 
association between NVIQ and hearing loss categories (OR 3.5 (95%CI 0.9-13.5)).  
Multivariate Analysis. The only significant potential confounder that could be 
applied to the multivariate model of HIV status (exposure) and NVIQ (outcome) was hearing 
loss severity. The crude and adjusted model outputs are reported in Table 14. The overall 
variance of the crude model (-2 Log L) was 87.3.  The amount of variance explained by 
adjusting this model by hearing loss severity was not significant (less than the threshold 


























HIV+  (crude) 15.4 
(3.7-63.8) 
19.9 1  3.8 p<0.05 





20.4 2 0.5 5.9 p>0.05 
 
Sample Descriptors. This research examined data of the 43 participants with no 
hearing loss (78.2% sample). There were 15 CLHIV (34.9% sample), of whom 8 (53.3%) 
were female, and 28 CNLHIV (65.1%), of whom 15 were female (53.3%).  
Overall, 30.2% of participants spoke English, 41.9% spoke Afrikaans, and the 
remainder (27.9%) spoke an African language. There was a significant difference (p<0.05) in 
the frequency of speaking a primary home language for CLHIV and CNLHIV, with 92% 
CNLHIV primarily speaking English, but only 7.7% CLHIV; 61.1% CNLHIV primarily 
speaking Afrikaans but only 38.9% CLHIV; and 41.7% CNLHIV primarily speaking an 
African language compared with 58.3% CLHIV. There was a difference in primary language 
spoken at school, between CLHIV and CNLHIV that trended towards significance (p=0.07), 
with 80% CNLHIV speaking English at school compared with 20% CLHIV; 57.9% CNLHIV 
speaking Afrikaans compared with 42.1% CLHIV; and 25% CNLHIV speaking an African 
language compared with 75% CLHIV.  Overall, approximately 1:5 participants (20.9%) 
spoke a different language at home and school, reflecting 14.3% CNLHIV and 33.3% CLHIV 
(p>0.05). No English-speaking children reported a difference between home and school 






Afrikaans-speaker (20%), and four African language speakers (80.0%); and in four African 
speaking CNLHIV (100%). 
Of the 14 CLHIV on whom information on ART was available from hospital records, 
the mean percentage of lifetime exposure to ART was 73.4% (21.5%).  
NVIQ and WM. CNLHIV with no HL had significantly higher TONI 4 and NMR 
percentile scores compared with CLHIV with no HL, but there was no difference in mean 
percentile scores for NMF between CLHIV and CNLHIV (Table 15).   
 
Table 15: NVIQ, STM and WM - Mean (SD) 
 CLHIV (n=15) CNLHIV (n=28) P-value ANOVA 
models 
TONI 4 percentile 
ranks 
20.4 (10.1) 40.6 (19.2) <0.05* 
Number memory 
forward (NMF) ranks 




11.2 (11.9) 31.9 (23.9) <0.05* 
 
Factor Analysis. Latent ‘composite learning capacity’ was explained by one factor, 
which included all three learning capacities (NMR ranked percent weighting = 0.79; NMF 
ranked percent weighting = 0.62; TONI 4 ranked percent weighting = 0.71). The mean per-
child overall latent learning capacity score was 1.2 (SD 0.7; range 0 to 2.1), with a significant 
difference between CLHIV and CNLHIV (mean CLHIV 1.6 (SD 0.5); mean CNLHIV (0.9 








Table 16: Auditory Processing  and Learning Capacities for Participants with Normal 
Hearing - Linear Measures of Association 
Means  CLHIV (n=15) CNLHIV(n=28) p-value (ANOVA 
models) 
AFG% 2.2 (4.2) 9.5 (10.2) 0.007* 
CWFR% 5.9 (10.4) 20.4 (21.7) 0.01* 
WD% 43.8 (28.7) 40.1 (21.4) 0.63 
NMF% 39.0 (27.4) 40.3 (26.5) 0.89 
NMR% 15.3 (15.1) 31.9 (23.9) 0.03* 
TONI 4 % 21.3 (9.8) 40.1 (19.7) 0.007* 
Linear measures of 
association (r2) 
With TONI 4 %   
AFG% 0.113 (11.3%)*   
CWFR% 0.177 (17.7%)*   
WD% 0.02   
 With NMF%   
AFG% 0.002   
CWFR% 0.001   
WD% 0.02   
TONI 4 % 0.02   
 With NMR%   
AFG% 0.104 (10.4%)*   
CWFR% 0.04   
WD% 0.01   
TONI 4 % 0.116 (11.6%)*   
 
Auditory Processing. Twenty-one participants of the sample (48.8%) presented with 
poor auditory processing scores, comprising 11 CLHIV and 10 CNLHIV (52.4%, 47.6%, 
respectively). CLHIV incurred a significantly higher risk of having poor auditory processing 
scores compared with CNLHIV (OR 4.95 (95%CI 1.24-19.69). Not surprisingly, the mean 






lower for CLHIV than CNLHIV (Table 16). There was modest evidence of an association 
between GD and HIV (OR 3.3 (95%CI 0.9-11.6)).  
Auditory Processing Capacities and Learning Capacities. Significant associations 
were found between the TONI 4 percentile rank score and the percentile rank scores for two 
auditory processing tests, namely AFG and CWFR. Significant associations were also found 
between NMR and AFG, as well as between NMR and TONI 4. NMF was not significantly 
associated with any auditory processing capacities or with TONI 4 (Table 16). 
Factor Analysis. There were two latent variables derived from the factor analysis 
(explaining 58% and 42% respectively, of the total variance). The factor explaining the 
largest percentage of variance included variables of AFG (weighting = 0.91); CWFR 
(weighting= 0.83); WD (weighting = 0.39); and laterality (weighting = 0.36).  The second 
factor contained only one variable, GD (weighting = 0.75). The mean per-case score for the 
first latent variable was 0.50 (0.36) while for controls, it was 0.29 (0.37). For the second 
latent variable, the per-CLHIV mean score was 1.74 (0.71) whilst for CNLHIV it was 0.96 
(0.82)). 
Univariate association between composite auditory processing capacity and 
learning capacity scores. There was a significant and moderately strong linear association 
between the continuous forms of these two latent variables without taking account of CLHIV 
or CNLHIV (r2=19.4% (p<0.01)). However, when considering these variables in binary 
form, the crude association was non-significant (Odds Ratio (OR) 2.8 (95% Confidence 
Interval (CI) 0.8-9.4) (Likelihood Ratio 2.8 (p<0.05)).  
Influence of Predictor Variables. Only HIV status produced significantly different 
means when considering outcomes of composite auditory processing and learning capacity 






(meaning that CLHIV accumulated more poor scores in the component auditory processing 
and learning capacity composite measures). Gender, language spoken at home, and 
differences between home and school language did not influence the mean composite 
auditory processing or the learning capacity composite measures.  
Table 17: Auditory Processing and Learning Capacities - Composite Scores 









Gender (degrees of 
freedom (df) =1) 
Female  1.8 (0.9) 0.05 1.1 (0.6) 0.4 
 Male 1.3 (0.9)  0.9 (0.8)  
Language at home (df=2) English 1.1 (0.8) 0.05 0.7 (0.6) 0.05 
 Afrikaans 1.8 (0.9)  1.2 (0.6)  
 African 
language 
1.8 (0.8)  1.3 (0.7)  
Difference between 




1.6 (0.9) 0.8 1.1 (0.7) 0.7 
 Difference 1.5 (0.8)  0.9 (0.5)  
HIV status (df=1) CNLHIV 1.2 (0.8) <0.001* 0.8 (0.7) <0.001* 
 CLHIV 2.2 (0.8)  1.5 (0.6)  
 
Association between Composite Learning Capacity and Composite Auditory 
Processing Variables. The Crude Odds Ratio (COR) for the association between the 
auditory processing and learning capacity composite measures (split at the median) was non-
significant (2.7 (95%CI 0.8-9.5)). Adjusting this by HIV status, the adjusted OR (AOR) was 






the Likelihood ratio (6.6 (df=2) p<0.05). The AOR was also non-significant. The wide 
confidence intervals potentially reflected the impact of small numbers in some cells.  
Lifetime Exposure to ART. There was some indication in the CLHIV that the extent of 
exposure to ARV influenced auditory processing and learning capacity, in particular in the NMF 
measure. Table 18 outlines the differences between CLHIV, whose lifetime exposure was less than 
75% (N=7), compared with those whose exposure was longer (N=8). There was a non-significant 
association between gap detection and ARV lifetime exposure (OR 0.67 (95%CI 0.08 – 5.87).  
 
Table 18: Auditory Processing Capacity, Learning Capacity and ARV Lifetime Exposure 
 <75% LT exposure  >75% LT exposure p value 
TONI 4 ranked percent 21.25 (11.54) 19.42 (9.09) >0.05 
NMF ranked percent 24.25 (18.12) 55.83 (27.78) <0.05* 
NMR ranked percent 14.71 (14.02) 6.20 (6.26) >0.05 
AFG ranked percent 2.47 (5.51) 2.42 (3.39) >0.05 
CWFR ranked percent 4.42 (8.33) 9.21 (13.47) >0.05 












Summary of Results 
• Hearing loss was found in CLHIV, despite being on HAART, and having a median 
lifetime ART exposure above 75% at some time during their lifetime. 
• Hearing loss was also found in CNLHIV. 
• Being HIV positive was significantly associated with compromised learning capacities 










































This chapter is a stand-alone chapter which aims to provide insights into the 
complexity of factors associated with children’s capacity to learn, by providing case studies 
that explore the subtlety of differences between CLHIV and CNLHIV in the same socio-
economic demographic.  
Background 
Chapter Two described the complexity of HIV in South Africa, particularly for the 
next generation, who, on the one hand, may be protected from opportunistic infection by 
ART, but on the other hand, may suffer consequences of being on ART that is yet to be fully 
understood. Chapter One highlighted the complex causal pathway in which HIV is potentially 
related to subsequent deficits in auditory functioning, and children’s potential to optimize 
learning capacity.  Educators in schools in low socio-economic areas in South Africa often 
deal with large classes, and they may not have the time to understand the learning needs of 
each student (Spaull, 2013). There are emergent concerns regarding how children process 
information auditorily while hearing loss appears to be on the decline.  Teachers confronted 
by a child, whose health status may or may not be known to them, and who has difficulty 
learning, may not have the skills or the time to ensure that the child is supported adequately 
to optimise learning. Screening for hearing loss does not provide a full picture of 
impediments to how children learn, particularly in low socio-economic areas where parents 
may not have the money or knowledge to seek help for their child who has fallen behind at 
school. Anecdotally, there is so much pressure on teachers within the school system (i.e., 






underpinned by subtle health and developmental issues, may not receive the attention that 
they require.  
Methods 
Study Design 
This chapter describes four case-control dyads, matched as closely as possible by age, 
gender and hearing loss, and four case-case dyads, matched for age and gender, whose 
differences were hearing loss (one case with intact hearing, and the other with hearing loss). 
These comparisons were undertaken to provide insights into how these children might present 
in class.  
Process of Matching 
Case-Control Dyad. Cases were identified, with and without hearing loss, and 
matched controls were then sought. Matching cases and controls for the extent of hearing loss 
was difficult; however, because of the eight cases with hearing loss, six had hearing loss in 
both ears, while of the four controls with hearing loss, only one had hearing loss in both ears. 
The case-control dyads are listed in Table 19. 
Table 19: Case-Control Dyads - Age, Gender and Hearing Loss 
Cases Control 
ID Age  Gender Hearing loss ID Age  Gender Hearing loss 
72 10.1 Female None 489 10.8 Female none 
399 10.2 Male None 56 10.0 Male none 
353 11.7 Female Yes (one ear) 392 12.6 Female Yes (one ear) 






Case-Case Dyad. Cases were identified, with and without hearing loss, and matched 
for age and gender. It was easier to match cases with no hearing loss, with cases with hearing 
loss, because there were more cases with hearing loss in both ears. Table 20 lists the case 
with normal hearing and case with hearing loss dyads.  
Table 20: Case-Case Dyads - Age, Gender and Hearing Loss 
Case with normal hearing Case with hearing loss Extent of hearing 
loss 
ID Age  Gender ID Age  Gender  
138 9.2 Male 295 9.2 Male  Both ears 
72 10.1 Female 456 10.2 Female Both ears 
62 10.8.7 Male 6 10.4 Male Both ears 
94 12.4 Female 40 12.5 Female Both ears 
 
Reporting Standard. The case report followed the CARE reporting standards where 
possible (Gagnier et al., 2013). However, much of the background, methods, and results were 
reported in earlier chapters; thus, this chapter focuses on individual results and how children 
may present in class.  
Measures of Outcome. Three measures are reported in this chapter. Auditory 
processing is reported using the total factor score (as described in Chapter 5). Not every child 
in the dyads had auditory processing information, as intact hearing was required before 
undertaking these tests. The total factor score was derived from summing the number of 
deficits for each child for each auditory processing test, from the sum of two factors, derived 
from weighted variables. Factor 1 consisted of weighted GD only, and Factor 2 consisted of 






element if they scored below the expected median value (poor score). Higher factor scores 
thus reflected poorer auditory processing. 
Similarly, the factor scores for the capacity to learn were reported, where higher 
scores also indicated poorer capacity to learn. Only one factor was required, including TONI 
4, NMF, and NMR. The only common test across all children was the TONI 4 (which did not 
require intact hearing) because children with hearing deficits could not be tested for NMF and 
NMR. This measure of learning capacity is consequently also reported separately to the 
overall learning capacity factor score. For TONI 4, higher scores mean better performance.  
 
For comparison purposes, the individual case scores are compared with the 95% confidence 
intervals of these measures. This information is provided below. 
Mean (95%CI) AP total factor for all children with intact hearing: cases 1.3 (0.9-1.6); 
controls 2.2 (1.7-2.7). 
TONI 4 percentile for all children: cases 21.2 (95%CI 7.9-14.5); controls 39.9 (95%CI 14.4-
23.9). 
- For children with no hearing loss: cases 20.4 (95%CI 14.8-26.0); controls 40.6 (95%CI 
33.1-48.0). 









Case-Control Dyad 1: 72 (Case) / 489 (Control) 
This dyad described two ten-year-old females, both with intact hearing. The case had 
commenced ART when she was 4.4 years old (56.4% lifetime exposure to ART). Both 
children spoke Afrikaans at home and at school. The case had factor scores for auditory 
processing almost five times higher than the control (4.6 times higher); however, their 
capacity to learn factor scores did not differ significantly (0.71 and 0.61 respectively). Lower 
factor scores indicated good performance. The control had a TONI 4 percentile rank score 
nearly twice (1.7 times higher) that of the case, which indicated significantly higher non-
verbal intelligence. Information on family circumstances and child history was available only 
for the case. 
Reflection. This case-control dyad reflects a typical scenario that might confront a 
Grade 3 teacher. The CLHIV would present similarly in class to her peer who is HIV 
negative, in that her hearing is unaffected, and she is an appropriate age for her grade. Her 
capacity to process auditory information is significantly impaired; however, this is not 
reflected in the overall measures of her capacity to learn (NVIQ, STM, and WM). This 
suggests that she has perhaps developed her memory to compensate for auditory processing 
difficulties, and the impact on her nonverbal capacity to learn only becomes apparent when 
the TONI 4 score is considered on its own. As this study is cross-sectional, it is not possible 
to determine the sequence of development of compensatory mechanisms. However, from a 
teacher’s perspective, this child may not be flagged as having learning difficulties because 











Case-Control Dyad 2: 353 (Case)/ 392 (Control) 
This female case-control dyad was aged 11.7 years (case) and 12.6 years (control), 
respectively. They were both classified as being from the same population group (coloured), 
and both had hearing loss in one ear. They were both in Grade 6, and neither had repeated a 
grade. They both spoke Afrikaans at home, but the case spoke Afrikaans at school, and the 
control spoke English. The case’s TONI 4 percentile rank score was 30, compared with the 
control TONI 4 score of 39 (this being 1.3 times higher than the case). Their TONI 4 scores 
were both within the 95th% for cases and controls with hearing deficits, respectively. The 
case had commenced ART at age 2.3 years and has a history of TB or malaria. She was 
currently taking the following ARVS:  Lamivudine, Abacavir, and Efavirenz, and she had 
never defaulted on her ART. Her CD4 count was 1494, and she had been initially classified 










being cared for by a single parent, who was employed, and whose family income was 
R12600 per year.  
Reflections. The classroom ramifications for these females, of having a unilateral 
hearing loss, is that both would have some difficulty in a noisy classroom environment and 
learning may be compromised due to both children missing acoustic information, as well as 
being fatigued from having to listen with only one ear (Kuppler et al., 2013). Their capacity 
to learn was within expected limits for their peers (cases and controls), although the control 
had a 33% better score for the capacity to learn than the case. Although the case presents with 
many factors that are related to poorer neurocognitive skills, such as a history of TB/Malaria 
(Hrapcak et al., 2016; Nakku et al., 2017), being classified as WHO Stage 3 at diagnosis (Iloh 
et al., 2017) and being on Efavirenz (Hammond et al., 2019), being schooled in her primary 
language may mitigate some of the academic risks (Ouane & Glanz, 2011) posed by the other 
factors, as she has not yet repeated a grade.     
 
 
Case-Control Dyad 3: 399 (Case) / 56 (Control) 
These males were aged 10.2 years and 10.6 years, respectively. The case and control 
were classified as belonging to different population groups (coloured and white, 
respectively). Both spoke Afrikaans at school and home, and neither had hearing deficits. The 
case had commenced ART at birth and was taking Lamivudine, Abacavir, and Efavirenz. His 
CD4 count was 1600, and he had initially been diagnosed with WHO stage 1 HIV. The viral 
load was undetectable. He was being cared for by his married parents, and his mother had 






The case male had a total auditory processing factor score 1.6 times higher than the 
control, while his capacity to learn factor score was twice as high (the control having an 
uncompromised score of 0, while the case score was 2.1). This indicated difficulties with 
both auditory processing and the capacity to learn. The control’s TONI 4 score was 
significantly higher by three times than the case score, indicating the significantly better 
capacity to learn. The case score fell within the expected 95%CI (range 14.8-26.0) while the 
control score exceeded the expected 95%CI range (33.1-48.0), indicating that this control was 
performing in the top 5% of the control group with no hearing loss.  
 
 
Figure 7. Auditory Processing Capacity, Learning Capacity and NVIQ (Dyad 3) 
Reflection. A teacher will experience these two males very differently. The case will 
struggle to follow and process information but will function similarly to other CLHIV; 
however, the control may perform better than his hearing peers. When one looks at the case’s 
information, such as an initial WHO classification of Stage 3 (Iloh et al., 2017), using 














Case Control Dyad 4: 6 (Case) / 184 (Control) 
These males were aged 10.4 years (case) and 11.5 years, respectively. Both belonged 
to the same population group (coloured), and both had hearing loss (the case in both ears and 
the control in one ear). In this case, they spoke a language other than English, Afrikaans, or 
isiXhosa at home but spoke isiXhosa at school, while the control spoke Afrikaans at both 
home and school. The case had commenced ART at birth and was currently taking 
Lamivudine, Abacavir, and Efavirenz. His CD4 count was 873, and he had a viral load of 1. 
He had not defaulted on ART during his lifetime. He was being cared for by a single parent, 
who had reached Grade 11 and was unemployed. The annual family income was R59616. He 
had a history of meningitis and TB / Malaria and was in Grade 3. He had previously repeated 
a grade.  
The case’s TONI 4 score was six compared to the control’s score of 30. The case’s 
score fell well below the 95%CI for cases with hearing loss (13.4-31.9) while the control 
score was within the 95%CI range (95%CI 29.5-42.0). The control score was five times 
higher than the case score.  
Reflection. Teachers with these males in their class would find the case significantly 
impaired when it came to capacity to learn, compared with his peer who is HIV negative and 
has a unilateral hearing loss. Factors, although inter-related, that may be contributing to his 






neurocognitive skills. Similar to some of the other cases, the male is taking Efavirenz 
(Hammond et al., 2019), has a history of meningitis (Rodenburg-Vlot et al., 2015) and is not 
being schooled in his primary language (Ouane & Glanz, 2011). All of these factors have  
been associated with compromised neurocognitive skills (Hammond et al., 2019).  
Furthermore, he has a history of TB/Malaria, which has also been associated with hearing 
loss in CLHIV (Hrapcak et al., 2016; Nakku et al., 2017). 
 
 
For the comparison between cases with normal hearing, and cases with hearing loss, 
only the TONI 4 percentage rank was appropriate, as all other tests required intact hearing 
(Auditory processing, Number Memory Forward and Back). All hearing-impaired cases in 
this section had hearing loss in both ears.  
Case-Case Dyad 1: 72 (Normal Hearing) / 456 (Hearing Loss) 
This case-case dyad reflected two ten-year-old females. Case 72 was already reported 
previously as part of a case-control dyad. Both cases spoke Afrikaans as a primary language 
at home, although case 456 spoke English at school. Both commenced ART late (4.4 years, 
five years respectively), and both were taking the following three ARVs: Lamivudine, 
Abacavir and Alluvia. Case 72 was reported to have defaulted on ART at some stage, 
although there was no information about the period when this happened. The hearing intact 
case (72) had a history of TB –? malaria. Both females were cared for by single parents. The 
case with hearing loss came from a relatively higher-income family (in this dataset) (R22360 






R3360 per year (social grant), and the single parent was unemployed. There was no 
information regarding the parent’s highest level of education. The case with hearing loss had 
repeated a grade and was currently in Grade 3, while the case with normal hearing was in 
Grade 4. The case with normal hearing had a TONI 4 percentile rank score of 29, which was 
1.4 times higher compared with the case with hearing loss (score of 19). Both cases’ TONI 4 
percentile scores were within the respective 95%CI for cases. 
Reflection. Although the HIV status of both these children may not be known to the 
teacher, the teacher would probably be aware that the case with hearing loss has academic 
issues since she has repeated a grade. The case with normal hearing had many factors (e.g., 
low socio-economic status) associated with poorer academic performance. However, the 
impact of these factors may have been mitigated by having normal hearing and being 
schooled in her primary language, which was not the situation for the case with hearing loss 
(Ouane & Glanz, 2011). 
 
 
Case-Case Dyad 2: 138 (Normal Hearing) / 295 (Hearing Loss) 
The second case-case dyad described two nine-year-old males. Both had been on 
ART since they were approximately three years old (2.9 years of age, 3.4 years of age, 
respectively). Both spoke Afrikaans at home and at school. The case with normal hearing 
obtained a TONI 4 percentile rank score of 19, compared with a score of 22 for the case with 
hearing loss. Both cases were in Grade 3, and neither had repeated a grade. The case with 






Lamivudine and Alluvia, one was taking Abacavir, one was taking Zidovudine). Both had 
defaulted at some stage on their ART. The case with normal hearing had been designated at 
WHO stage 3 (indicating a more severe HIV state when initially diagnosed) while the case 
with hearing loss had been designated as WHO Stage 2. The case with hearing loss had a 
viral load of 2 and was being cared for by a single parent. No further information on social 
circumstances was available. The case with normal hearing had a viral load of 0, was being 
cared for by two parents, and the family income was R16200 per year (which came from a 
pension).  
Reflections. As with the first case-case dyad, the teacher may not be aware of the 
cases’ HIV status, nor of the implications of the disease. The case with normal hearing 
presented with more severe symptoms at diagnosis (WHO stage 3), as well as a history of 
meningitis, which has been associated with greater compromised neurocognitive skills (Iloh 
et al., 2017; Rodenburg-Vlot et al., 2015), perhaps explaining poorer TONI 4 scores. From a 
teacher’s perspective, the child with normal hearing may not be considered to be at-risk for 
learning difficulties as compromised neurocognitive skills may be less evident than hearing 
loss. These cases were not able to be compared for auditory processing (which required intact 
hearing); however, the child with normal hearing had an auditory processing factor score 
(2.9) that was greater than the 95% percent confidence interval for his HIV peers with normal 
hearing (95% 1.8-2.6) and a capacity to learn score of 0.71, which was within the 95% 
confidence intervals for the same peer group. These results imply that the case with normal 
hearing is performing similarly, in terms of capacity to learn, to his HIV positive peers with 
normal hearing (95% CI 1.3-1.9).  His poorer auditory processing score may be attributed to 
an immature auditory perceptual system, as variable performance on auditory processing 






Case-Case Dyad 3: 62 (Normal Hearing) / 6 (Hearing Loss) 
This case-case dyad describes two males aged 10.4 and 10.8 years, respectively. Case 
6 had bilateral hearing loss, while case 62 had normal hearing. Both had started ART 
relatively young - at birth (case 6) and at two months of age (case 62). One spoke English at 
home and school, and the other spoke a language other than English, Afrikaans or isiXhosa at 
home but spoke isiXhosa at school. The case with hearing loss had a history of meningitis 
and TB/malaria, while the case with normal hearing had a history of attention deficit disorder. 
Neither had defaulted on their ART during their lifetime, and the case with hearing loss was 
currently taking Lamivudine, Abacavir, and Efavirenz, while the case with normal hearing 
was taking Lamivudine, Abacavir, and Alluvia. CD4 counts of 873 were recorded for the 
case with hearing loss and 608 for the case with normal hearing. The case with normal 
hearing had a classification of WHO Stage 2. Both cases were being cared for by single 
parents, who had reached grades 10 and 11, respectively. The parent of the case with normal 
hearing was employed, with an annual family salary of R24000. The family income of the 
case with hearing loss was R59616, even though this parent was unemployed.   
There was a significant difference (more than four times)  between TONI 4 scores for 
these two cases. The case with hearing loss had a score of 6 (which fell well below the 
95%CI for cases with hearing loss (13.4-31.9)), while the case with normal hearing had a 
score of 27 (which exceeded the upper 95%CI (95%CI 14.8-26.0).  
Reflections. Teachers with these two cases in their class would notice the difference 
in their capacity to learn, specifically related to differences in hearing and significant 
differences in nonverbal intelligence (learning capacity). In this study, there was no 
association between hearing loss and capacity to learn, hence such a poor TONI 4 score was 






who are taking Efavirenz (Hammond et al., 2019) and in children who have had meningitis 




Case-Case Dyad 3: 94 (Normal Hearing) /40 (Hearing Loss) 
This case-case dyad described two females aged 12.3 years and 12.4 years, 
respectively. Case 40 presented with bilateral hearing loss. She had commenced ART at six 
months of age, while the case with normal hearing commenced ART at 16 months. The case 
with normal hearing spoke isiXhosa at home and English at school, while the case with 
hearing loss spoke Afrikaans at both home and school. The case with hearing loss had 
repeated a grade and was currently in Grade 6, while the case with normal hearing was in 
Grade 5. This suggests that the case with hearing loss may have commenced school earlier 
than the case with normal hearing.  
The case with normal hearing had a TONI 4 percentile rank score of 10, which was 
lower than the lowest 95%CI for CLHIV with normal hearing (95%CI 14.8-26.0). The case 
with hearing loss had a TONI 4 percentile rank score of 30, which was within the 95%CI 
range for her HIV positive peers with hearing loss (13.4-31.9) although she had a history of 
TB (or Malaria). Both cases were taking Lamivudine and Abacavir, while the case with 
hearing loss was taking Alluvia, and the case with normal hearing was taking Efavirenz. Both 
cases had initially been classified as WHO stage 3, and the case with hearing loss had an 
undetectable viral load. The case with normal hearing had a CD4 count of 1077, but there 
was no information on CD4 count of the case with hearing loss. Information related to social 






single working parent who had completed grade 9. The family income was reported to the 
R66000 per annum. 
Reflections. A teacher who has these two cases in their class may expect the case with 
hearing loss to display more learning difficulties than the case with normal hearing, as 
compromised capacity to learn is less obvious than hearing loss. For the case with normal 
hearing, being classified as WHO Stage 3 (Iloh et al., 2017) and being schooled in a language 
that was not her primary language (Ouane & Glanz, 2011) may have negatively affected her 
neurocognitive skills. An additional factor that may be associated with compromised 
neurocognitive skills is the use of Efavirenz (Hammond et al., 2019), particularly long-term 



















Case studies are currently making resurgence in scientific literature (Carey, 2010; 
Heale et al., 2016). They are being promoted as a way of interpreting group data into the real 
world, where healthcare providers, educators, or policymakers are required to make decisions 
on how best to manage individual cases (Plsek & Greenhaugh, 2001; Greenhalgh, Howick, 
Maskrey, 2014; McLean, 2016). Moreover, case studies enable patient complexities and 
individual issues to be explored in a way that cannot occur in large sample studies 
(Greenhalgh et al., 2015).  
When designing experimental studies, inclusion criteria must be carefully considered 
to ensure homogeneity of groups, and hence, comparability. Greenhalgh, Thorne, and 
Malterud (2018) argue that the increasing elegance ?of group designs potentially loses 
sensitivity that is inherent in individual cases. Sufficiently large sample sizes have been seen 
to provide confidence to end users regarding the generalizability of findings (Faber & 
Fonseca, 2014). However, when individual cases are complex, as is evident from the research 
reported in this dissertation, combining data into groups for analysis is likely to mask 
important findings that can inform clinical, policy, and educational practices (Plsek & 
Greenhaugh, 2001).  For this reason, case studies were felt to be informative in the current 
study. 
One of the drivers for undertaking this research was to assist CLHIV to make the 
most of their educational opportunities. International research on preteens with HIV has 
raised awareness that CLHIV continue to be affected by their diagnosis despite the enormous 
positive benefits of ART. The complex sociodemographic issues surrounding CLHIV in 






educationally may also be dealing with issues such as living in poor, single-parent families 
(or being the responsible carer for ill parents or younger siblings), being unable to study 
because of overcrowding at home, or not having access to a well-balanced diet (Sekgoka, 
Mothiba & Malema, 2013). The reluctance of many parents to provide details on home 
circumstances in this study highlights the difficulty in identifying and interrogating the 
factors that could be related to compromised learning, but the low annual income of the 
families of children recruited provides some insight in this regard.  
While this study focused on CLHIV, it was also clear that CNLHIV may experience 
barriers (social and medical issues) that could constrain their capacity to learn. These case 
studies also suggest that teachers may struggle to provide appropriate assistance to children 
who are not learning to their capacity, irrespective of their hearing deficits or HIV status. 
Decreased auditory functioning may present as inattention or behavioural problems, when, in 
fact, it may reflect undiagnosed hearing loss or a true neurocognitive barrier to learning. 
It is also important to note that teachers in primary schools in the poorer socio-
economic areas of metropolitan Cape Town often have fewer supports than teachers in 
wealthier schools (Pienaar & McKay, 2014). They may, for instance, have large classes and 
fewer teacher aides - if any. And parents may be unable to assist in the class, or even at home 
because they are working or have limited literacy.  
A teacher’s knowledge of the child’s social and medical history is also an important 
variable to consider: These dyads suggest that children who are taking Efavirenz, or who 
have experienced TB/Malaria infection in the past or have a disconnect between their home 
and school language, may be at risk of poorer auditory functioning and the capacity to learn. 






child’s performance. Thus, relying only on the group statistics to provide evidence for 
learning difficulties experienced by CLHIV, and their peers who are HIV negative, is 
insufficient to highlight the extent of barriers to the next generation of South Africans in 
making a better life for themselves. 
Despite best efforts, the small numbers in case and control samples in this study were 
unavoidable because of the previously unforeseen barriers to recruitment. Nonetheless, they 
served to highlight pertinent issues that can be further explored in future studies. 
Key Learnings 
Teachers need to be alerted to the fact that there may be children in their class who 
are at unforeseen risk of not learning efficiently due to medical and social issues. In addition 
to information related to these medical and social issues, profiles of  learners’ auditory 
functioning and learning capacities would enable teachers to design teaching activities that 
are mindful of the learners compromised capacities. For example, avoiding presenting  
complicated multiple-step instructions to a learner who has reduced WM capacity (Cowan, 









This chapter discusses the findings, as well as the limitations of the study.  Although 
research related to hearing has included the preteen population, to the researcher’s 
knowledge, no research has been reported on auditory processing capacities in this 
population. This population group has been neglected as HIV research has typically focussed 
on the developmental effects of HIV in young children or long-term consequences in adults.  
Given the paucity of information on auditory functioning in the preteen population, 
this study sought to describe hearing loss, auditory processing capacities and learning 
capacities, in preteens living with HIV.  
In particular, the study sought to address the following objectives: 
1. Describe a profile of hearing in CLHIV and CNLHIV; 
2. Describe a profile of auditory processing in CLHIV and CNLHIV; 
3. Investigate the predictor variables associated with hearing loss in CLHIV; 
4. Test the association between auditory functioning (hearing and auditory processing) 
and learning capacities (NVIQ, STM and WM) in CLHIV and CNLHIV 
Hearing profile of CLHIV and CNLHIV 
Prevalence of Hearing Loss  
The prevalence of hearing loss for the study population, consisting of both CLHIV 
and CNLHIV, was 19%. This was higher than expected as a previous study conducted in 
Cape Town reported estimated prevalence rates of hearing loss of 4.3%  for children aged 
four to nine years and 2.6% for children aged 10 to 19 years (Ramma & Sebothoma, 2016). 






Firstly, the current study included a high percentage of CLHIV; a population reported 
to have a higher prevalence of hearing loss (Ianacone et al., 2017; Nakku et al., 2017; Matas 
et al., 2006, 2010; Palacios et al., 2008; Taipale et al., 2011; Chao et al., 2012; Makar et al., 
2012; Torre et al., 2012; Torre et al., 2015; Hrapcak et al., 2016; Maro et al., 2016; Matsekete 
et al., 2014) which may have contributed to the higher prevalence rate observed in the study 
sample. Approximately one-third of the CLHIV presented with hearing loss. Although this 
finding is lower than that reported by Buriti et al. (2013), where included children were not 
all on ART, it is similar to other studies, also using pure tone audiometry, that reported on 
hearing loss prevalence rates ranging from 17% to 39% (Ianacone et al., 2017; Nakku et al., 
2017; Matas et al., 2006, 2010; Palacios et al., 2008; Taipale et al., 2011; Chao et al., 2012; 
Makar et al., 2012; Torre et al., 2012; Torre et al., 2015; Hrapcak et al., 2016; Maro et al., 
2016; Matsekete et al., 2014). 
Furthermore, the cut-off criteria for hearing loss in this study differed depending on 
the site at which the children were tested, with 15dBHL being used for tests undertaken in a 
soundproof booth (Northern & Downs, 2002) and 25dBHL being used for tests undertaken in 
quiet environments. Ramma and Sebothoma (2016) only used 25dBHL as the cut-off criteria 
for normal hearing, and the lower cut-off point that was used in this study for CLHIV may 
have resulted in a higher prevalence of hearing loss than what was reported by Ramma and 
Sebothoma (2016).  
Lastly, “volunteer bias” should be considered as a likely reason for the high 
prevalence rate.  “Volunteer bias” is a systematic error that occurs because the participants 
who volunteer to participate in a study may be different to the general population (Salkind, 






study, were concerned about their child’s hearing and agreed to the study as it provided an 
opportunity for the parent to address their concerns. 
Comparing prevalence rates across studies is difficult as these rates are not only 
influenced by the testing methods used but are also dependent on the demographics of the 
population being tested.  
Type of Hearing Loss 
Due to the testing methods used for CNLHIV, the type of hearing loss was only 
determined for CLHIV. Despite all the CLHIV in this study being on HAART, CLHIV 
presented with conductive hearing loss more often than any other type of hearing loss. 
Conductive hearing loss, which is generally associated with middle ear infections, has been 
reported as the most common type of hearing loss in HIV positive children (Ensink & Kuper 
2017). These findings are consistent with those reported by Palacios et al. (2008), Matas 
(2010), Chao et al. (2012), Matsekete et al. (2014), Torre et al. (2015), Hrapcak et al. (2016), 
Nakku et al. (2017) and Smith et al. (2017). The successful rollout of ART has resulted in 
reduced rates of opportunistic infections in CLHIV (Gona et al. 2006). Although HAART has 
been reported to decrease the occurrence of opportunistic diseases, time of treatment 
initiation appears to have an impact on the incidence of middle ear pathologies. Hainline et 
al. (2011) reported that early initiation of ART was associated with a greater decrease in the 
incidence of middle ear pathology than deferred initiation. Nakku et al. (2017) similarly 
reported an inverse relationship between duration of ART and hearing loss. These findings 
correlate with those of the current study as hearing loss was strongly associated with lifetime 
exposure to HAART. These findings suggest that deferred initiation or periods of 






(conductive hearing loss). However, due to the small sample, Type I error should also be 
considered. 
Profile of Auditory processing capacities in CLHIV and CNLHIV 
Auditory processing capacities were only assessed in participants with normal 
hearing. Performance on these tests was generally poor for both CLHIV and CNLHIV, with 
almost half (48.8%) presenting with poor auditory processing scores. All participants in this 
study came from lower socio-economic backgrounds and many were multilingual. Thus, both 
socio-economic status (Kraus & Anderson, 2015) and language (Loo, Bamiou & Rosen, 
2013) should be considered as possible reasons for the participants’ poor performance. 
 CLHIV performed significantly poorer than CNLHIV on the AFG and CWFR tests 
(p<0.05). These results correlate with the study hypothesis as auditory processing capacities 
were expected to be poorer in CLHIV.  Romero et al. (2016) reported poor performance in 
CLHIV for dichotic speech and attributed the poor performance to attention and memory. 
When considering the well-documented neurocognitive effects of HIV (Crowell et al., 2014; 
Laughton et al. 2013), the effect of working memory and cognitive ability on auditory 
processing (Moore, 2011) needs to be considered: (a) auditory processing disorders are 
defined as “difficulties in the perceptual processing of auditory information in the central 
nervous system and the neurobiological activity that underlies that processing” (American 
Speech-Language-Hearing Association, 2005); (b) HIV causes disruption in CNS activity, 
with subsequent neurocognitive impairment. Thus, cognitive ability and its effect on auditory 
processing capacities (Tomlin et al., 2015) is an important consideration when assessing 
CLHIV.  
Another important variable to consider in this study is the effect of home language on 






the AFG or CWFR tests, a greater percentage of children who performed poorly, did not have 
English as their home language. However, based on the small sample size, the probability of 
a Type II error occurring should also be considered.  
When examining the performance on the GD tests, although the difference was not 
significant, there was a trend towards significance (p=0.06), with the majority (60.7%) of 
CNLHIV meeting the pass criteria compared to a third (33.3%) of CLHIV. Although Maro et 
al. (2016) reported similarly findings to this study, that CLHIV did not perform significantly 
poorer than CNLHIV, the lack of significance for both studies may have been due to the 
small sample.  
The use of factor weighting, albeit on a small sample provides a better indication of 
the relative importance of the individual components than simply combining binary (1,0) 
forms of each measure into a composite score. Providing the data in two separate ways gives 
readers the opportunity to consider individual auditory processing measures or one composite 
measure. Individual scores may assist in planning therapy goals, but composite scores are 
useful as a screening tool to determine which children should be referred for diagnostic 
assessment. 
 
CLHIV: Variables associated with hearing loss 
The only variable in this study that was significantly associated with hearing loss, was 
lifetime exposure to HAART. The findings therefore suggest that treatment should be 
initiated as early as possible to reduce the likelihood of hearing loss.  These findings are 
consistent with Nakku et al. (2017), who reported a direct relationship between duration of 






HIV status, auditory functioning and learning capacities 
The study results supported the hypotheses, namely, that HIV status is related to 
poorer learning capacities in children with, and without, hearing loss;  that HIV status is 
related to auditory processing capacities in children with no hearing deficits. Gender and 
primary language spoken at home, or school, did not appear to be related to auditory 
processing performance and learning capacities, and auditory processing appeared to be 
strongly and positively correlated with learning capacities in children without hearing 
deficits. The findings also suggested that STM might be affected for CLHIV with normal 
hearing, whose lifetime exposure to ARV was less than 75%. Furthermore, it can be said that 
there are complex causal pathways for paediatric auditory processing, HIV status, ARV 
lifetime exposure, and learning capacities, and that these require further investigation in 
larger samples (Hill, 1965).   
Overall, an average performance for learning capacities was obtained for our sample 
(Brown, Sherbenov & Johnsen, 2010) (TONI 4 percentile rank score of 25 to 75). However, 
after stratifying the sample by HIV status, the CLHIV performed significantly poorer (with 
percentile rank scores corresponding to “below average” ratings) than the CNLHIV (rated 
“average”). These findings agree with those reported by Laughton et al. (2013) in their 
review of 11 studies on the neurocognitive effect of HIV. One of the impacts of HIV reported 
by these authors was poorer school performance and lower non-verbal scores than those of 
CNLHIV. HIV has been shown to negatively impact neurocognitive development with the 
major neurocognitive disorder being reported for simultaneous processing, planning, and 
nonverbal index on the Kaufmann Assessment Battery for Children – second edition 
(Musindo et al., 2018). Similar findings were also reported for 9-15-year-old children, with 






(Brackis-Cott et al. 2009). Although these tests differ from the nonverbal test used in our 
study, these verbal tests are also considered to measure cognition. These authors noted that 
the poor outcomes on the cognition tests were not necessarily related to HIV, as the 
children’s performance was  similar to that of children in studies of uninfected participants 
living in poor neighbourhoods. This notion that poverty influences cognition is supported by 
Sherr et al. (2009) as they suggested that neurocognitive ability was not necessarily a result of 
HIV status, but that family, environment, and treatment also influenced this ability.  
Causal Path 
 The analysis undertaken in this research was based on a theory-driven, hypothesised 
causal path using the Bradford Hill (1965) mechanisms of causality (Appendix D). This 
causal path described HIV as an antecedent cause of auditory processing and hearing loss 
(exposures), with the primary outcome of nonverbal intelligence (learning capacity). 
However, the mechanisms by which HIV or its treatment impacts children’s ability to process 
auditory information are not understood (Dawood et al., 2019), and this study demonstrated 
that even if CLHIV have normal hearing, they can have significant deficits in their auditory 
processing capacities. How auditory processing capacities relate to nonverbal intelligence is 
also unclear, as is the directionality of the relationships (de Wit et al., 2016; Tomlin et al., 
2015).  
HIV is now widely considered to be a chronic condition, and many CLHIV are living 
relatively normal lives, with near-normal life expectancy, on medications that manage their 
HIV infection (Melhuish & Lewthwaite, 2018; Gates & Cysique, 2016; Lewthwaite & 
Wilkins, 2009). However, like other chronic diseases, living with HIV may be associated 
with co-morbid conditions, such as dyslipidaemia (Innes et al., 2015; Tadesse et al., 2019).  






known that HIV is associated with lower socio-economic circumstances (Bunyasi & Coetzee, 
2017; Steinert et al., 2017). Thus, CLHIV have been reported as having a greater burden than 
might be suspected because not only are they dealing with their health, but they often have 
family circumstances where parents/caregivers are also affected by HIV (Newlin, Reynold, & 
Nombutho, 2016; Pufall et al., 2014). This could mean ill or deceased heads of families, 
parent unemployment due to ill health, or poor living circumstances due to low family 
income (Pufall et al., 2014). Moreover, it may mean that families are headed by grandparents 
(Mtshali, 2016), extended family, or children themselves (Newlin et al., 2016). 
Clinical implications of study 
Improving their Circumstances. South Africa is an economically and culturally 
diverse country with a large inequity in opportunity, income, employment, education, and 
health status (Sulla & Zikhali, 2018). CLHIV must therefore be empowered to improve their 
circumstances; otherwise, the same poverty cycle as affects many of their families will 
influence their chances in adulthood (Sulla & Zikhali, 2018). One way to assist children 
living with HIV is to ensure that they have educational opportunities at least as good as their 
uninfected peers (Spaull, 2013; Statistics South Africa, 2017). In most South African 
classrooms, learning occurs through the exchange of auditory information between educator 
and learner. This requires the learner not only to hear properly but also to process the 
information they hear in order to make sense of it. The mechanism by which HIV affects 
hearing in children is believed to be primarily through conductive mechanisms (Ensink & 
Kuper, 2017), which can be affected by opportunistic infections such as middle ear 
infections. This is the area in which HAART has had the greatest impact, in that it has 
reduced the child’s susceptibility to opportunistic infections (B-Lajoie et al., 2016; Gona et 






irrespective of HIV status, with the incident peaking at two and five years (Robb & 
Williamson, 2016). Attending a day-care, limited breastfeeding, seasonal changes, passive 
smoking (Robb & Williamson, 2016), and low socio-economic status (Hunt et al., 2017; 
Karppinen et al., 2019). Hearing loss, however transient, can impact children’s language, 
ability to learn, and social interaction (Madell, Hewitt, & Rotfleisch, 2018). 
The Emerging Impost of Living with HIV. This research showed that while hearing 
loss prevalence is no longer greater in CLHIV compared to their uninfected peers, there are 
other constraints on these children’s capacity to learn. For instance, a child’s inability to 
localise sound and listen to speech in noise may result in compromised ability to listen 
effectively in confusing and noisy environments (e.g., a typical classroom) (Bamiou, Musiek, 
& Luxon, 2001). Furthermore, poor auditory discrimination has been linked to reading and 
spelling difficulties, while poor auditory pattern recognition has been linked to difficulties 
following oral instructions (Bamiou et al., 2001).  
This study suggests that there may be a relationship between the inability to process 
auditory information and learning capacities. Thus, healthy CLHIV with normal hearing 
should still be considered as learners with special educational needs (Tikly & Barrett, 2011). 
Undiagnosed auditory processing difficulties, although invisible, has the potential to severely 
impede a child’s capacity to learn (Tomlin et al., 2015), and by implication, their long-term 
capacity to leave the poverty trap. Thus, CLHIV have potentially less visible problems than 
they might have had previously, i.e., they are not sick (B-Lajoie et al., 2016; Gona et al., 
2006); however, they may be carrying an equally problematic burden of the disease that is no 
longer as visible or easily addressed. By implication, health and educational services in South 
Africa therefore need to recognise the new wave of ramifications of HIV and plan for these  






Measuring Auditory Processing. The systematic scoping review undertaken when 
first framing this research identified only five studies on auditory processing capacities in 
CLHIV. The evidence was inconclusive regarding the association between HIV, and auditory 
processing difficulties as the studies did not necessarily assess the same auditory processing 
capacities, and findings were, therefore, not comparable (Dawood et al., 2019). As a result, 
the limited data could not be used to guide the development of the auditory processing test 
battery that was constructed for this study. Auditory processing was, therefore, reduced to 
auditory processing capacities as these skills were measurable. Currently, there is no standard 
internationally accepted comprehensive auditory processing test battery (British Society of 
Audiology, 2018; Keith, 2009b). While this precludes best practice measurement of this 
construct, it may also be contributing to the hidden nature of auditory processing deficits. 
Moreover, current auditory processing test batteries include tests that require intact language 
systems and are, therefore not suitable for use across linguistically and culturally diverse 
populations (DeBonis, 2015). Future research in auditory processing should include 
functional assessments (e.g. questionnaires) that are less susceptible to the influences of 
cognition, language and socio-economic background of the child. 
Critique of study 
Overview of Sampling Concerns. Children with and without HIV may come from 
varying SES backgrounds, for instance, single or no-parent families, low income homes, low 
caregiver literacy, poor understanding of hygiene, little understanding on how to optimize 
learning (Poudel et al., 2017; Pufall et al., 2014; Sekgoka et al., 2013). These complex and 
interrelated issues make robust sampling difficult, and assumptions need to be made 
regarding the homogeneity of sample estimates. One assumption is that children who live in 






characteristics. This is similar to studies using postal/zip codes. However, in South Africa, 
this assumption may not necessarily hold for all residents of a suburb and can lead to 
misclassification bias, as suggested by Lieu & Dewan (2010). The vestige of Apartheid, 
specifically the Group Areas Act of 1950, is that South African suburbs and towns are still 
segregated on racial lines, rather than purely on socio-economic lines, as people were forcibly 
moved to areas based on their classified race (Khalfani & Zuberi, 2001).  
South Africa is a culturally and racially diverse country with 11 official languages 
(South African Government, n.d.-b), of which three are official in the Western Cape - namely 
English, Afrikaans and isiXhosa (Western Cape Government: Department of Cultural Affairs 
and Sport, 2019). Children are variably fluent in at least two of these languages because they 
are required to study two languages (home language and first additional language) in all 
South African schools (Department of Basic Education, n.d.). Depending on the language in 
which they are taught in school, there may be a mismatch between the language spoken at 
home and educational language, with resultant academic difficulties in the learning 
environment (Taylor & von Fintel, 2016). Thus, performance on assessment measures, which 
were typically only available in English, may have been compromised due to the mismatch 
between language of assessment and home language.   
Sampling CLHIV. An unexpected difficulty was encountered when recruiting 
CLHIV for this study. Opportunities to access South African population registers are 
governed by strict legislation, Protection of Personal Information Act 4 of 2013 (South 
African Government: Department of Justice, 2013), thus access to the population registers of 
CLHIV were limited, which constrained robust sampling. This was known before study 
commencement, and thus, a purposive, personal recruitment approach was designed. In the 






ART in line with provincial health policy (Provincial Government of the Western Cape: 
Department of Health, 2018). Thus, accessing children through an IDC in one large tertiary 
hospital in the Western Cape, which serviced a large socioeconomically disadvantaged 
population, was considered to be an appropriate recruitment site. What was not clear until 
recruitment started was the reticence of many parents/caregivers attending with the child on 
their follow up appointment, to enrolling their child in the study. However, Hudson et al. 
(2017), in their review of 215 studies looking at recruitment strategies in children with life-
threatening conditions, reported similar issues. There were many reasons for recruitment 
difficulties including parent reluctance to take the child out of school for testing; concern 
with the child being involved with even more research (there were many concurrent research 
projects on CLHIV being conducted at this hospital); and perhaps less well articulated, 
concerns that the child’s health status would become known at school and thus would attract 
stigmatisation.  Moreover, participation in this research required parents/caregivers to 
complete a questionnaire that required a level of literacy, and despite offers to assist them to 
complete the questionnaire verbally, they were still reluctant. The possible reasons for poor 
recruitment in this study concur with those that have been reported for other studies involving 
children with other medical conditions (Hudson et al., 2017; Nguyen et al., 2014).  
Incentives in the form of a free, comprehensive hearing test was offered. Control 
children received this at school, while CLHIV were required to travel to the tertiary hospital 
to receive it. Their parents were given a small travel allowance. Hearing screening is not 
routinely provided in South African primary schools despite its importance being recognised 
in the Integrated School Health Policy (Department of Health & Department of Basic 
Education, 2012). Thus, the children who participated in this study had the opportunity to 






this service or paying for it in the private sector.  Although the policies exist to support 
universal hearing screening within the school environment, implementation has been 
hampered by poor collaboration between the various stakeholders and lack of resources 
(trained staff and equipment) resulting in many children not being tested (Lenkokile et al., 
2019; Rasesemola et al., 2019).   
Sampling CNLHIV. There were similar, unexpected findings when recruiting control 
children (uninfected). However, poor recruitment has similarly been reported by Mirick 
(2016) for non-probability sampling. Initially, it was hoped that sufficient CNLHIV could be 
recruited to enable matching with CLHIV for age, gender, language, and educational grade. 
However, very similar barriers to recruitment were found for controls, and considering that 
non-probability sampling was used for both groups, similar issues can be expected (Mirick, 
2016). Some schools are aware of children’s HIV status, but there are ethical restrictions on 
disclosing this information. Thus, one school was chosen (Full-service school) as the source 
of controls because HIV status was known to the school administration. No personal, face-to-
face contact  was made with parents/caregivers to discuss the study (as was possible for 
parents/caregivers of CLHIV). Thus, recruitment of controls required parents reading, 
understanding, and replying to a written invitation sent home with the child. Although 
literacy may have been an issue in this sample, Mirick ( 2016) and Hudson et al. ( 2017) has 
also reported on the difficulties in executing research where there are multiple levels of 
gatekeeping (school, parent and child) as “buy-in” may occur at one level but enrolment into 
the study is not guaranteed. Given the several reasons why parents may not have responded 
and the concerns of three parents who refused participation, it appears that better sampling 






Potential Biases. The small study sample was disappointing and constrained 
confidence in the findings. Similar low recruitment rates, where less than 50% of eligible 
participants were recruited, were reported by Hudson et al. (2017). While most of our 
findings reflected others’ research findings, the wide variability in our findings highlighted 
the potential for Type II errors, as well as the need for further research. We suspect that 
volunteer bias influenced the sample as, anecdotally, some parents said that they wanted their 
child to be tested because they suspected a problem. These parents were, therefore, motivated 
to enrol their child into the study. According to Lieu & Dewan (2010), self-selection resulting 
in volunteer bias has been reported in studies about hearing loss and possible reasons for 
parents agreeing for their child to participate was that they would receive confirmation or 
additional information about an issue of concern. Another concern was that parents of 
CLHIV who had low levels of literacy and who did not speak the same language as the 
investigator, it may have been easier to refuse permission initially or to agree to participate 
and then fail to attend (as happened for 48.9% of consenting CLHIV). For parents of controls 
who had low levels of literacy and who received the written invitation via the school, it may 
have been easier to refuse permission or not return the form, than to find out more about the 
study. Thus, parents from both groups may not have had sufficient health knowledge to 
consider the benefits of participation (DeWalt & Hink, 2009). Moreover, due to ethics 
requirements, the invitation letter spoke about HIV and thus some parents of control children 
may have misinterpreted the intent of the study and the role that their child might play therein 
(Hudson et al., 2017). 
Measurement of learning capacities. The relationship between capacity to learn, 
school performance, auditory processing difficulties, as well as hearing loss, has been 






2017; Tomlin et al., 2015). Adding HIV status and its attendant socio-economic concerns in 
the diverse country that is South Africa complicates this causal relationship. There is no 
standard definition for learning capacity, nor is there an agreed test. Different assessments for 
the capacity to learn may include verbal IQ, non-verbal IQ, and  academic progress (e.g., 
achievement in reading) (Lakin, 2012). Given  SA’s  language diversity, race and family 
circumstances, the choice of a non-verbal measure of capacity to learn was likely to provide 
the least biased measure and to ensure that no child was discriminated against (Brown et al., 
2010; DeThorne & Schaefer, 2004). 
Not all children were able to complete the working memory tests because intact 
hearing was a requirement as a hearing loss would impact performance (Martin & Brownell, 
2005). 
Language Disconnects. Our findings suggest that children who learn in a language 
other than their home language may be disadvantaged in terms of an opportunity to learn 
(Taylor & von Fintel, 2016; Prinsloo, Rogers, & Harvey, 2018). These children may be 
misdiagnosed as having cognitive difficulties when in fact, they are simply struggling with 
the mismatch between home and school, particularly if the home environment does not 
support them to achieve their best (Taylor & von Fintel, 2016). Examples of this may be 
where caregivers do not speak the academic language, are illiterate, are drug or alcohol 
affected, chronically unwell, too young or old to assist the child, or absent from home for 
long periods because of migrant work. Moreover, one of the post-apartheid legacies is the 
continuing reality that despite the integration of three schooling systems (white, coloured, 
black) into one, there remains inequity in terms of school resources (McKeever, 2017). Some 
parents choose to send their child to a school where the home language is not spoken on the 






who has to learn in a different language and culture, which becomes exponentially more 
difficult if the child has auditory processing problems (Prinsloo et al., 2018).   
Reflections on the Data. There was a large amount of missing data from hospital 
records, which precluded extraction of information on important measures such as CD4 
count, viral load, compliance with ART, and other medical histories that may have impacted 
the child’s auditory processing capacities and learning capacities. Moreover, parents were 
universally reluctant to provide medical, social, and academic information on their family, 
and it was impossible to find information from independent school records on child scholastic 
performance because access was denied. Incomplete information was provided by some 
teachers and this was not sufficient to enable interrogation of scholastic performance, 
capacity to learn, and auditory processing.  Difficulties in accessing accurate records reflected 
the difficulties of obtaining information in low socio-economic environments where lack of 
money, time, and standard databases compounded the availability of standard, easily accessed 
information as might expected in a first world country.  
The clinical nature of the data used in this study provided both advantages and disadvantages. 
The advantages were that it reflected clinical data collected under clinical conditions. 
Therefore, any relationships found between the screening and diagnostic test results for APD 
would reflect relationships that exist under clinical rather than laboratory conditions. The 
disadvantages were that it contained missing data that required the use of case-wise (and, in 
one instance, list-wise) deletion of missing data in the correlation and regression analyses and 
because it was likely to contain errors of a clinical nature that might have been avoided under 
laboratory conditions.  






1. Barriers to robust recruitment in preteen CLHIV and uninfected children from low 
socio-economic areas in South Africa should be better understood before future study 
commencement. This will enable environment-specific recruitment strategies to be 
developed that address the concerns of parents/caregivers in giving consent for their 
children to participate in research; 
2. There is a need for a comprehensive and ubiquitous test battery for auditory 
processing that is appropriate for any child, in any circumstance; 
3. The TONI 4 was an appropriate measure of (nonverbal intelligence) learning capacity 
because it was accessible to all children , irrespective of hearing loss or primary home 
language;   
4. Hearing loss was a concern for both preteen CLHIV and uninfected children; 
5. CLHIV without hearing loss had poorer auditory processing capacities than their 
CLHIV, and their auditory processing scores correlated with their NVIQ: 
6. Children who did not learn at school in their home language (mostly children with an 
African home-language) appeared to perform more poorly on the auditory processing 
tests and the learning capacity tests, compared with children who learned in their 
spoken home language; 
7. The educational needs of pre-teen children with hearing loss, or HIV, should be 
considered on an individual basis;  
8. A preliminary audit of the medical records of CLHIV should have been undertaken to 
identify data items that were likely to be incomplete, so that this could be sourced 
elsewhere during data collection. Moreover, permission should have been sought from 
children’s parents and their schools in order to access information on school 






9. Future research into auditory processing and learning capacity of preteen South 
Africans should aim to:  
a. Collect larger samples so that case complexities can be better understood by 
robust subgroup analysis. This will require a more robust sampling frame 
based on qualitative research findings, which have identified the reasons 
underpinning parents’ or caregivers’ reluctance to allow their children to 
participate in research.   
b. Develop a comprehensive list of data items that explores not only the objective 
measures of auditory functioning and learning capacity but also social factors 
that may impact negatively on a child’s educational performance.  
c. Use multiple measures that reflect clinical, as well as research imperatives, 
and which enables all children to participate equitably in testing, irrespective 
of HIV status, hearing loss, or primary home language. Measures are required 
to determine hearing loss relevant to the testing environment, provide access 
to all potentially-useful measures for auditory processing for children with 
intact hearing, and use a measure of non-verbal intelligence (learning 
capacity) that does not discriminate against children with hearing loss, or 
whose primary home and school languages differ.  
d. Explore the impact on auditory processing and cognition, of ART and drugs 
for TB/Malaria, in preteen children who need the best start possible to their 
learning.   
10. Teachers need to be alerted because there may be children in their class who may be 
at unforeseen risk of not learning efficiently because of medical and social issues. 






and parents may be unaware, that compromises the child’s educational potential. 
While the findings reported in this dissertation are not sufficiently robust to spark 
immediate action (because of the potential for Types I and II error), they do flag the 
notion that a risk profile could be developed of children who may struggle to achieve 
their academic potential. Such a risk profile could alert teachers to alternative 
explanations as to why a child is not doing well in class.  Moreover, a risk profile 
could be applied at the beginning of any new school year, to assist the teacher to 









This study attempted to use non-discriminatory methods to assess auditory 
functioning and nonverbal intelligence in preteen children with different language and 
cultural backgrounds, from a low socio-economic environment in metropolitan Cape Town, 
South Africa. An equitable way of measuring auditory processing was proposed, despite the 
lack of an industry standard. Sampling and recruitment issues compromised the power of this 
study in producing believable findings, as well as generalisability of findings. These issues 
were unexpected, as was a large amount of missing data in hospital records and from parents. 
Despite this, this study adds to the scarce body of knowledge about the auditory processing 
capacities of children who live with chronic HIV and its impact on their capacity to learn. 
This appears to be significantly poorer than in uninfected children. Ensuring that preteen 
children have the best possible opportunities in life begins with maximizing their learning 
potential. Preventing hearing loss in children with and without HIV, from low socio-
economic backgrounds, is only one element thereof. The more subtle implications of living 
with HIV on children’s capacity to process auditory information, and learn, would appear to 
be the next challenge for healthcare professionals and educators.  
Further studies are urgently needed in this area to ensure that CLHIV are not 
disadvantaged in achieving their learning potential. Studies should first concentrate on 
optimising recruitment by understanding why parents in low socio-economic environments, 
are reluctant to provide consent for participation in studies such as these. From what was 
learned in this study, this was a problem irrespective of the child’s HIV status. Developing 






low socio-economic areas in South Africa are therefore essential to ensure that future studies 
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Abstract: Introduction: In South Africa, HIV affects approximately 1:3 
children under 12 years.  Most children commence antiretroviral therapy 
(ART) as soon as they are diagnosed.   Amongst other health benefits, ART 
protects children from opportunistic infections; such as chronic ear 
conditions, which can result in hearing loss.  However, living with HIV 
as a chronic disease may challenge children's health and development in 
other ways.   
Objectives: In this study we investigate the prevalence of hearing loss 
in a group of 9 to 12 year old, school going children, test for 
associations between hearing loss and key physiological, health history 
and family circumstance predictor variables. 
Methods: Children (HIV positive) were consecutively recruited from the 
Infectious Disease clinic at a XXX tertiary hospital servicing a low 
sociodemographic area. Audiologic assessments comprised parent 
questionnaire, otoscopy, tympanometry and pure tone testing from 250 
through 8000 Hz.  Hearing loss was defined as a pure tone average (500Hz, 
1000Hz and 2000HZ) greater than 15db hearing level (HL) assessed in a 
soundproof booth. Descriptive statistics and measures of association were 
reported.   
Results: Data was collected on 23 eligible, consenting children, aged 9 
to 12 years old. Hearing loss prevalence was 34.8%. There was a 
significant association between hearing loss and less than lifetime 
exposure to ART, OR = 4.4 (95% CI 1.1-18.5). There was no association 
between hearing loss and any other variables.  
Conclusions: The findings suggest that hearing loss, perhaps related to 
opportunistic infections such as middle ear infection, continue to be 
present in HIV infected children, despite them being on highly active 
antiretroviral therapy (HAART). This may be associated with non-exposure 
to ART at some stage during their lifetime, which may have been due to 
late diagnosis, late initiation of HAART or non-compliant periods. 
 













































































South Africa continues to have the biggest HIV epidemic globally 
1
 and is currently home to 260 
000 [200 000–360 000] children living with HIV, aged 0-14 years, with new infections in this 
age group reported to be 14 000 [11 000–35 000] per year 
2
.  
However, South Africa also has the most extensive antiretroviral (ARV) programme in the world 
1
. This has resulted in near-normal life expectancy for the approximately 163 000 children, or 
63% [49–87%] of infected children, who are on ARVs 
1,2
. For these children, HIV is no longer 
considered a terminal disease but rather a chronic condition that may be accompanied by various 
disabilities 
3
, including hearing loss 
4
. 
High prevalence of hearing loss has been reported in both HIV-infected adults and children, with 
the bulk of the literature on adults 
4
. Estimated prevalence in the paediatric population varies 
from 6% to 84% depending on the assessment measure used, as well as the age of the children 
4
. 
Many variables have been associated with hearing loss, including the HIV disease itself, ARV 
use, opportunistic infections such as otitis media, meningitis and tuberculosis, as well as ototoxic 
treatment for opportunistic diseases 
4
. 
The aim of this study was to investigate the prevalence of hearing loss in a group of 9 to 12 year 
old, school going children, and to test for associations between hearing loss and key 
physiological, health history and family circumstance predictor variables. 
METHODS 
Ethics: This research was approved by the Health Research Ethics Committee of XXX 
University on 22 March 2016 (Reference number S15/10/220).  Permission for conducting the 
study was also obtained from the XXX Department of Health (XXX DoH) and the relevant 
*Manuscript









































































tertiary hospital where recruitment occurred. Written informed consent was obtained from 
children, and their parents/caregivers after the study had been explained to them. 
Sample reported for this paper: This study reports on cases (HIVP children) recruited for a 
larger study (which was an unmatched case-control study of HIVP and HIVN children aged 9-12 
years). 
Source of HIVP children: One large tertiary metropolitan hospital in XXX provided access to 
paediatric HIV cases attending its Infectious Diseases Clinic (IDC).  This hospital provided 
services for over 3.4 million people in surrounding socioeconomically disadvantaged suburbs, 
most of whom relied on public health care.    
Sampling: Convenience sampling occurred at point of contact with the IDC between June 2017 
and November 2018, although consecutive sampling occurred on each recruitment day.  This 
was the most efficient approach to recruit HIVP children to this study
5
, to deal with the difficulty 
in accessing comprehensive records for random subject selection, parent suspicion of being 
approached by researchers, stigma, or the problem of HIVP children being over-researched).  
Sample size calculation: The IDC at the participating tertiary hospital had records of 836 patients 
on ART at the end of February 2017. This included 412 children (aged 0 to 18 years).  Attempts 
were made to recruit all 110 children who were aged 9-12 years, and who were on the register to 
attend the IDC for medical follow up appointments. The IDC operates from Monday to 
Wednesday (8h00 – 13h00), with the majority of paediatric appointments available on Tuesdays. 
The researcher attended the IDC and physically identified and recruited eligible children on each 
clinic day. Each morning, the medical records (folders) of all children with appointments for the 
particular day were accessed at the IDC, and the researcher identified all potential candidates 









































































approached and informed about the study.  If they were interested, the child’s eligibility was 
confirmed by questioning, and if caregivers consented, the child was enrolled in the study.  A 
small reimbursement for travelling costs was offered to each family to assist in bringing the child 
for testing.   
Inclusion and exclusion criteria: Boys and girls were included if they had: (1) documented HIVP 
status; (2) were aged between 9 – 12 years; (3) had verbal proficiency in at least one of English, 
XXX or XXX language; (4) were enrolled in at least Grade 3 in a mainstream primary school; 
and (5) had the ability to understand and complete a consent form.  Exclusion criteria were: (1) 
comorbid conditions causing cognitive impairment (e.g. neurological conditions) that could 
affect understanding of, and performance in, the assessment batteries; (2) cognitive impairment 
(e.g. intellectual disability) that could affect understanding of and performance on the assessment 
test batteries; or (3) on a waiting list for, or enrolled, in a school for learners with special 
education needs.  
Study measures: We tested for hearing loss, and collected caregiver reports and/or case note 
information on lifetime exposure to ARVs, history of serious illness likely to affect hearing 
(malaria, TB or meningitis); gestational age, birthweight, current CDC4 count, estimate of viral 
load, World Health Organisation HIV stage, school performance, caregiver relationship to child, 
caregiver marital status, employment capacity and level of education; and family income.   
Hypotheses: We tested:   
1. The prevalence of hearing loss (HL); 
2. Whether HL was associated with predictor variables including:  
a. Lifetime exposure to ARVs; 









































































c. Gestational age 
d. history of repeating school grades, or absence from school; 
e. history of meningitis, TB or malaria; and  
f. family circumstances (person in caregiver role, level of caregiver education, 
family income).   
Measurements: A standard case history was taken by interview from the primary caregiver as the 
initial step in the paediatric audiologic test battery
6
. This provided important information 
regarding the nature of the auditory complaint, possible contributing factors, developmental 
progress, communication abilities and academic achievement
6
.  Information was corroborated or 
expanded by reviewing the child’s case history. The case history interview also included relevant 
health and medical information, as well as information on the child’s academic progress and 
hearing capabilities. If the caregiver preferred, the questions were administered verbally in their 
chosen language (i.e. English, XXX or XXX). The interview format allowed the primary 
investigator to probe for answers where necessary, and to clarify questions that were not 
understood
5
.  This was only done when the caregiver was unable to provide an adequate 
response. In addition, the verbal administration of the questionnaire ensured that caregivers were 
not excluded based on literacy levels. In all instances however, to ensure consistency of data 
collection, question wording was strictly adhered to, as it appeared on the questionnaire.   
An otoscopic examination investigated the condition of the outer ear and tympanic membrane 
using a Welch Allyn pocket otoscope
6
. This was included in the test battery to determine 
abnormalities of the outer ear and tympanic membrane, reported in people who are HIV 
positive
7









































































perforations of the tympanic membrane were recorded on the audiogram. If abnormality was 
noted, the child was referred to the treating doctor for medical management.  
Tympanometry was conducted to assess the transmission of sound through the middle ear 
6
. This 
component of the test battery was included, as research has reported an increase in abnormal 
middle ear function in persons with HIV
7
. After the audiologist explained the procedure, 
tympanograms were obtained using a GSI Tympstar with a 226 Hz probe tone. The pressure 
direction was from positive to negative (200 to -400daPa). The results were recorded on the 
audiogram, and the following parameters were used to indicate normal middle-ear function: 
Type A tympanogram with a middle ear pressure of -100 to =100 daPa; acoustic compliance of 
0.3 to 1.7 ml; and ear canal volume of 0.4 – 1.5 ml.  Participants presenting with abnormal 
tympanograms were referred to the treating doctor (IDC) or their closest clinic for medical 
management.  Pure tone audiometry was conducted to determine the behavioural hearing 
thresholds of each participant as well as the type of hearing loss
6
. This component of the test 
battery was included as research reports that hearing loss is associated with HIV
8,9
. 
Pure tone audiometry was performed in a sound proof booth, using a GSI 61 audiometer. 
Circum-aural earphones were used and air conduction thresholds were obtained at 250Hz, 500 
Hz, 1000 Hz, 2000Hz, 4000Hz, 8000 Hz as per conventional audiometry
6
, for the left and right 
ears separately. All thresholds were plotted on an audiogram.  Bone conduction threshold testing 
was only conducted at frequencies where the air conduction threshold was >15dBHL, to 
determine the type of hearing loss; i.e. conductive, sensorineural or mixed hearing loss.  If bone 
conduction threshold testing could not be completed, tympanometry results were used to 




























































































Figure 1. CONSORT Diagram for case children  
Assessed for eligibility n=110                       
Excluded HIVP n=87  
1. Declined to participate (n=52) 
2. Not meeting inclusion criteria (n=13) 
3. Did not attend study appointment 
(n=22)  
Analysed (n=23) 











































































ART descriptors: Data was available for all 23 cases regarding ART history.  Considering the 
percentage of the child’s life spent on ART, the average percentage of life spent on ART was 
78.5% (SD 20.7%) (range 23-6% - 100%).   All children were on HAART, with 22 of the 
children (95.6%) being on 3TC; N=21 (91.3%) being on ABC; N=16 on Aluvia (69.5%); N=7 
(30.4%) on EFV; N=1 on TDF and N=1 on AZT. Six children (28.6%) had a history of 
defaulting on ART.   
Hearing loss: Eight children (14 ears) had hearing loss in one or both ears (34.8% total cases).  
Six of these children had bilateral hearing loss, with the remaining two children presenting with 
unilateral hearing loss. The unilateral cases were only in the right ear. Of the 14 ears presenting 
with hearing loss, nine ears (64.2%) presented with conductive hearing loss (associated with 
middle ear pathology) and five ears presented with sensorineural hearing loss.  
The mean PTA-Right was 15.2 (12.7) and PTA-Left was 12.6 (9.9).   The mean overall severity 
score of hearing loss in the left ear was 0.4 (SD 0.8), and in the right ear it was 0.6 (SD 0.9).  For 
hearing loss in both ears the severity score was 1.0 (SD 1.7).    
Factors associated with hearing loss: CD4 count was only available from the casenotes of 11 
children, precluding analysis of associations with HL.  Only ART lifetime exposure less than the 













































































Table 1. Associations between HL in either ear and predictor variables  
Variable Cut point Odds ratio (95%CI) 
ART lifetime exposure  <80.6%  4.4 (1.1-18.5) 
History of defaulting on 
ARV 
Yes 1.0 (0.2-7.4) 
WHO staging Stages 3 or 4  1.9 (0.5-7.9) 
Viral load LDL 1.7 (0.3-9.1) 
Disease history TB, malaria, meningitis 2.6 (0.7-11.5) 
Prematurity  <38 weeks gestation 0.6 (0.2-3.7) 
Developmental delay Any  1.7 (0.1-36.7) 
History of absence from 
school 
Yes 0.4 (0.1-3.4) 
History of repeating grade Yes 0.7 (0.2-3.6) 
Age-for-grade Grade 3 ≥10 years or Grade 4 ≥11 years 
or Grade 5 ≥12 years or 6 ≥13 years 
2.6 (0.6-10.9) 
Family income < R28320 / year 1.7 (0.3-8.8) 
Parent care giver No 1.6 (0.3-9.2) 











































































This study provides further information for the scant current body of evidence regarding the 
prevalence of hearing loss in 9 to 12-year-old South African children, who are currently on 
HAART.  Given their recruitment from a low socioeconomic environment (supported by 
evidence of parent education and family income in this study), these children were potentially 
exposed to opportunistic infections associated with poor nutrition, cramped living quarters and 
poor hygiene. Findings suggest that hearing loss in this sample was primarily conductive in 
nature, despite the common use of HAART.  This was supported by the finding that hearing loss 
was associated with a less than 80% lifetime exposure to ART. 
Approximately one third of the sample presented with hearing loss. Although this finding is 
lower than that reported by Buriti et al
14
, where included children were not all on ART, it is 
similar to other studies, also using pure tone audiometry, that reported on hearing loss prevalence 
rates ranging from 17% to 39%. 
7, 8,15-22, 23-25
 
The strong finding of conductive hearing loss in our study suggests that this could be associated 
with middle ear pathologies, despite all the children being on HAART.  These findings are 
consistent with those reported in the literature.
8-9,16-17,19,22-23,25
 Although HAART has been 
reported to decrease the occurrence of opportunistic diseases, including middle ear pathologies, 
early initiation of ART has been found to decrease the incidence of otorrhea to a greater extent 
than deferred initiation of ART
26
. As hearing loss in our study was strongly associated with 








































































noncompliance with ART has an impact on hearing. These findings are consistent with Nakku et 
al
8
 that reported a direct relationship between duration of ART use and hearing loss.  
CONCLUSION 
Our findings suggest that hearing loss continues to be present in HIV infected children, despite 
them being on HAART. It may be related to opportunistic infections such as middle ear infection 
associated with non-exposure to ART at some time during their lifetime (due to late diagnosis, 
late initiation of HAART or non-compliant periods).  
REFERENCES 
1.  AVERT. HIV and AIDS in South Africa. [AVERT.org website]. 2019. Available at 
https://www.avert.org/printpdf/node/404. Accessed September 2, 2019 
2.  UNAIDS Joint United Nations Programme on HIV/AIDS. UNAIDS Data 2019. Geneva; 
2019.  
3.  Nixon SA, Hanass-Hancock J, Whiteside A, Barnett T. The increasing chronicity of HIV 
in sub-Saharan Africa: Re-thinking “HIV as a long-wave event” in the era of widespread 
access to ART. Global Health. 2011;7:1-5. 
4.  Ensink RJH, Kuper H. Is hearing impairment associated with HIV? A systematic review 
of data from low- and middle-income countries. Trop Med Int Heal. 2017;22:1493-504. 
5.  Babbie E. The Practice of Social Research. 12th ed. Belmont: Cengage Learning; 2010. 
6.  Stach BA. Clinical Audiology: An Introdcution. 2nd ed. New York: Delmar, Cengage 
Learning; 2010. 








































































Prevalence of chronic ear disease among HIV+ children in Sub-Saharan Africa. Int J 
Pediatr Otorhinolaryngol. 2017;103:133-6.  
8.  Nakku D, Nyaiteera V, Llowet E, Nanseer D, Nakalema G, Westerberg, B et al. HIV 
status and hearing loss among children between 6 and 12 years of age at a large urban 
health facility in south western Uganda. Int J Pediatr Otorhinolaryngol. 2017;101:172-7. 
9.  Smith AF, Ianacone DC, Ensink RJH, Melaku A, Casselbrant ML, Isaacson G. Prevalence 
of hearing-loss among HAART-treated children in the Horn of Africa. Int J Pediatr 
Otorhinolaryngol. 2017;98:166-70.  
10.  Northern J, Downs M. Hearing in Children. 5th ed. Baltimore: Lippincott Williams & 
Wilkins; 2002. 
11.  Bandason T, Langhaug LF, Makamba M, Laver S, Hatzold K, Mahere S et al. Burden of 
HIV among primary school children and feasibility of primary school-linked HIV testing 
in Harare, Zimbabwe: A mixed methods study. AIDS Care - Psychol Socio-Medical Asp 
AIDS/HIV. 2013;25:1520-6. 
12.  Pufall EL, Nyamukapa C, Eaton JW, Campbell C, Skovdal M, Munyati S et al. The 
impact of HIV on children’s education in eastern Zimbabwe. AIDS Care. 2014;26:1136-
43.  
13.  Statistics South Africa. National Poverty Lines. Pretoria; 2018. 
14.  Buriti A, dos Santos Oliveira S, Muniz L. Hearing loss in children with HIV / AIDS Perda 
auditiva em crianças com HIV / AIDS. CoDAS. 2013;25:513-20. 








































































evaluation of children with acquired immunodeficiency syndrome (AIDS). Braz J Infect 
Dis. 2006;10:264-8. 
16.  Palacios GC, Montalvo MS, Fraire MI, Leon E, Alvarez MT, Solorzano F. Audiologic and 
vestibular findings in a sample of Human Immunodeficiency Virus type-1-infected 
Mexican children under Highly Active Antiretroviral Therapy. Int J Pediatr 
Otorhinolaryngol. 2008;72:1671-81. 
17.  Matas CG, Santos Filha VAV, Juan KR, Pinto FR, Gonçalves IC. Audiological 
manifestations in children and adults with AIDS. Pro Fono. 2010;22:269-74. 
18.  Taipale A, Pelkonen T, Taipale M, Roine I, Bernardino L, Peltola H et al. 
Otorhinolaryngological findings and hearing in HIV-positive and HIV-negative children 
in a developing country. 2011:1527-32. 
19.  Chao CK, Czechowicz JA, Messner AH, Alarcón J, Kolevic Roca L, Larragán Rodriguez 
MM et al. High Prevalence of Hearing Impairment in HIV-Infected Peruvian Children. 
Otolaryngol Neck Surg. 2012;146:259-65.  
20.  Makar SK, Dhara S, Sinha AK, Chatterjee I, Dutta P. Nature and onset of communication 
disorder in pediatrics with HIV. Int J Pediatr Otorhinolaryngol. 2012;76:1065-6 
21.  Torre P, Zeldow B, Hoffman HJ, Buchanan A, Siberry GK, Rice M et al. Hearing Loss in 
Perinatally HIV-infected and HIV-exposed but Uninfected Children and Adolescents. 
Pediatr Infect Dis J. 2012;31:835-41. 
22.  Torre P, Cook A, Elliott H, Dawood G, Laughton B. Hearing assessment data in HIV-









































































23.  Hrapcak S, Kuper H, Bartlett P, Devendra A, Makawa A, Kim M et al. Hearing Loss in 
HIV-Infected Children in Lilongwe, Malawi. Sokolowski B, ed. PLoS One. 
2016;11:e0161421.  
24.  Maro II, Fellows AM, Clavier OH, Gui J, Rieke CC, Wilbur JC et al. Auditory 
Impairments in HIV-Infected Children. Ear Hear. 2016;37:443-51.  
25.  Matsekete J, Chidziva C, Matinhira N, Dzongodza T, Ferrand R, Mujuru H et al. Hearing 
impairment and deafness among HIV-infected children and adolescents in Harare, 
Zimbabwe. HIV Med. 2014;15:67. 
26.  Hainline C, Taliep R, Sorour G, Nachman S, Rabie H, Dobbels E et al. Early 
Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early 
and deferred antiretroviral therapy : Evidence from the Children with HIV Early 























Background: In South Africa, HIV affects approximately 1:3 children under 12 years.  Most children 23 
commence antiretroviral therapy (ART) as soon as they are diagnosed.   Amongst other health benefits, 24 
ART protects children from opportunistic infections; such as chronic ear conditions, which can result in 25 
hearing loss.  However, living with HIV as a chronic disease may challenge children’s health and 26 
development in other ways.  This paper tests associations in children aged 9-12 years, HIV status, hearing 27 
loss and learning capacity.  28 
Methods: Case children (HIV positive) were recruited from the Infectious Disease clinic at a South 29 
African tertiary hospital servicing a low sociodemographic area.  Control children (HIV negative) were 30 
recruited from a school in a surrounding suburb.  Audiologic assessments comprised parent questionnaire, 31 
otoscopy, tympanometry and pure tone testing from 250 through 8000 Hz.  Hearing loss was defined as a 32 
pure tone average (500Hz, 1000Hz and 2000HZ) greater than 15db hearing level (HL) assessed in a 33 
soundproof booth (cases), or greater than 25dBHL assessed in a quiet school environment (controls).  The 34 
Test of Nonverbal Intelligence (TONI 4) percentile rank scores were used to assess learning capacity.  35 
Descriptive statistics and measures of association were reported.   36 
Results: Data was collected on 56 children (42.8% cases, 57.2% controls).  There was no association 37 
between hearing loss and HIV status (OR 2.8 [95%CI 0.8-10.1). TONI 4 scores differed significantly 38 
between cases and controls (control mean scores 39.5% (SD 18.5%), case mean scores 21.4% (SD 10.1%)).  39 
There was a significant association between HIV status, and binary division TONI 4 scores (OR 15.4 40 
(95%CI 3.7-63.8)).  There was no association between hearing loss and learning capacity (loss in one ear 41 
OR 0.8 (95%CL 0.1-6.2), loss in both ears OR 1.3 (95%CI 0.1-15.7)).   42 
Conclusions: Lack of association between hearing loss and HIV status suggests that ART may be 43 
protecting case children from opportunistic infections that result in hearing loss.   The strong association 44 
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 3 
development.  This has implications for educational policies, as HIV positive children potentially require 46 
additional support to fully participate in available learning opportunities.  47 











































































People are living for longer with HIV as with better medical management it is now a chronic disease, 50 
rather than a terminal one (Nixon et al. 2011a). Seven million people are currently living with HIV in 51 
South Africa, with 320 000 (260 000 – 400 000) of these being children between the ages of 0 and 14 52 
years (World Health Organization 2017). Although the prevalence of HIV in children has declined since 53 
2002, with better mother-child transmission prevention practices (Shisana et al. 2014), new infections 54 
continue to occur, with the World Health Organization (2017) estimating that 12 000 (9600 – 22000) 55 
South African children became infected in 2016.  56 
Despite these new infections, the initiation and maintenance of ART programmes has had a positive 57 
impact on the fight against HIV (Mayosi et al. 2012). Advances in ART, in particularly the introduction 58 
of Highly active antiretroviral therapy (HAART), has been associated with decreased mortality (Patel et 59 
al. 2008) and a reduction in opportunistic diseases (Gona et al. 2006) in the paediatric population. 60 
Globally, 55% (45% - 70%) of infected children aged between 0 and 14 years, are receiving ART (World 61 
Health Organization 2017) and are thus expected to live longer lives. The status of HIV has thus changed 62 
from a life-threatening disease to a chronic disease, with accompanying consequences that may challenge 63 
the rehabilitation, health and social sectors in resource-poor settings (Gates & Cysique 2016; Nixon et al. 64 
2011b; Nixon et al. 2011a; Worthington et al. 2009).  65 
Hearing loss is considered to be associated with HIV (Ensink & Kuper 2017; Torre 2015). Adult-based 66 
studies suggest a higher prevalence of hearing disorders (such as hearing loss, tinnitus and vertigo) in  67 
HIV positive individuals (compared to HIV negative individuals), as well as changes that the disease 68 
itself may produce in the auditory system (Khoza-Shangase 2010; Maro et al. 2014; van der Westhuizen 69 
et al. 2013).  Possible reasons for the hearing disorders include the HIV infection itself, opportunistic 70 
infections resulting from reduced immunity, or ototoxicity from factors such as ART, or repeated 71 
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 5 
Abnormal audiological findings related to HIV status have also been reported in paediatric studies (Buriti 73 
et al. 2013; Christopher et al. 2013; Devendra et al. 2013; Hrapcak et al. 2016; Nakku et al. 2017; Smith 74 
et al. 2017; Torre et al. 2015).  Although all these studies report on abnormal findings, the studies that 75 
have included control groups have differed with regards to whether the prevalence of hearing loss in HIV-76 
positive and HIV-negative children are significantly different. Torre et al. (2015) and Nakku et al. (2017) 77 
did not find significant differences in hearing loss prevalence rates between these children while Smith et 78 
al. (2017) found HIV-infected children had a significantly higher occurrence of hearing loss than HIV-79 
negative children.   80 
Children with hearing loss have reduced access to auditory information, which among other constraints, 81 
can result in reduced exposure to spoken language and subsequent delays in listening and language 82 
development, as well as in difficulties with academic work (Madell et al. 2018; Northern & Downs 2002). 83 
The degree of hearing loss does not necessarily affect the magnitude of academic difficulties as poorer 84 
learning outcomes (namely, language and literacy and the child’s approach to learning) have been 85 
reported by teachers for children with slight to mild hearing loss when compared to children with normal 86 
hearing (Wang et al. 2019).  87 
The effect of hearing loss on learning is not only due to a lack of access to auditory information but also 88 
due to fatigue associated with hearing loss (Gustafson et al. 2018; Key et al. 2017). Children with hearing 89 
loss show reduced attention and fatigue during difficult listening tasks and may, therefore show a reduced 90 
ability to focus on classroom instruction (Gustafson et al. 2018). They may, therefore, process auditory 91 
information that has been presented, inefficiently as learning within a class environment requires 92 
sustained attention (Key et al. 2017).  93 
HIV has not only been associated with hearing loss but also with other neurocognitive deficits that can 94 
affect learning (Govender et al. 2011). Developmental delays, including delays in cognitive development, 95 
have been described in HIV-infected children (Kerr et al. 2014) with major neurocognitive disorder and 96 
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 6 
be as a direct consequence of having the disease, but may also be due to the indirect consequences of 98 
living with the virus, or living with an adult who has the virus  (Guo et al. 2012). HIV positive children 99 
may be more prone to illness, and have poorer school attendance due to sick days, or medical 100 
appointments (Anabwani et al. 2013).  101 
In South Africa, poorer learning outcomes and poorer performance on cognitive tests have also been 102 
reported for children from low socioeconomic environments  (Maswikiti 2008). According to Hackman et 103 
al. (2010) there are three classes of mechanism to explain the effects of socioeconomic status on the brain 104 
and cognition; first, prenatal influences that can affect early brain development (e.g. impaired fetal growth 105 
and poor nutrition during pregnancy), second, parental care factors that could influence 106 
neurodevelopment, such parent-child interaction and parental sensitivity towards the child, and third, the 107 
level of cognitive stimulation in the home environment such as the availability of books and educational 108 
outings. 109 
Measuring cognitive skills is challenging, particularly when considering that the constructs that are 110 
measured are not relevant across all cultures and languages (Holding et al. 2018). For the purposes of this 111 
study, nonverbal intelligence was used as a proxy for learning capacity as this would eliminate the effect 112 
of socioeconomic variables and linguistic, cultural and literacy differences  (Brown et al. 2010). Although 113 
nonverbal intelligence is less robust in predicting academic outcomes than verbal intelligence, it reflects 114 
fluid intelligence abilities (Dethorne & Schaefer 2004). Fluid intelligence is defined as “the innate 115 
learning capacity of an individual, not dependent on education or experience, which is used with 116 
relatively novel tasks, reasoning, and information analysis. Based on the Cattell-Horn theory of 117 
crystallized and fluid intelligence” (APA PsycNET n.d.) and describes the ability to use inductive and 118 
deductive reasoning to identify patterns and relations, and to make inferences (Dethorne & Schaefer 119 
2004). These mental operations occur independent of prior knowledge and predicts performance on a 120 
range of cognitive skills (Horn & Cattell 1966). The use of a nonverbal measure was therefore considered 121 











































































Aim: This study was undertaken to assess whether chronic HIV status in children on long-term ART, was 124 
still associated with hearing loss, and whether learning capacity was affected.  This paper explores the 125 
associations between HIV status, hearing loss and learning performance in children aged 9-12 years in a 126 
low socioeconomic South African metropolitan area. 127 
Study context: One large tertiary metropolitan hospital in Cape Town provided access to paediatric HIV 128 
cases attending its Infectious Diseases Clinic (IDC).  This hospital provided services for over 3.4 million 129 
people in surrounding socioeconomically-disadvantaged suburbs, most of whom relied on public health 130 
care.   In South Africa, only 17% of citizens is estimated to have medical insurance, resulting in the 131 
majority attending public health facilities (South African Government n.d.).  A tertiary hospital is a public 132 
hospital to which more complex cases are referred, however in this instance, the participating hospital 133 
also provided an ART clinic to patients who were unwilling to be transferred to local community level 134 
health facilities.  135 
Sample: This study investigated school learners aged 9-12 years who had confirmed HIV positive status 136 
(HIVP) or reported HIV negative status (HIVN)).  The sample was not age-or gender-matched. 137 
Sampling: Convenience sampling at point of contact with the healthcare system, or school, was used to 138 
recruit children in both HIVP and HIVN groups.  Convenience sampling was considered to be the most 139 
efficient approach to recruit children to this study (Babbie 2010), to deal with the complexities of 140 
recruitment in low socioeconomic circumstances (difficulty in contacting potential subjects when not 141 
attending health appointments or school, parent literacy, difficulty in accessing comprehensive records for 142 
random selection of subjects, parent suspicion of being approached by researchers, stigma, constraints on 143 
attendance at appointments, being over-researched etc). 144 
Inclusion and exclusion criteria: Males and females were included if they had: (1) documented HIV-145 
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 8 
proficiency in at least one of English, Afrikaans or Xhosa language; (4) were enrolled in at least Grade 3 147 
in a mainstream primary school and (5) had the ability to understand and complete a consent form.  148 
Exclusion criteria were: (1) HIV status not documented/reported; (2) comorbid conditions causing 149 
cognitive impairment (e.g. neurological conditions) that could affect understanding of, and performance 150 
in, the assessment batteries; (3) cognitive impairment (e.g. intellectual disability) that could affect 151 
understanding of and performance on the assessment test batteries; or (4) on a waiting list for, or enrolled, 152 
in a school for learners with special education needs.  153 
Recruiting the HIVP group: The IDC at the participating tertiary hospital, had records of 836 patients on 154 
ART at the end of February 2017. This included 412 children (aged 0 to 18 years).  Attempts were made 155 
to recruit 110 children attending the IDC for their medical follow up appointments, between June 2017 156 
and November 2018. The recruitment process involved the researcher attending the IDC and physically 157 
identifying and recruiting children on each clinic day. The IDC operates from Monday to Wednesday 158 
(8h00 – 13h00), with the majority of paediatric appointments available on Tuesdays. Each morning, the 159 
medical records (folders) of all children with appointments for the particular day were accessed at the 160 
IDC, and the researcher identified all potential candidates based on their date of birth.   Children’s parents 161 
were approached and informed about the study.  If they were interested, the child’s eligibility was 162 
confirmed by questioning the parents, and if parents consented, the child was enrolled in the study. A 163 
small reimbursement for travelling costs was offered to each family to assist them to bring their child for 164 
testing.   165 
Recruiting the HIVN groups: Children were recruited from one local primary school in the same area as 166 
the participating hospital.  Information pamphlets were distributed to 137 children aged 9-12 years in this 167 
school, together with informed consent forms and the researcher’s contact telephone number. The school 168 
was considered as a full-service school by the WCDoE, where the children’s HIV status was known by 169 
the school.  The school principal assisted the researcher in distributing research information only to 170 
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Causal relationships: Because of the lack of clarity in the literature to unravel the complexity of putative 172 
associations between HIV status, hearing loss and learning capacity, the Bradford Hill criteria for causality 173 
(Hill 1965) was applied to map a likely causal path that underpinned analysis.  The role of HIV was difficult 174 
to place in this model as it was a plausible antecedent cause for hearing loss (with the disease and/or its 175 
treatment affecting structures of the ear), but it also could plausibly have a direct relationship with learning 176 
capacity (as time spent away from school for illness or medical treatment, which could interrupt learning).   177 
Being on ART for HIV could also have had a biochemical influence on learning capacity.   178 
For this study, we proposed that HIV status acted as an exposure variable in a causal pathway in which 179 
hearing loss was an interim outcome, and where learning capacity was the final outcome (Rothman 1985).  180 
As all children came from the same sociodemographic areas, we assumed that their socio-economic status 181 
was also similar.  Potential confounders on the association between HIV and hearing loss, and hearing loss 182 
and learning capacity were proposed as gender because girls have been reported to perform better 183 
academically than boys (Kingdon et al. 2017; O’Dea et al. 2018) and language as the language of schooling 184 
is a reflection of educational inequalities that continue to be a legacy of Apartheid (McKeever 2017).      185 
Hypotheses: We tested four associations relevant to the causal path.   186 
1. HIV status, hearing loss and learning capacity are all associated with gender; 187 
2. There are significant associations, all confounded by gender, and language of schooling between: 188 
a. HIV status and hearing loss, 189 
b. HIV status and learning capacity; and 190 
c. Hearing loss and learning capacity. 191 
Measurement procedures: Step 1. A case history was taken from the primary caregiver.  This is the initial 192 
step in a paediatric audiologic test battery (Stach 2010). This typically provides important information 193 
regarding the nature of the auditory complaint, possible contributing factors, developmental progress, 194 
communication abilities and academic achievement (Stach 2010).  For this study, the case history 195 
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the child’s academic progress and hearing capabilities. This information was also used to identify possible 197 
clinical complexities (such as history of opportunistic disease).  198 
A standard questionnaire was used to elicit the case history, although it was delivered differently for HINP 199 
and HIVN participants.  For the HIVP group, if the caregiver preferred, the complete set of questions were 200 
administered verbally in their chosen language (i.e. English, Afrikaans or isiXhosa). The interview format 201 
allowed the primary investigator to probe for answers where necessary, and to clarify questions that were 202 
not understood (Babbie 2010).  This was only done where the caregiver was unable to provide an adequate 203 
response. In addition, the verbal administration of the questionnaire ensured that caregivers were not 204 
excluded based on literacy levels. In all instances however, to ensure consistency of data collection, 205 
question wording was strictly adhered to, as it appeared on the questionnaire.  For the HIVN group, the 206 
case history questionnaires were sent home with the child, as the caregivers were not present during testing.  207 
Caregivers were requested to complete the questionnaire and return it to school, in a sealed envelope, where 208 
the primary investigator collected it. Literacy levels were not taken into account for this group as it was 209 
assumed that the parents/caregivers could consult with literate neighbours or family members if they 210 
required assistance.  211 
Step 2. An otoscopic examination was conducted in order to investigate the condition of the outer ear and 212 
tympanic membrane (Stach 2010). This part of the assessment was included in the test battery as there are 213 
reports about abnormalities of the outer ear and tympanic membrane in patients who are HIV positive 214 
(Ianacone et al. 2017). After the procedure was explained to the participant, an audiologist used a Welch 215 
Allyn pocket otoscope to examine the relevant structures. Abnormalities such as inflammation, growths, 216 
foreign objects, excessive wax or perforations of the tympanic membrane were recorded on the audiogram. 217 
If abnormality was noted, the child was referred to the treating doctor for medical management.  218 
Step 3. Tympanometry was conducted to assess the transmission of sound through the middle ear (Stach, 219 







































































Dawood et al 
 
 11 
middle ear function in persons with HIV (Ianacone et al. 2017). After the audiologist explained the 221 
procedure, tympanograms were obtained using a GSI Tympstar (HIVP group) and Interacoustics MT10 222 
(HIVN groups) with a 226 Hz probe tone. The pressure direction was from positive to negative (200 to -223 
400daPa). The results were recorded on the audiogram, and the following parameters were used to indicate 224 
normal middle-ear function: Type A tympanogram with a middle ear pressure of -100 to =100 daPa; 225 
acoustic compliance of 0.3 to 1.7 ml; and ear canal volume of 0.4 – 1.5 ml.  Participants presenting with 226 
abnormal tympanograms were referred back to the treating doctor (IDC) or their closest clinic for medical 227 
management.  228 
Pure tone audiometry was conducted to determine the behavioural hearing thresholds of each participant 229 
as well as the type of hearing loss (Stach 2010). This component of the test battery was included as 230 
research reports that hearing loss is associated with HIV (Nakku et al. 2017; Smith et al. 2017). 231 
The same testing circumstances were not available for all children.  232 
HIVP group: After the audiologist explained the procedure, pure tone audiometry was performed in a sound 233 
proof booth, using a GSI 61 audiometer. Circum-aural earphones were used and air conduction thresholds 234 
were obtained at 250Hz, 500 Hz, 1000 Hz, 2000Hz, 4000Hz, 8000 Hz as per conventional audiometry 235 
(Stach 2010), for the left and right ears separately. All thresholds were plotted on an audiogram.  236 
Participants were considered to have hearing loss if a pure tone average (PTA) of >15dbHL was obtained 237 
(Northern & Downs 2002). Bone conduction threshold testing was only conducted at frequencies where the 238 
air conduction threshold was >15dBHL. The bone conduction thresholds were obtained in order to describe 239 
the type of hearing loss; i.e. conductive, sensorineural or mixed hearing loss.  Any participant presenting 240 
with a sensorineural hearing loss was referred to the Audiology Department at Tygerberg Hospital for 241 
diagnostic testing and further management. Any participant presenting with a conductive or mixed hearing 242 
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HIVN group: After the audiologist explained the procedure, the Pure Tone Audiometry was performed in a 244 
quiet venue, as provided by the school. Sound proof booths were not available at the school.  Testing was 245 
completed using an Interacoustics AS608 screening audiometer. Circum-aural earphones were used and air 246 
conduction thresholds were obtained at 250Hz, 500 Hz, 1000 Hz, 2000Hz, 4000Hz, 8000 Hz as per 247 
conventional audiometry (Stach 2010), for the left and right ears separately. All thresholds were plotted on 248 
an audiogram. A participant was considered to have a hearing loss if a pure tone average (PTA) of >25dbHL 249 
was obtained (Northern & Downs 2002). Bone conduction was not conducted due to the limitations of the 250 
audiometer and testing room environment (Schlauch & Nelson 2009).  251 
Due to the differences in testing conditions for the HIVP and HIVN groups, a pure tone average of less 252 
than or equal to 15dBHL (Northern & Downs 2002) for the HIVP group, and less than or equal to 253 
25dBHL for the HIVN group, was considered to constitute normal hearing. The pure tone average was 254 
calculated as the average of thresholds for 500Hz, 1000Hz and 2000Hz. The degree of hearing loss was 255 
classified as: minimal (PTA = 16 to 25dBHL), mild (PTA = 25 to 40dBHL), moderate (PTA = 41 to 256 
55dBHL), moderately-severe (PTA = 56 to 70 dBHL), severe (71 to 90 dBHL) or profound (greater than 257 
90dBHL) (Clark 1981 in (Welling & Ukstins 2015). Classification of type of hearing loss was based on 258 
the size of the air-bone gap (ABG). A hearing loss was considered to be conductive if the ABG was 259 
greater than 10dB, sensorineural if the ABG was less than or equal to 10dB (Stach 2010) and unspecified 260 
if bone conduction testing was not conducted.  261 
Step 4. The Test of Nonverbal Intelligence – Fourth edition (TONI 4) was used as a proxy for learning 262 
capacity, as the test purports to measure aptitude, abstract reasoning and problem solving ability (Brown et 263 
al. 2010).  The TONI 4 model is based on the premise that cognitive ability can be estimated by measuring 264 
the ability to problem solve. As the TONI 4 is not loaded with language and does not require the respondent 265 
to read, write, speak or even listen; the test is considered suitable to assess people with communication 266 
disorders (including hearing loss), learning disorders and those who are not proficient in English. The test 267 
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the developers, performance is not influenced by familiarity with the items. The abstract nature of the items, 269 
as well, as the lack of language reduces the possibility of educational, cultural and experiential biases 270 
(Brown et al. 2010). However, the instructions were given in the preferred language of the child, with the 271 
parent present. The parent/caregiver was provided with a written translation of the instructions and was 272 
requested to give these instructions to the child. Where literacy was a problem, the researcher explained the 273 
instructions to the parent with the aid of the written translation and the parent then transmitted the 274 
information to the child. The percentile rank score was used and provided an indication of the percentage 275 
of the normative population that obtained a score equal to or below the score obtained by the participant 276 
(Brown et al. 2010) 277 
Data management: Hearing loss was reported for the purpose of this study as none (0) or as three 278 
different types (conductive hearing loss (CHL), sensorineural hearing loss (SNHL) or unspecified) (all 279 
coded as 1) in left or right ear. “Unspecified” referred to hearing loss where the type of hearing loss could 280 
not be determined as bone conduction thresholds were not available. 281 
The degree of hearing loss in each ear was recorded as mild (PTA = 25 to 40dBHL), moderate (PTA = 41 282 
to 55dbHL) or severe (71 to 90dBHL) (Clark 1981 in (Welling & Ukstins 2015). The category 283 
“unspecified” was used when the hearing testing had not been conducted in a sound proof booth. 284 
A cumulative integer score was determined for hearing loss as the per-child sum of severity scores (hearing 285 
loss (yes, no) in either ear multiplied by the numeric code given to the severity of loss.  Hearing loss was 286 
then applied to models as a three-level variable (no hearing loss, hearing loss in only one ear, or hearing 287 
loss in both ears).  A total severity score was calculated per child and reported as an integer variable for 288 
analysis of variance models.  The higher the severity score the more severe the hearing loss.  For logistic 289 
regression modelling purposes, the severity score was split into three independent variables (0 for children 290 
without hearing loss), and then at the median value of severity for children with hearing loss (>0 to 2 (mild 291 
hearing loss), >2 (moderate or severe loss)). For the purposes of analysis, the TONI 4 score was expressed 292 
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Data analysis: All data was described as frequencies or mean values (standard deviations), as appropriate.   294 
Differences in potential confounders (gender, languages spoken at home and school), and outcome variables 295 
(hearing loss, severity of hearing loss, and learning capacity) were estimated for two HIV groups (HIVP, 296 
HIVN), and the significance of differences was calculated using chi2 or ANOVA models, as appropriate.  297 
Potential confounders which appeared to be important were retained for subsequent modelling.   298 
To gain the most leverage from the sensitivity of the integer variables, linear regression models were 299 
initially constructed to test the association between severity of hearing loss and learning performance 300 
scores, using the Pearson r2 statistic as an estimate of strength of association (Katz 2006). The significant 301 
predictor variables identified in initial testing were individually applied to this model with differences in 302 
impact being determined as significant change in the r2 statistic.   303 
Univariate logistic regression models were then constructed to test the association between binary forms of 304 
HIV status with hearing loss (model 1), HIV status and learning performance (model 2) and hearing loss 305 
and learning performance (model 3).  Potential confounders were added to these models in a step-wise 306 
manner applying the strongest predictor variable first.  Predictor variables were retained in the model if 307 
they significantly changed the amount of variance, determined from the chi square value associated with 308 
the Likelihood Ratio, assessed against the critical chi square value for the degree of freedom associated 309 
with the model (https://web.ma.utexas.edu/users/davis/375/popecol/tables/chisq.html). 310 
At p<0.05, for one degree of freedom, the critical chi2 value is 3.8, for two degrees of freedom, it is 5.9 and 311 
for three degrees of freedom, it is 7.8.   312 
RESULTS 313 
Sample: There were 110 cases identified at the IDC, who were potentially-relevant for recruitment. Of 314 
these, 52 declined to participate, 12 did not meet the inclusion criteria and 22 did not attend their 315 
appointment for testing (even after reminders were sent and/or appointments were rescheduled). This left 316 
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participating school, 34 consent forms were returned.  Of these, two parents declined their child’s 318 
participation. This left 32 eligible controls with consenting parents. Thus, the dataset consisted of 56 319 
children, of 24 cases (42.8%) and 32 controls (57.2%).  Figure 1 outlines the study inclusion and exclusion 320 
flow diagram. 321 
<<Figure 1 here>> 322 
Demographics: Thirty children were male (53.6%) and there were no gender differences between cases and 323 
controls (p>0.05).  324 
o Average age of children in the sample was 11.2 years (SD 0.9) (reflecting the age limits of 9-325 
12 years).   326 
o Children who were identified, in hospital or school records or by their parents on the case 327 
history forms, as Coloured predominated (79.8%), with smaller percentages of children 328 
identified as Black (19.1%) or White (1.1%);   329 
o English as a primary language, was spoken both at home and school by 31.7% sample, 330 
Afrikaans as a primary language, was spoken both at home and school by 31.7% sample, and 331 
other African languages (e.g. IsiXhosa) were spoken as primary languages both at home or 332 
school, by 7.9% children; 333 
o Most children spoke the same language at home and school (87.5%).    334 
Hearing loss: Eleven children overall (19.6% sample) were diagnosed with hearing loss (Yes/No), with 335 
seven recording it in both ears (63.6% of those with hearing loss).  Considering the entire sample (children 336 
with, and without hearing loss), the overall severity of hearing loss score for either ear ranged from 0-3 337 
(mean 0.3, SD 0.7), and the overall both-ear score ranged from 0-6 (mean 0.6, SD 1.4).  Considering only 338 
those children with hearing loss (all with severity ranges from 1-3), for children with Right ear loss only, 339 
the severity score was 2.1 (SD 0.9), and for children with Left ear loss only, the severity score was 1.6 (SD 340 







































































Dawood et al 
 
 16 
Learning capacity: The mean TONI 4 percentile rank score was 31.8 (SD 17.8) ranging from 6-84.   342 
Demographics as a predictor of HIV: Gender was not associated with HIV status (OR 0.7, 95%CI 0.2-1.9). 343 
Demographics as a predictor of learning capacity: There was no influence of gender on learning capacity 344 
(TONI 4 percentile rank scores (girls mean 33.0 (SD 18.1) and boys (36.1 (SD 21.2 (F value 0.4 (df=1) 345 
p>005). There was a significant effect of speaking English at home on language performance scores (mean 346 
TONI 4 percentile rank score 47.7 (SD 21.0), compared with Afrikaans language (mean 28.8 SD 14.1) and 347 
African languages (mean 27.5, SD 18.3) (F value 8.3 (df=2) p<0.01)). There were similar significant 348 
findings for languages spoken at school, with English school-language TONI 4 percentile rank scores being 349 
significantly higher than the other school languages (English mean TONI 4 score 42.8 (SD 21.0), Afrikaans 350 
mean 28.6 (SD 13.9) and African languages mean 14.8 (SD 8.7) (F value 8.1 (df=2) p<0.01)). Moreover, 351 
there was no influence of experiencing a difference in languages spoken at home and school on TONI 4 352 
percentile rank scores (same language mean 34.7% (SD 20.3%), different language mean 33.5% (SD 353 
17.9%) (F value 0.04 (df=1) p>0.05). 354 
HIV as a predictor of hearing loss and learning capacity: Seven cases (29.1%) and four controls (12.5%) 355 
were diagnosed with hearing loss, and there was no significant association between HIV status and hearing 356 
loss (OR 2.8, 95%CI 0.8-10.1).  This finding persisted when further considering the severity of hearing 357 
loss.  Compared with children with no hearing loss (severity=0), the association between HIV status and 358 
minimal/ mild severity of hearing loss was OR 8.2 (95%CI 0.9-79.4) and for moderate/ high severity of 359 
hearing loss, the association with HIV status was OR 2.1 (95%CI 0.4-11.3).  Learning capacity was 360 
significantly different between HIV status groups, with the controls having significantly higher TONI 4 361 
scores (mean 39.5%, SD 18.5%) compared with mean TONI 4 scores for the cases (21.4% (SD 10.1%)).  362 
Using the median division in TONI 4 scores (30%), there were significant odds that HIV status was 363 
associated with low TONI 4 scores (OR 15.4 (95%CI 3.7-63.8)).   364 
Hearing loss and learning capacity: The association between hearing loss and learning capacity was 365 
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learning capacity as integer variables in a linear regression model, there was a minimal association 367 
(r2=1.0%, p>0.05).   Using categories of hearing loss of none (default comparator), one ear or both ears, 368 
and testing against learning capacity divided at the median value, there was no significant association for 369 
one ear (either Left or Right) OR 0.8 (95%CL 0.1-6.2), or both ears affected OR 1.3 (95%CI 0.1-15.7)).  370 
There were insufficient numbers of children with mild-moderate hearing loss to resolve a logistic regression 371 
model which considered three independent levels of hearing loss severity (none (default), mild-moderate 372 
or severe).  Thus, a binary form of hearing loss severity data was developed, as none, or combined categories 373 
of mild, moderate and severe.  There was no association between learning capacity and hearing loss 374 
categories (OR 3.5 (95%CI 0.9-13.5)).   375 
Multivariate analysis: The only significant potential confounder for application to the multivariate model 376 
of HIV status (exposure) and learning capacity (outcome) was hearing loss severity.  The crude and adjusted 377 
model outputs are reported in Table 1.  The overall variance of the crude model (-2 Log L) was 87.3.  The 378 
amount of variance explained by adjusting this model by hearing loss severity was not significant (less than 379 
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20.4 2 0.5 5.9 p>0.05 
 385 
DISCUSSION 386 
This study presents rare evidence about associations between HIV status, hearing loss and language-free 387 
learning capacity in pre-pubescent South African children, sampled from one low socioeconomic 388 
environment. The findings suggest that HIV was more strongly associated with learning capacity than it 389 
was with hearing loss. 390 
The causal pathway between these variables is potentially complex (Hill 1965), and how HIV influences 391 
hearing loss and learning capacity in pre-teens requires further research.  The causal model was constructed 392 
on an assumption that hearing loss was the most proximal exposure for learning capacity.  The role of HIV, 393 
considered initially to be an antecedent cause of hearing loss, appears to operate in differently than we 394 
anticipated.  An increasing number of recent studies have reported on a significant relationship between 395 
positive HIV status and hearing loss in children, and although our findings suggested no significant 396 
difference, the prevalence of hearing loss in our cases (29.1%) and controls (12.8%) is similar to previous 397 
reports (Chao et al. 2012; Hrapcak et al. 2016; Matas et al. 2010; Palacios et al. 2008; Smith et al. 2017; 398 
Torre et al. 2015).     399 
Our findings may well provide a view of current circumstances with HIV children, as ART had been 400 
initiated early for case children, and all were currently on HAART.  Therefore they were potentially less 401 
susceptible to opportunistic infections than they previously would have been (Gona et al. 2006). Conductive 402 
hearing loss, which is generally associated with middle ear infections, has been reported as the most 403 
common type of hearing loss in HIV positive children (Ensink & Kuper 2017). The successful rollout of 404 
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HIVP children may now have the same susceptibility to infections as HIVN children, resulting in similar 406 
rates of hearing loss.   407 
The children all lived in the same low socioeconomic area (surrounding the case catchment hospital), and 408 
thus our sampling approach assumed that all children had similar exposure to poverty.   In the 25 years of 409 
post-Apartheid South Africa, poverty continues to be related to race and the language spoken, with  64% 410 
black South Africans and 46% Coloured South Africans believed to be living in poverty (Statistics South 411 
Africa 2017).  While our subjects were all potentially living in the same socioeconomic circumstances, our 412 
sample was heterogenous in terms of race and language spoken (reflecting expected local area statistics).  413 
This suggests that exposure to poverty rather than race and language spoken, may be the mediating factor 414 
for hearing loss, or learning capacity for our cases and controls.  The complex nature of the causal pathways 415 
for paediatric hearing loss, HIV status and learning capacity requires further investigation (Hill 1965).   416 
Association between HIV and hearing loss: The prevalence of hearing loss for the study population (19%) 417 
was higher than the estimated prevalence of hearing loss (3.2%) reported recently by Ramma & Sebothoma 418 
(2016) on 4-19 year old children in Cape Town.  One reason for this is that the Ramma and Sebothoma 419 
(2016) study used 25dBHL as the cut-off point for normal hearing, whereas our study used 15dBHL for 420 
tests undertaken in the sound proof booth, as recommended for children aged 0 to 18 years (Northern & 421 
Downs 2002).  This lower cut-off point that we used for the HIV-infected children may have resulted in a 422 
higher prevalence of hearing loss than what was reported by (Ramma & Sebothoma 2016).   423 
Association between HIV and learning capacity: Overall, an average (TONI 4 percentile rank score of 25 424 
to 75) performance for learning capacity was obtained for our sample (Brown et al. 2010). However, after 425 
stratifying the sample by HIV status, the cases performed significantly poorer (with percentile rank scores 426 
corresponding to “below average” ratings) than the controls (rated “average”).  These findings agree with 427 
those reported by Laughton et al. (2013) in their review of 11 studies on the neurocognitive effect of HIV. 428 
One of the impacts of HIV reported by these authors, was poorer school performance and lower non-verbal 429 







































































Dawood et al 
 
 20 
major neurocognitive disorder being reported for simultaneous processing, planning and nonverbal index 431 
on the Kaufmann Assessment Battery for Children – second edition (Musindo et al. 2018). Similar findings 432 
were also reported for 9-15 year old children, with HIVP children performing at a “below average” rating 433 
on tests of verbal and reading ability (Brackis-Cott et al. 2009). Although these tests differ from the 434 
nonverbal test used in our study, these verbal tests are also considered to measure cognition. These authors 435 
noted that the poor outcomes on the cognition tests were not necessarily related to HIV, as the children 436 
performed in a similar manner to studies involving uninfected children living in poor neighborhoods. This 437 
idea that poverty may influence cognition is supported by Sherr et al. (2009) as they suggested that 438 
neurocognitive ability were not necessarily a result of HIV status, but that family, environment and 439 
treatment also influenced this ability.  440 
Limitations: The cross-sectional design of the study does not allow for causal associations to be made.  The 441 
non-significant differences in hearing loss prevalence may reflect Type II error from our small sample size.  442 
Moreover, as the sample was recruited from one tertiary hospital and surrounding suburbs within the Cape 443 
Metropole, the findings cannot be generalized more broadly. Likely systematic biases which would have 444 
been introduced in the pragmatic, circumstantially-driven strategies which we had to employ to recruit 445 
children.  Although the control children were recruited from the same sociodemographic area serviced by 446 
the tertiary hospital, key variables such as race, home circumstances, noise exposure and history of previous 447 
ear infections between cases and controls could not be matched.  Whilst this limits interpretation of the 448 
study findings, future studies seeking larger and more randomly-sampled subjects would have to employ 449 
innovative recruitment approaches to deal with the difficulties of recruiting children in low socioeconomic 450 
areas, for research in this sensitive health area. 451 
CONCLUSIONS 452 
HIV status is significantly associated with learning capacity in children aged 9 to 12 years, but not hearing 453 
loss. The study findings suggest that the TONI 4 is an appropriate for children with hearing loss, as having 454 
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learning capacity has important implications for educational policies as HIVP children will probably need 456 
additional support to fully participate in the learning opportunities provided within the schooling system. 457 
The implication of these findings is that the learning needs of these children cannot be addressed by a 458 
uniform approach, and research into factors impeding full participation in learning opportunities should be 459 
investigated in order to provide evidence-based, appropriate learning support.   460 
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Introduction: The human immunodeficiency virus (HIV) affects 1.7 million children 26 
globally, with 260 000 of these children living in South Africa.  Due to the impact of highly 27 
active antiretroviral treatment (HAART), HIV has evolved into a chronic disorder with 28 
children living with HIV (CLHIV) having near normal life expectancy.  However, as with 29 
chronic disorders in children, other health and educational issues may arise.  This paper 30 
tests associations between HIV status, auditory processing skills and learning capacity, 31 
in preteen children.  32 
Methods: HIV-infected children (cases) were recruited from an Infectious Disease Clinic 33 
at a South African tertiary hospital, situated in a low sociodemographic area.  HIV-34 
uninfected children (controls) were recruited from a primary school in the surrounding 35 
suburb.  Only children who were assessed (pure tone audiometry) as having normal 36 
hearing were included in this study.  The Test of Nonverbal Intelligence Fourth Edition 37 
(TONI 4) was used to assess learning capacity.  Auditory processing skills were assessed 38 
using subtests of the SCAN 3 for Children: Tests for Auditory Processing Disorder (Gap 39 
Detection, Auditory Figure Ground 8+ and Competing Words-Free Recall) and the Test 40 
of Auditory Processing Third Edition (TAPS), as well as sound laterality.  Descriptive 41 
statistics and measures of association were reported. 42 
Results: Data were reported on 43 children (15 cases, 28 controls) with normal hearing.  43 
CLHIV had significantly poorer learning capacity (mean cases 1.6 (SD 0.5) mean controls 44 
(0.9 (SD 0.7) (p<0.05)) and had a greater risk for having poor auditory processing scores 45 







Conclusion: A sampling frame sought to minimise differences for cases and controls 47 
for sociodemographic factors thus, it is unlikely that these factors were responsible for 48 
the differences in learning capacity and auditory processing.  There must, therefore, be 49 
subtle factors related to living with HIV as a chronic disease, that explain the findings.  If 50 
CLHIV are performing poorly in class, they should be referred for investigations of 51 
neurocognitive skills so that they can be provided with the support they need. 52 
 53 
INTRODUCTION 54 
Globally, an estimated 1.7 million children (aged 0 to 14 years) are living with the human 55 
immunodeficiency virus (HIV), with an additional 160 000 children being infected annually 56 
[1]. The widespread rollout of effective antiretroviral therapy (ART), coupled with 57 
adherence to the medication, has resulted in the life expectancy of these children being 58 
near normal [2]. Thus, HIV is now considered to be a chronic condition, with associated 59 
conditions that may require additional health, social and educational services [3]. 60 
 61 
Auditory impairments, including hearing loss [4] and difficulties with auditory processing 62 
[5], have been reported in children living with HIV (CLHIV). Auditory processing refers to 63 
“what we do with what we hear” [6] and comprises various processes or skills which are 64 
required to make sense of our auditory world. According to the American Speech-65 
Language-Hearing Association (ASHA) these skills include: “sound localization and 66 
lateralization, auditory discrimination, auditory pattern recognition, temporal aspects of 67 
audition, auditory performance decrements with competing acoustic signals, and auditory 68 







present with auditory processing difficulties, but poor speech, language, literacy, attention 70 
and academic performance have also been reported [8]. 71 
 72 
Auditory processing disorders have been associated with neurological involvement, 73 
including degenerative diseases and exposure to neurotoxic substances [9]. According 74 
to the American Psychological Association,  “impairment in perceptual, learning, memory, 75 
linguistic, or thinking abilities” is defined as cognitive impairment [10]. Cognitive 76 
impairments associated with HIV have been reported in CLHIV [11–13], thus it may be 77 
assumed that CLHIV are at risk of presenting with auditory processing deficits.  78 
 79 
Poor academic performance and/or school functioning and neurocognitive deficits have 80 
been reported in CLHIV [11,14–16].  The effects of HIV may not necessarily be as a direct 81 
consequence of the virus but may be due to the indirect consequences of living with a 82 
chronic disease or living with an adult who has the virus [11].  School performance may 83 
be affected as CLHIV may be more prone to illness, resulting in poorer school attendance 84 
due to sick days, or medical appointments [17].  In addition, living with an infected adult 85 
may have implications on socioeconomic status as HIV is more prevalent in lower 86 
socioeconomic households [18].  87 
 88 
Lower socioeconomic status has also been associated with poorer learning outcomes 89 
and poorer performance on cognitive tests [19,20]. The effect of socioeconomic status on 90 
the brain and on cognition has been attributed to three possible mechanisms; namely (1) 91 







pregnancy), (2) parental care issues that could affect neurodevelopment and (3) the level 93 
of stimulation in the home (e.g. availability of books) [21].  94 
 95 
Assessing cognition is challenging as cognitive ability is not an isolated construct.  It 96 
includes skills that underlie the processes of “perception, learning, memory, 97 
understanding, awareness, reasoning, judgment, intuition and language” [22]. The 98 
assessment tool should, therefore, be able to assess individuals across different contexts, 99 
and consideration should be given to the fact that the constructs being assessed may not 100 
be relevant for all cultures and across all languages [21]. For the purpose of this study, 101 
nonverbal intelligence was selected as the proxy for learning capacity as this construct is 102 
considered to be less affected by socioeconomic status and linguistic, cultural and literacy 103 
diversity  [23]. Nonverbal IQ tests measure an individual’s capacity to learn and problem 104 
solve, and is also known as fluid intelligence, as compared to crystallized intelligence 105 
which refers to the knowledge an individual has learnt [24].  The use of a nonverbal 106 
measure was therefore considered a valid method of measuring learning capacity in a 107 
sample of CLHIV and controls who spoke different languages and came from different 108 
contexts.   109 
 110 
METHODS 111 
Ethics: Approval for this research was obtained from Stellenbosch University Human 112 
Research Ethics Committee (S15/10/220).  Both the Western Cape Department of Health 113 
and Western Cape Department of Education granted permission for the study to be 114 







primary school. Written informed consent was obtained from all the children and their 116 
parents/caregivers.  117 
 118 
Study aims: To investigate the association between HIV status, gender and language 119 
spoken at home and school, auditory processing skills and learning capacity.  120 
Sample: This study investigated school learners aged 9 to12 years who had confirmed 121 
HIV positive status (HIVP) or reported HIV negative status (HIVN).  The sample was not 122 
age-or gender-matched. 123 
 124 
Sampling context: One large tertiary metropolitan hospital in Cape Town provided access 125 
to paediatric HIV cases attending its Infectious Diseases Clinic (IDC).  This hospital 126 
provided services for over 3.4 million people in surrounding socioeconomically-127 
disadvantaged suburbs [25]. 128 
 129 
Sampling: The case children (HIVP group) were recruited at point of contact with the IDC 130 
in the participating hospital, and control children (HIVN group) were recruited from one 131 
school in the suburbs serviced by the participating hospital.  Sampling participants from 132 
the hospital IDC, or from a school in the surrounding suburbs guaranteed homogeneity 133 
of sociodemographic status.  Convenience sampling was applied for both groups, this 134 
being considered as the most efficient approach to deal with the complexities of 135 
recruitment in low socioeconomic circumstances (difficulty in contacting potential subjects 136 
when not attending health appointments or school, parent literacy, difficulty in accessing 137 







approached by researchers, stigma, constraints on attendance at appointments, being 139 
over-researched etc).  140 
 141 
Inclusion and exclusion criteria: Girls and boys were eligible to be included if they had: 142 
(1) documented HIV-positive status or reported HIV-negative status; (2) were aged 143 
between 9 – 12 years; (3) had verbal proficiency in at least one of English, Afrikaans or 144 
an African language; (4) were enrolled in at least Grade 3 in a mainstream primary school 145 
and (5) had a parent or caregiver with the ability to understand and complete a written 146 
consent form.  Exclusion criteria were: (1) HIV status not documented/reported; (2) 147 
diagnosed comorbid conditions causing cognitive impairment (e.g. neurological 148 
conditions) that could affect understanding of, and performance in, the assessment 149 
batteries; (3) diagnosed cognitive impairment (e.g. intellectual disability) that could affect 150 
understanding of and performance on the assessment test batteries; or (4) on a waiting 151 
list for, or enrolled, in a school for learners with special education needs.  152 
 153 
Recruiting HIVP children: According to the IDC records at the participating tertiary 154 
hospital, 836 patients (adults and children) were managed at the clinic, at the end of 155 
February 2017. Of these, 412 were children (aged 0 to 18 years), with an estimated 110 156 
children in the target age range.  Between June 2017 and November 2018, attempts were 157 
made to recruit all these children when they attended the IDC for their medical 158 
appointments. The recruitment process involved the researcher attending the IDC and 159 
identifying and recruiting appropriate children. On each of the paediatric clinic mornings 160 







(folders) of all children with appointments for the particular day and identified potential 162 
candidates based on their date of birth.   The parents/caregivers, who accompanied the 163 
child on the day, were approached and informed about the study.  If they were interested, 164 
the child’s eligibility was confirmed by questioning, and if parents/ caregivers and child 165 
consented, the child was enrolled in the study. Each family was offered a small 166 
reimbursement for travelling costs, to assist them to bring their child for the study 167 
appointment.   168 
 169 
Recruiting HIVN children: Children were recruited from one local primary school from the 170 
surrounding area. Information pamphlets were distributed to all 162 children aged 9-12 171 
years, together with informed consent forms and the researcher’s details. The school was 172 
considered as a Full-service school by the WCDoE, where the children’s HIV status was 173 
known by the school.  The school manager assisted the researcher in distributing 174 
research information only to children who were recorded as HIVN.   175 
Hypotheses: In children with no hearing deficits: 176 
1. HIV status is related to auditory processing performance and learning capacity, 177 
with HIVP status being associated with poorer performance; 178 
2. Gender, and primary language spoken at home, or school, is unrelated to auditory 179 
processing performance and learning capacity; and 180 









Demographic information: Data was collected from clinic or school records as HIV status, 184 
gender, and language spoken at home and school.   185 
 186 
Screening for hearing loss: All consenting children were tested for hearing loss using pure 187 
tone audiometry. The same test circumstances were unavailable for cases and controls.  188 
For cases, testing occurred in a soundproof booth in the hospital, using a GSI 61 189 
audiometer and circum-aural earphones.  Air conduction thresholds were obtained at 190 
250Hz, 500 Hz, 1000 Hz, 2000Hz, 4000Hz, 8000 Hz as per conventional audiometry [26], 191 
for separate ears.  For controls, testing occurred in a quiet venue at school, as a 192 
soundproof environment was re unavailable.  Testing was completed using an 193 
Interacoustics AS608 screening audiometer, and circum-aural earphones.  Air conduction 194 
thresholds were obtained at 250Hz, 500 Hz, 1000 Hz, 2000Hz, 4000Hz, 8000 Hz as per 195 
conventional audiometry [27], for separate ears.  Due to differences in test conditions for 196 
cases and controls, different pure tone averages were used to determine normal hearing 197 
( ≤ 15dBHL for cases, ≤ 25dBHL for controls) [28,29].   198 
 199 
Learning capacity: All children were assessed for learning capacity using the Test of 200 
Nonverbal Intelligence Fourth edition (TONI 4).  According to Brown, Sherbenov and 201 
Johnsen [30], the TONI 4 measures aptitude, abstract reasoning and problem solving 202 
ability. The test was considered to be most suitable for the purposes of this study as it is 203 
not loaded with language and does not require the respondent to read, write, speak or 204 
even listen and can and can be used with children who are not proficient in English. The 205 







according to the developers, performance is not influenced by familiarity with the items. 207 
The abstract nature of the items, as well, as the lack of language reduces the possibility 208 
of educational, cultural and experiential biases [30]. However, the instructions were given 209 
in the preferred language of the child, with the parent present. The parent/caregiver was 210 
provided with a written translation of the instructions and was requested to give these 211 
instructions to the child. Where literacy was a problem, the researcher explained the 212 
instructions to the parent with the aid of the written translation and the parent then 213 
transmitted the information to the child. The TONI-4 percentile score provided an 214 
indication of the percentage of the normative population that obtained a score equal to or 215 
below the score obtained by the participant [30].  216 
 217 
Working memory: Only those children with normal hearing, proceeded to be assessed for 218 
the measures of memory. These tests  were included based on the review of the position 219 
statements and clinical guidelines commenting on the impact on memory on auditory 220 
processing, as well as studies reflecting the association between working memory and 221 
learning difficulties [31].  222 
- Subtests of the TAPS-3 [32] 223 
o Number Memory Forward (NMF): The child has to listen to a series of digits 224 
and repeat the sequences verbatim. 225 
o Number Memory Reversed (NMR): The child has to listen to a series of 226 








Auditory processing:  Only those children with normal hearing proceeded to auditory 229 
processing testing. The components of the test battery was based on the auditory skills 230 
that this study aimed to  assess and was informed by a review of position statements and 231 
clinical guidelines on auditory processing [7,9,33–35].   232 
The auditory processing test battery consisted of the following: 233 
- Subtests of the SCAN 3C [36] 234 
o Gap Detection (GD) 235 
o Auditory Figure-Ground (+8 dB signal to noise ratio) (AFG)  236 
o Competing Words-Free Recall (CWFR) 237 
- Subtest of the TAPS 3 [32] 238 
o Word Discrimination (WD) 239 
- Laterality as measured by correct identification of ear that the stimulus was 240 
presented during the AFG test.  241 
AFG, CWFR, WD, NMF and NMR (measured as percentage of total possible scores), 242 
and GD and laterality (measured in binary form).    243 
 244 
Data management: Only those children with no hearing deficits were retained for the 245 
analysis reported in this paper.  The percentage of total scores for the auditory processing 246 
and learning capacity variables (AFG, CWFR, WD, NMF, NMR, TONI 4) were converted 247 
into binary form by splitting them at the median value.  Primary language spoken at home 248 
and school was recorded for testing purposes as English, Afrikaans or other African 249 
languages (these being combined because of small numbers).  HIV status was reported 250 








Data analysis: Factor analysis was first applied to the auditory processing measures 253 
(AFG, CWFR, WD, gap, laterality) and the learning capacity variables (TONI-4 NMF, 254 
NMR), to identify underlying composite latent variables.  These variables were first tested 255 
for normality of distribution to ensure that they were appropriate for inclusion in factor 256 
analysis models. Spearman (1904) first developed the notion of factor analysis.  Its key 257 
concept is that a latent (not measured) variable will underpin a number of observed 258 
(potentially correlated) variables because research subjects may express similar patterns 259 
of responses in the observed variables. In most instances, the latent factor is abstract, 260 
and therefore not readily measured.  However, the abstract notion underpinning the latent 261 
factor may have multiple measurable elements, which, when combined, can provide a 262 
single estimate of the new (latent) variable. .Thus, the purpose of factor analysis is to 263 
analyse these patterns of responses, identify underlying latent factors, and use each 264 
latent factor as single measure, expressing a combination of observed variables. Factor 265 
analysis also weights item responses within each latent factor (called factor loadings).  266 
These can be combined and then expressed as an individual score for each person, as 267 
an estimate of the latent variable.  Factor loadings can be interpreted in the same was as 268 
standardized regression coefficients.  If an observed variable has a factor loading of, say, 269 
0.7 then it can be assumed that that observed variable has a correlation of 70% with the 270 
latent factor (a strong relationship).  Conversely, if the loading is 0.2, the correlation of 271 
20% with the latent factor would be considered to be weak.  On this assumption, the rules 272 
of correlation are applied when considering the factor loadings, as usually only those 273 







Each factor captures an amount of the overall variance in the observed variables, and 275 
statistical programs which calculate factor analysis usually list factors in order of the 276 
amount of variation that each factor explains of the overall variance.  The eigenvalue is a 277 
measure of how much variance in the observed variables is explained by one factor. As 278 
a rule of thumb, any factor with an eigenvalue greater than one explains more variance 279 
than a single observed variable.  280 
 281 
The weighted auditory processing scores were combined into a new latent variable of 282 
per-child overall auditory process performance, and the weighted learning capacity 283 
scores were combined into a new latent variable of per-child overall learning capacity.   284 
This was calculated as the cumulative sum of the binary value (1,0) for each variable 285 
multiplied by the relevant weighing.  Given that scores of 1 indicated poor performance, 286 
the higher the composite score, the poorer the child performed overall.    287 
 288 
Influence of predictor variables: The influence of potential predictor variables (HIV status, 289 
gender, and primary language spoken at home or school) on the new (continuous 290 
measure) latent variables of auditory performance and learning capacity was assessed 291 
using Analysis of Variance models, with significance reported at p<0.05.  The association 292 
between the new latent variables of auditory performance and learning capacity was 293 
assessed using a univariate linear regression model, with the strength of the association 294 
reported as r2 value (significance p<0.05).   295 
Univariate logistic regression models were also constructed to test the association 296 







learning capacity (reported as Odds Ratios (OR), 95% Confidence Intervals (95%CI).  If 298 
a potential predictor variable was found to significantly influence the mean values  of the 299 
composite auditory processing or learning capacity variables, its confounding effect was 300 
assessed by adding it to logistic regression models, and testing whether the Likelihood 301 
ratio chi2 value changed significantly.  This was an expression of the amount of variance 302 
in the model explained by the component variables.  The significance of change was 303 
determined by whether the amount of exceeded the critical amount of change in the chi2 304 
value for the number of degrees of freedom in the model.   305 
 306 
RESULTS 307 
Sample descriptor: This paper reports on the 43 children in the sample with no hearing 308 
loss (78.2% sample).  There were 15 case children (34.9% sample), of whom 8 (53.3% 309 
of cases) were girls, and 28 control children (65.1%), of whom 15 were girls (53.3%).  310 





















cases; and 25% controls speaking an African language compared with 75% cases.   345 
Overall, approximately 1:5 children (20.9%) spoke a different language at home and 346 
school, reflecting 14.3% controls and 33.3% cases (p>0.05).  No English-speaking 347 
children reported a difference between home and school language, however, home-348 
school language difference was found in five cases (one Afrikaans-speaker (20%), and 349 
four African language speakers (80.0%); and in four African speaking controls (100%). 350 
 351 
Of the 14 cases on whom information on ART was available from hospital records, the 352 
mean percentage of lifetime exposure to ART was 73.4% (21.5%).  353 
 354 
Learning capacity and working memory: Controls had significantly higher TONI 4 and 355 
NMR percentile scores compared with cases, but there was no difference in mean 356 
percentile scores for NMF between cases and controls (Table 1).    357 
 358 
Table 1. Learning capacity and working memory scores for cases and controls  359 
 Cases (n=15) Controls (n=28) P value ANOVA models 
TONI percentile ranks 20.4 (10.1) 40.6 (19.2) <0.05 
Number memory 
forward (NMF) ranks 
37.8 (27.1) 38.4 (26.7) >0.05 
Number memory 
backward (NMR) ranks 
11.2 (11.9) 31.9 (23.9) <0.05 
a 360 
Factor analysis: Latent ‘composite learning capacity’ was explained by one factor which 361 







NMF ranked percent weighting = 0.62; TONI 4 ranked percent weighting = 0.71).  The 363 
mean per-child overall latent learning capacity score was 1.2 (SD 0.7; range 0 to 2.1), 364 
with a significant difference between cases and controls (mean cases 1.6 (SD 0.5); mean 365 
controls (0.9 (SD 0.7) (p<0.05)).    366 
 367 
Table 2. Means (SD) by HIV status, and linear measures of association of auditory 368 
processing skills and learning capacity (considering only children with intact hearing) 369 
Means  HIVP (n=15) HIVN (n=28) p value (ANOVA 
models) 
AFG% 2.2 (4.2) 9.5 (10.2) 0.007 
CWFR% 5.9 (10.4) 20.4 (21.7) 0.01 
WD% 43.8 (28.7) 40.1 (21.4) 0.63 
NMF% 39.0 (27.4) 40.3 (26.5) 0.89 
NMR% 15.3 (15.1) 31.9 (23.9) 0.03 
TONI% 21.3 (9.8) 40.1 (19.7) 0.007 
    
Linear measures of 
association (r2) 
With TONI%   
AFG% 0.113 (11.3%)   
CWFR% 0.177 (17.7%)   
WD% 0.02   
 With NMF%   
AFG% 0.002   
CWFR% 0.001   
WD% 0.02   







 With NMR%   
AFG% 0.104 (10.4%)   
CWFR% 0.04   
WD% 0.01   
TONI% 0.116 (11.6%)   
 370 
Auditory processing: Twenty-one children of the sample (48.8%) presented with poor 371 
auditory processing scores, comprising 11 cases and 10 controls (52.4%, 47.6% 372 
respectively).  Cases incurred a significantly greater risk of having poor auditory 373 
processing scores compared with controls (OR 4.95 (95%CI 1.24-19.69).  Not 374 
surprisingly, the mean percentile scores for each of the auditory processing tests (AFG, 375 
CWFR, WD) was generally lower for cases than controls (see Table 2).  There was 376 
modest evidence of an association between GD and HIV (OR 3.3 (95%CI 0.9-11.6)).  377 
 378 
Auditory processing and learning capacity (including working memory): Significant 379 
associations were found between the TONI percentile rank score and the percentile rank 380 
scores for two auditory processing tests; namely AFG and CWFR. Significant 381 
associations were also found between NMR and AFG, as well as between NMR and TONI 382 
4. NMF was not significantly associated with any auditory processing tests or with TONI 383 
4 (Table 2). 384 
 385 
Factor analysis: There were two latent variables derived from factor analysis (explaining 386 
58% and 42% respectively, of the total variance).  The factor explaining the largest 387 







0.83); WD (weighting = 0.39); and laterality (weighting = 0.36).  The second factor 389 
contained only one variable, GD (weighting = 0.75).  The mean per-case score for the 390 
first latent variable was 0.50 (0.36) whilst for controls it was 0.29 (0.37).  For the second 391 
latent variable, the per-case mean score was 1.74 (0.71) whilst for controls it was 0.96 392 
(0.82)).   393 
 394 
Univariate association between composite auditory processing and learning capacity 395 
scores: There was a significant and moderately-strong linear association between the 396 
continuous forms of these two latent variables without taking account of cases or controls 397 
(r2=19.4% (p<0.01)).  However, when considering these variables in binary form, the 398 
crude association was non-significant (Odds Ratio (OR) 2.8 (95% Confidence Interval 399 
(CI) 0.8-9.4) (Likelihood Ratio 2.8 (p<0.05)).   400 
Influence of predictor variables: Only HIV status produced significantly different means, 401 
when considering outcomes of composite auditory processing and learning capacity 402 
scores (See Table 3). The cases produced significantly higher scores than the controls 403 
(meaning that cases accumulated more poor scores in the component auditory 404 
processing and learning capacity composite measures).  Gender, language spoken at 405 
home and differences between home and school language did not influence the mean 406 
component auditory processing or the learning capacity composite measures.  407 










Table 3. Means (SD) of composite auditory processing and learning performance scores, 412 
and significance from univariate ANOVA models 413 











Gender (degrees of 
freedom (df) =1) 
Girls  1.8 (0.9) 0.05 1.1 (0.6) 0.4 
 Boys 1.3 (0.9)  0.9 (0.8)  
Language at home 
(df=2) 
English 1.1 (0.8) 0.05 0.7 (0.6) 0.05 
 Afrikaans 1.8 (0.9)  1.2 (0.6)  
 African 
language 
1.8 (0.8)  1.3 (0.7)  
Difference between 
primary home and 
school language (df=1) 
No 
difference 
1.6 (0.9) 0.8 1.1 (0.7) 0.7 
 Difference 1.5 (0.8)  0.9 (0.5)  
HIV status (df=1) Control  1.2 (0.8) <0.001 0.8 (0.7) <0.001 








Association between composite learning capacity and composite auditory processing 415 
variables: The Crude Odds Ratio (COR) for the association between the auditory 416 
processing and learning capacity composite measures (split at the median) was non-417 
significant (2.7 (95%CI 0.8-9.5)).  Adjusting this by HIV status, the adjusted OR (AOR) 418 
was significantly lower than the COR (1.8 (95%CI 0.5-7.5)), supported by a significant 419 
change in the Likelihood ratio (6.6 (df=2) p<0.05). The AOR was also non-significant.  The 420 
wide confidence intervals potentially reflected the impact of small numbers in some cells.   421 
Lifetime exposure to ART: There was some indication in the cases that the extent of exposure to 422 
ARV influenced auditory processing and learning capacity, in particular in the NMF measure.  423 
Table 4 outlines differences between children whose lifetime exposure was less than 75% (N=7), 424 
compared with cases whose exposure was longer (N=8).  There was a non-significant association 425 
between gap detection and ARV lifetime exposure (OR 0.67 (95%CI 0.08 – 5.87).   426 
 427 
Table 4.  428 
 <75% LT exposure  75+% lifetime exposure  
TONI ranked percent 21.25 (11.54) 19.42 (9.09) >0.05 
NMF ranked percent 24.25 (18.12) 55.83 (27.78) <0.05 
NMR ranked percent 14.71 (14.02)_ 6.20 (6.26) >0.05 
AFG ranked percent 2.47 (5.51) 2.42 (3.39) >0.05 
CWFR ranked percent 4.42 (8.33) 9.21 (13.47) >0.05 
WD ranked percent 48.14 (25.96) 36.71 (33.30) >0.05 
 429 
DISCUSSION 430 
This study provides new information in an area with scarce research to date, regarding 431 







African children aged 9 to 12 years old, recruited from a low socioeconomic area in Cape 433 
Town.  The findings supported all three hypotheses, that HIVP status is related to poorer 434 
learning capacity in children with and without hearing loss, and that HIVP status is related 435 
to auditory processing performance in children with no hearing deficits.  Gender, and 436 
primary language spoken at home, or school, is unrelated to auditory processing 437 
performance and learning capacity; and auditory processing is strongly and positively 438 
correlated with learning capacity in children without hearing deficits. The findings also 439 
suggest that for case children with intact hearing, whose lifetime exposure to ARV was 440 
less than 75%, there may be an influence on number forward memory. These findings 441 
suggest that there are complex causal pathways for paediatric auditory processing, HIV 442 
status, ARV lifetime exposure and learning capacity, and that these require further 443 
investigation in larger samples [38].   444 
 445 
In CLHIV, cognitive impairments may be caused by the HIV virus itself affecting the 446 
central nervous system (CNS) (primary HIV CNS disease), or by an opportunistic infection 447 
due to compromised immune system affecting the CNS (secondary CNS disease) [39]. 448 
During acute infection, HIV enters the CNS through infected macrophages (immune cells) 449 
that cross the blood brain barrier, causing CNS infection and triggering immune activation 450 
[40].  Due to the CNS infection, inflammatory cytokines and neurotoxins are released by 451 
the macrophages. This results in neuronal damage leading to primary HIV CNS [39]. 452 
Infants are particularly susceptible to neuronal damage, with resultant neurologic 453 








Although ART has resulted in a decrease in the prevalence of severe forms of CNS 456 
pathology, neurocognitive impairment continues to be seen in CLHIV [41]. According to 457 
Brahmbatt et al [15], despite the early initiation of ART, with complete viral suppression 458 
being achieved, mild to moderate cognitive impairment may still be observed. Ellis, Calero 459 
and Stockin [39] suggest that the continued presence of cognitive impairment may relate 460 
to the mechanism of the blood brain barrier, which has been see to restrict the movement 461 
of antiretrovirals into the CNS, possibly reducing the efficacy of ART in the brain.   462 
 463 
Our findings of high prevalence of poor auditory processing skills in children with HIV are 464 
similar to those reported by Romero et al. [43] (52.4% compared with 60%).  Specifically, 465 
our HIVP children performed more poorly on tasks involving language (speech in noise 466 
tasks and dichotic listening) than the controls. Although no other study has reported on 467 
speech in noise results in CLHIV, Romero et al. [43] also reported difficulties with dichotic 468 
listening in CLHIV. The authors ascribed their results to attention, memory and problems 469 
with auditory figure ground skills. In addition to working memory, we would also suggest 470 
that cognitive ability (learning capacity), is an important factor to consider in CLHIV. 471 
Considering that: (a) auditory processing disorders are defined as “difficulties in the 472 
perceptual processing of auditory information in the central nervous system and the 473 
neurobiological activity that underlies that processing” (9) and that (b) HIV causes 474 
disruption in CNS activity, with subsequent neurocognitive impairment; cognitive ability 475 
and its effect on auditory processing skills [44] are important considerations when 476 








Our findings regarding learning capacity and HIV concurs with the growing number of 479 
studies, conducted in Africa, reporting on lower cognitive functioning in school-aged 480 
CLHIV [11,12,15,45]. According to Phillips et al. [13] , who conducted a systematic review 481 
of 22 articles and a meta-analysis of six of these articles, working memory, executive 482 
function and processing speed were the cognitive domains most notable affected.  Our 483 
findings are in agreement with these reported findings on impaired working memory in 484 
CLHIV, as well as with those reported by Musindo et al. [11] and Boivin et al. [45] on the 485 
association between nonverbal intelligence and HIV.  486 
 487 
Poverty has been suggested as a factor affecting cognition [17,46]. By controlling for 488 
socioeconomic status by recruiting all children from the one sociodemographic area, we 489 
believe that we have identified HIV status as an important factor in compromised auditory 490 
processing and non-verbal learning capacity.  As all the children in our study lived in the 491 
same low socioeconomic area (surrounding the case catchment hospital), we assumed 492 
that they all had similar exposure to poverty, and the concomitant diseases that 493 
accompany such circumstances.  Our sample also reflected expected local area statistics 494 
in terms of language spoken at school and home.  This suggests that in our sample, 495 
exposure to HIV may be the mediating factor for auditory processing difficulties or learning 496 
capacity for our cases.   497 
 498 
Limitations: The cross-sectional design of this study does not support inferences about 499 
causality, and the small sample size potentially influences the significance of our findings.  500 







backgrounds for cases and controls, however as the sample was recruited from only one 502 
tertiary hospital and its surrounding suburbs within the Cape Metropole, generalisability 503 
is limited. Likely systematic biases may have been introduced by the pragmatic, 504 
circumstantially-driven strategies which we had to employ to recruit children.  Cases and 505 
controls could not be matched on variables such as diet, noise exposure, health status, 506 
home emphasis on learning, or history of ear infections.  Our learnings were that whilst 507 
future studies should seek to recruit larger samples, using random selection, they would 508 
have to employ innovative recruitment approaches to deal with the difficulties of recruiting 509 
children in low socioeconomic areas, for research in this sensitive health area. 510 
 511 
CONCLUSIONS 512 
HIV status appears to be significantly associated with learning capacity in children aged 513 
9 to 12 years who have no hearing loss.  Moreover, auditory processing is significantly 514 
associated with learning capacity in case and control children with no hearing deficit. The 515 
association between HIV, auditory processing and learning capacity has significant 516 
implications for educational policies, as children living with HIV may require additional 517 
support within the schooling system to overcome neurocognitive deficits. The findings 518 
have further implications when prioritising school assessments, as testing learning 519 
capacity may need to be prioritised above testing for auditory processing deficits to 520 
ensure that cognitive deficits are not the cause of underlying scholastic difficulties. The 521 
implications are that the learning difficulties faced by HIVP children may be multifactorial, 522 
and research is needed into the various factors that may impede children’s engagement 523 
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Explanation of Potential Associations 
 
Explanation of Potential Associations: In order to frame this study and determine the most 
appropriate study measures, we applied the Bradford Hill criteria for causality (Hill, 1965). 
These nine criteria provide opportunities to consider the research question and the proposed 
associations and to defend our choice of measures.  
Strength: Observational studies show strong evidence supporting relationships between 
hearing loss and auditory processing (Halliday, Tuomainen, & Rosen, 2017) (Rohlfs et al., 
2017; van Wieringen et al., 2018); hearing loss and learning; auditory processing difficulties 
and learning; HIV and learning; as well as HIV and hearing loss (Ensink & Kuper, 2017; 
Smith et al., 2017). Limited evidence is available, supporting the relationship between HIV 
and auditory processing (Dawood, Klop, Olivier, Elliott, & Pillay, 2019). This is the area to 
which the findings of this dissertation will contribute. Collecting both auditory processing 
data, and hearing loss data in this study provided the opportunity to explore how these 
measures of auditory function present in children, and what impact they had. 
CLHIV has historically missed many opportunities for schooling because of 
absenteeism due to ill health and medical care (Anabwani et al., 2016). Moreover, it is likely 
that CLHIV has one or more caregivers who also have HIV, and who may have died, or are 
unwell, leading to more reasons why the child may be absent from school (Harrison et al., 
2017). In South Africa, CLHIV also tend to come from low socioeconomic areas (Bunyasi & 
Coetzee, 2017a) where nutrition and hygiene may be inadequate, there may be overcrowding 






Schneider, & Sanders, 2017). This dissertation will provide more information about preteen 
children’s capacity to learn and whether this differs between CLHIV and uninfected controls. 
Consistency: The relationship in children between HIV and hearing loss has been 
demonstrated in a small number of studies (Buriti et al., 2013; Khoza-Shangase & Turnbull, 
2009; Palacios et al., 2008; Taipale et al., 2011; Torre et al., 2012). What does the evidence 
say? The relationship between HIV and auditory processing difficulties has received less 
attention, and the evidence supporting this relationship is inconclusive. Although studies 
within the paediatric population are limited, Matas et al. (2008) found that children with HIV 
were poorer at localizing sound than children who were not infected with HIV.   
There is a consistent body of knowledge that supports the relationship between the 
capacity to hear, the capacity to process the information that is heard (auditory processing) 
and the capacity to learn, with three systematic reviews providing the best current evidence 
for these associations (de Wit et al., 2016; Kuppler, Lewis, & Evans, 2013; Moeller, 
Tomblin, Yoshinaga-Itano, Connor & Jerger, 2007).   
Neurocognitive disorders are one of the most common consequences of HIV, which 
occur despite active ART (Farhadian et al., 2017). The central nervous system (CNS) can 
serve as an anatomic reservoir for HIV and continued immune activation of macrophages and 
microglia in the brain can lead to central neurological signs and symptoms (Ellis et al., 2009). 
Although the central auditory system has centres with special functions (e.g., recognizing 
pitch and timing), the overall task of extracting meaning from the sound is distributed 
throughout the CNS (Kraus & Anderson, 2016). This suggests that processes producing 
diffuse damage to the CNS, such as HIV infection, could affect central auditory processing in 






generalized brain injury is reflected in performance on central auditory tasks (Kraus & 
Anderson, 2016). 
Specificity:  Poor auditory functioning is not the only construct associated with the inability 
to learn. Other factors include chronic illness (Compas et al., 2017), nutrition, socioeconomic 
status, sleep deprivation, and family support structures (Habibullah & Ashraf, 2013). The 
complexity of the impact of factors on a child’s capacity to learn is not fully understood, thus 
for this dissertation, we needed to propose a defensible causal path involving HIV, hearing, 
auditory processing, and learning with clearly defined roles in the causal path. 
Temporality: Many things can impact a child’s capacity to learn, but it is unlikely that a lack 
of capacity to learn precedes hearing difficulties and auditory processing. However, disease 
processes such as HIV, TB, malaria, their sequelae, and the treatments for these diseases 
impact learning. In CLHIV, hearing loss is more likely to be conductive while in adults living 
with HIV, it is more likely to be sensorineural (Ensink & Kuper, 2017). This supports the 
evidence of ototoxicity of ART, with resultant sensorineural hearing. Furthermore, auditory 
processing difficulties in adults who have been using ART have been reported (Maro et al., 
2014). 
Biological Gradient: Not only is it likely that hearing loss and poor auditory processing 
difficulties in children are associated with suboptimal learning, but it is also likely that the 
longer (e.g., delay in intervention) and more profound the auditory functional difficulties, the 
more the capacity to learn will be impacted (Vohr et al., 2012).  Moreover, when adults who 
have HIV use ART, there appears to be a dose-response, i.e., the longer the ART is being 
used, the higher the odds of having a form of hearing loss (Maro et al., 2014). In children and 
adults, lower CD4+ counts (compromised immune system) have been associated with hearing 






comorbid diseases (e.g., multi drug-resistant TB), they are more likely to present with hearing 
loss than uninfected people (Hong, Budhathoki & Farley, 2018).  
Plausibility: It is well established that children who cannot hear properly, or process sounds, 
are less able to learn than children without hearing difficulties (de Wit et al., 2016; Kuppler et 
al., 2013; Moeller et al., 2007). Hearing loss in all children is mostly due to middle ear 
involvement (Robb & Williamson, 2016). However, a middle ear infection is also associated 
with decreased immunity associated with HIV (Ensink & Kuper, 2017). Despite a decrease in 
opportunistic diseases, a history of middle ear disease (even if it has been resolved) is 
associated with later auditory proceeding difficulties (Khavarghazalani et al., 2016; Machado 
& Teixeira, 2018),  
Coherence: The argument for coherence is similar to the one for consistency.  
Experiment: It is known that, generally, antibiotics are effective for resolving middle ear 
infections (Robb & Williamson, 2016), and that children whose hearing improves, show 
improved learning outcomes (Vohr et al., 2012). However, auditory processing deficits may 
remain (Khavarghazalani et al., 2016; Machado & Teixeira, 2018). The effectiveness of ART 
in managing opportunistic infections for CLHIV is well known, as systemic infections such 
as pneumonia were generally the cause of death with HIV (B-Lajoie et al., 2016; Iroezindu, 
2016). Despite ART, hearing loss prevalence and middle ear pathology continue to be 
reported, with approximately 33% of CLHIV presenting with hearing loss (Ensink & Kuper, 
2017). However, this means that there are approximately 67% of CLHIV who have intact 
hearing and are not necessarily learning optimally (Devendra et al., 2013; Pufall et al., 2014). 
Thus, continuing concerns with the capacity to learn for CLHIV must be focused on more 






and uninfected peers, without hearing loss, process what they hear and how they learn from 
this. 
Analogy: It is not possible with the current body of knowledge, to draw an analogy with 
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approval is required BEFORE approval can be obtained from these health authorities.
We wish you the best as you conduct your research.
For standard HREC forms and documents please visit: www.sun.ac.za/rds








Letter to Western Cape Department of Health 
Ms Charlene Roderick 
Assistant Director: Research 
Department of Health 
Western Cape 
Health.Research@westerncape.gov.za   
 
REQUEST FOR PERMISSION TO CONDUCT RESEARCH IN HEALTH FACILITIES 
 
Dear Ms Roderick 
My name is Gouwa Dawood, and I am a student in the Division of Speech-Language 
Therapy, Stellenbosch University. The research I wish to conduct for my Doctoral degree 
involves the analysis of hearing functioning and capabilities in children with HIV/AIDS. This 
project will be conducted under the supervision of Dr Daleen Klop (Stellenbosch University) 
and Associate Professor Mershen Pillay (University of KwaZulu Natal).  
I am hereby seeking your consent to research various health facilities. XXX Hospital 
will serve as the primary site, with all audiological assessments being conducted in the 
Audiology Clinic. The other health facilities will be approached to refer candidates for the 
study and to provide medical information for the relevant participants. All data collected in 
this study will be kept confidential, and data from individual children will not be shared with 






I have provided you with a copy of my proposal, which includes copies of the 
questionnaire and consent/assent forms to be used in the research process, as well as a copy 
of the approval letter which I received from the Stellenbosch University Human Research 
Ethics Committee (HREC). The completed application documents, as required by the 
Department of Health, are also included. 
Upon completion of the study, I undertake to provide the Department of Health with a 
summary of the research findings. If you require any further information, please do not 
hesitate to contact me on 0727288022 or gouwa@sun.ac.za. Thank you for your time and 












Permission from Western Cape Department of Education 
  
 
 Directorate: Research 
 
Lower Parliament Street, Cape Town, 8001 Private Bag X9114, Cape Town, 8000 
tel: +27 21 467 9272    fax: 0865902282    Employment and salary enquiries: 0861 92 33 22  







tel: +27 021 467 9272  
Fax:  0865902282 
Private Bag x9114, Cape Town, 8000 
wced.wcape.gov.za 
REFERENCE: 20180523–2436 
ENQUIRIES:   Dr A T Wyngaard 
 
 
Mrs Gouwa Dawood 





Dear Mrs Gouwa Dawood 
 
 
RESEARCH PROPOSAL: AN ANALYSIS OF THE AUDITORY FUNCTIONING AND CAPABILITIES OF 
CHILDREN WITH HIV/AIDS LIVING IN LOW SOCIO-ECONOMIC COMMUNITIES 
 
Your application to conduct the above-mentioned research in schools in the Western Cape has been approved 
subject to the following conditions: 
1. Principals, educators and learners are under no obligation to assist you in your investigation. 
2. Principals, educators, learners and schools should not be identifiable in any way from the results of the 
investigation. 
3. You make all the arrangements concerning your investigation. 
4. Educators’ programmes are not to be interrupted. 
5. The Study is to be conducted from 19 July 2018 till 28 September 2018 
6. No research can be conducted during the fourth term as schools are preparing and finalizing syllabi for 
examinations (October to December). 
7. Should you wish to extend the period of your survey, please contact Dr A.T Wyngaard at the contact 
numbers above quoting the reference number?  
8. A photocopy of this letter is submitted to the principal where the intended research is to be conducted. 
9. Your research will be limited to the list of schools as forwarded to the Western Cape Education 
Department. 
10. A brief summary of the content, findings and recommendations is provided to the Director:  Research 
Services. 
11. The Department receives a copy of the completed report/dissertation/thesis addressed to: 
          The Director: Research Services 
Western Cape Education Department 




We wish you success in your research. 
 
Kind regards. 
Signed: Dr Audrey T Wyngaard 
Directorate: Research 

















Participant Information Leaflet and Informed Consent Form (Parents - Hospital) 
Title of the study: An analysis of the hearing abilities of children with HIV/AIDS  
Reference Number: S015/10/220 
Principal Investigator: Gouwa Dawood 
Address:  Room 4065, 4th Floor 
Division of Speech, Language and Hearing Therapy 
Faculty of Medicine and Health Sciences 
Stellenbosch University 
Tygerberg 
Contact Number: (021) 938 9494 / 072 278 8022 
This information is provided to help you decide whether you and your child will be willing to 
take part in this clinical research study. Please read this form carefully and ask the study staff 
to explain any words or procedures you do not understand. 
 
Dear Parent 
My name is Gouwa Dawood and I am a student at Stellenbosch University. I would like to 
invite you and your child to take part in a study looking at Hearing Abilities in Children with 
HIV/AIDS. Before agreeing to participate in this study, it is essential that you fully 
understand what is involved. If you have any questions, which are not fully explained in this 
leaflet and consent form, do not hesitate to ask the study staff at any time.  
If you agree and allow your child to take part in this study, you will be asked to sign 
and date this consent form. You will get a copy of the signed consent form to keep. You 






willing to take part in this study with your child, and if you completely understand your and 
your child’s rights as participants in this study. 
Why is this Study being Done? 
In this study, we want to learn how HIV may affect a child’s hearing ability. We would like 
to do different hearing tests on children who have HIV or have been exposed to HIV and on 
children without HIV. We would like to assess if children who have HIV have a higher 
chance of developing hearing problems and to find out what these problems are. 
How Many Children will take Part and How Long will my Child be in this Study? 
Approximately 400 children will take part in the study. Your child will only need two study 
visits, and each visit will be approximately 1hour and 30 minutes long. Completing the 
questionnaire will take approximately 30 minutes, and the other tests will be about 2 hours 
and 30 minutes. This time will be divided over the two sessions.  
Study Procedures 
If you agree to have your child take part in this study, you will need to come with your child 
to XXX hospital for two visits, where the following will take place: 
We will ask you some questions about your child’s medical, social, and school history, 
including previous or current illnesses and medication. 
We will also ask you questions about your age, health, educational, and employment status.  
We will ask your child’s teacher questions about your child’s learning and school behaviour. 
We will perform the following examination on your child: 
An examination of the outer ear and ear canal, using an otoscope, will be conducted. 
The middle ear function will be assessed. An earplug will be placed in your child’s ear, and 
they will feel slight pressure during the test. The child will not need to respond to anything 






Hearing assessment where soft tones will be played through earphones. Your child will need 
to respond to these tones by raising their hand. 
Inner ear function will be measured using distortion product otoacoustic emissions 
(DPOAEs). An earplug will be placed in your child’s ear, and they will hear soft tones. Your 
child will be asked to remain quiet, and they will not have to respond to the tones. 
Listening skills will be assessed. Your child will need to listen to speech sounds and respond 
where necessary.  
If we notice problems with your child’s ears, we may refer him/her for treatment and then ask 
you to come back to us for the hearing assessment after treatment.  
We will not be taking any blood samples, but we will need to find out your child’s HIV 
status, medical history, blood results, and treatment given from their doctor or your child’s 
medical records.  
If you are the mother of the child and you are HIV-infected, we would like to ask you 
questions about your CD4 counts, viral loads and medication during your pregnancy and birth 
of this child, or get this from your child’s medical records if they are available. 
What are the Risks to my Child when he/she Participates in the Study? 
None of the procedures we use are painful or dangerous, and all are used routinely in hearing 
clinics. Your child may feel worried or nervous during some of the tests, but we will reassure 
your child not to worry, and we will not put pressure on him or her. If your child is terrified 
or does not want the earplug in his/her ear, we will not do the test.  
Are there Potential Benefits for my Child for being in the Study? 
There may be no direct benefits to you or your child; however, information from this 
study may help other children now or in the future. We will use the findings from this study 






improve with help, we will discuss this with you. If you agree, we will then refer your child 
to an audiologist or doctor. No information about your child will be given to any doctors, 
hospitals, or schools unless you ask us and allow us to do so in writing. 
What About Confidentiality? 
All medical information collected during the study will be treated as confidential and will be 
available only to staff members involved with this study who are directly involved in your 
child’s care. Any information that is used for research or publication purposes or at scientific 
meetings will be kept confidential and will not have your name or your child’s name recorded 
on it. Except if we see evidence of child abuse or neglect, it will be reported to the 
appropriate authorities, as required by law.  
It is possible that the regulatory authorities, such as the Ethics Committees, may want to 
review the study documents at a later stage, in which case every effort will be made to protect 
your child’s confidentiality. 
Your Child’s Participation is Voluntary 
Your child’s participation in the study is voluntary. You can refuse to let him/her participate 
or stop his/her participation at any time that you choose. You and your child are also free not 
to answer any questions or to stop any task before it is finished.  
Your child’s withdrawal from the study will not affect his/her access to other medical care.  
What Happens if your Child is Injured? 
A study-related injury or illness is one that occurs as a direct result of the study-specific 
procedures.  If your child is injured as a result of being in this study, the study staff will give 
your child immediate necessary treatment for the injuries. If you think that your child has 
suffered a research-related injury, let the investigator know right away.  






Neither you nor your child’s medical scheme will be expected to pay for the study-related 
visit or study procedures. 
Will you Receive any Payment for your Child’s Participation? 
You will not receive payment for your child’s participation in the study, although you will 
receive money for transport expenses to the clinic for each scheduled study visit.  
Ethical Approval  
This clinical study protocol has been submitted to and approved by the Faculty of Health 
Sciences Health Research Ethics Committee of Stellenbosch University and the faculty of 
Health Sciences Human Research Ethics Committee of the San Diego State University. 
The study has been structured per the Declaration of Helsinki (2013), which deals with 
recommendations guiding doctors in biomedical research involving human participants. 
I do not have any financial or personal interest in this organization that may bias my actions. 
What to do if you have Questions or Problems? 
If you have any questions now or in the future, you may contact me on 072 278 8022. 
If you have questions or concerns about you or your child’s rights as a research participant, 
you can contact the Chair of the Stellenbosch University Health Research Ethics Committee 
(021 938 9677). This independent committee is established to help protect the rights of 
research participants and gave written approval for the study protocol. 
Referral Option 
Please indicate below whether you want the study team to refer your child for help if we 
notice that your child has problems with the hearing testing. 







□ NO, I do not want you to refer my child for further help if problems are identified in the 
hearing testing.   
 
Hearing Abilities in Children with HIV: Study Informed Consent Signature Page 
 Name of participant: _______________________________               
To parents/legal guardians: 
Have you read this information sheet about this study, or 

















Have you received enough information about this study? Yes  No  
Do you understand that you are free to withdraw your child 






Do you agree to let your child take part in this study? Yes  No  
 
Parent/legal guardian: 
          
Name   Signature  Date  Time 
Witness (if applicable): 
          







A person conducting informed consent process: 
I am satisfied that the parent/legal guardian understands what the consent form is about and 
that his/her questions have been answered. 
          























Participant Information Leaflet and Informed Consent Form (Parents-School) 
Title of the study: An analysis of the hearing abilities of children with HIV/AIDS  
Reference Number: S15/10/220 
Principal Investigator: Gouwa Dawood 
Address:   Room 4065, 4th Floor 
Division of Speech, Language and Hearing Therapy 
Faculty of Medicine and Health Sciences 
Stellenbosch University 
Tygerberg 
Contact Number:  (021) 938 9494 / 072 278 8022 
 
This information is provided to help you decide whether you and your child will be willing to 
take part in this clinical research study. Please read this form carefully and ask the study staff 
to explain any words or procedures you do not understand. 
 
Dear Parent 
My name is Gouwa Dawood, and I am a student at Stellenbosch University. I would like to 
invite you and your child to take part in a study looking at Hearing Abilities in Children with 
HIV/AIDS. Before agreeing to participate in this study, it is vital that you fully understand 
what is involved. If you have any questions, which are not fully explained in this leaflet and 
consent form, do not hesitate to ask the study staff at any time.  
If you agree and allow your child to take part in this study, you will be asked to sign and date 






sign the consent form if all details of the study are apparent to you, if you are willing to take 
part in this study with your child, and if you completely understand your and your child’s 
rights as participants in this study. 
Why is this Study  being Done? 
In this study, we want to learn how HIV may affect a child’s hearing ability. We would like 
to do different hearing tests on children who have HIV or have been exposed to HIV and 
on children without HIV, who are 9 to 12 years of age. We would like to assess if children 
who have HIV have a higher chance of developing hearing problems and to find out what 
these problems are. 
How Many Children will take part and How Long will my Child be in this Study? 
Approximately 400 children will take part in the study. Your child will only need one study 
visit that will be approximately 1 hour long.  
Study Procedures 
If you agree to have your child take part in this study, the study visit will be done at your 
child’s school or at XXX Hospital (if you prefer), where the following will take place: 
We will send you a questionnaire that asks you questions about: 
Your child’s medical, social and school history, including previous or current illnesses and 
medication 
Your age, health, educational and employment status 
We will ask your child’s teacher questions about your child’s learning and school behaviour. 
We will perform the following examination on your child: 






The middle ear function will be assessed. An earplug will be placed in your child’s ear, and 
they will feel slight pressure during the test. The child will not need to respond to anything 
during this test. 
Hearing assessment where soft tones will be played through earphones. Your child will need 
to respond to these tones by raising their hand. 
Inner ear function will be measured using distortion product otoacoustic emissions 
(DPOAEs). An earplug will be placed in your child’s ear, and they will hear soft tones. Your 
child will be asked to remain quiet, and they will not have to respond to the tones. 
Listening skills will be assessed. Your child will need to listen to speech sounds and respond 
where necessary.  
If we notice problems with your child’s ears, we may refer him/her for treatment and then ask 
you to come back to us for the hearing assessment after treatment.  
What are the Risks to my Child when he/she Participates in the Study? 
None of the procedures we use are painful or dangerous, and all are used routinely in hearing 
clinics. Your child may feel worried or nervous during some of the tests, but we will reassure 
your child not to worry, and we will not put pressure on him or her. If your child is terrified 
or does not want the earplug in his/her ear, we will not do the test.  
Are There Potential Benefits for my Child for being in the Study? 
There may be no direct benefits to you or your child; however, information from this study 
may help other children now or in the future. We will use the findings from this study for 
research purposes. If any of the tests show that your child has hearing problems that may 
improve with help, we will discuss this with you. If you agree, we will then refer your child 
to an audiologist or doctor. No information about your child will be given to any doctors, 






What About Confidentiality? 
All medical information collected during the study will be treated as confidential and will be 
available only to staff members involved with this study who are directly involved in your 
child’s care.  Any information that is used for research or publication purposes or at scientific 
meetings will be kept confidential and will not have your name or your child’s name recorded 
on it. Except if we see evidence of child abuse or neglect, it will be reported to the 
appropriate authorities, as required by law.  
It is possible that the regulatory authorities, such as the Ethics Committees, may want to 
review the study documents at a later stage, in which case every effort will be made to protect 
your child’s confidentiality. 
Your Child’s Participation is Voluntary 
Your child’s participation in the study is voluntary. You can refuse to let him/her participate 
or stop his/her participation at any time that you choose. You and your child are also free not 
to answer any questions or to stop any task before it is finished.  
Your child’s withdrawal from the study will not affect his/her access to other medical care.  
What Happens if your Child is Injured? 
A study-related injury or illness is one that occurs as a direct result of the study-specific 
procedures. If your child is injured as a result of being in this study, the study staff will give 
your child immediate necessary treatment for the injuries. If you think that your child has 
suffered a research-related injury, let the investigator know right away.  
What are the Costs to You? 
Neither you nor your child’s medical scheme will be expected to pay for the study-related 
visit or study procedures. 






You will not receive payment for your child’s participation in the study, although you will 
receive money for transport expenses to Tygerberg Hospital if you prefer to have the 
assessment done there.  
Ethical Approval  
This clinical study protocol has been submitted to and approved by the Faculty of Health 
Sciences Health Research Ethics Committee of Stellenbosch University.  
The study has been structured per the Declaration of Helsinki (2013), which deals with 
recommendations guiding doctors in biomedical research involving human participants. 
I do not have any financial or personal interest in this organization that may bias my actions. 
What to Do if You Have Questions Problems? 
If you have any questions now or in the future, you may contact me on 072 278 8022. 
If you have questions or concerns about you or your child’s rights as a research participant, 
you can contact the Chair of the Stellenbosch University Health Research Ethics Committee 
(021 938 9677). This independent committee is established to help protect the rights of 
research participants and gave written approval for the study protocol. 
 
Referral Option 
Please indicate below whether you want the study team to refer your child for help if we 
notice that your child has problems with the hearing testing. 
□ YES, I want you to refer my child for further help if problems are identified in the hearing 
testing.  
□ NO, I do not want you to refer my child for further help if problems are identified in the 
hearing testing.  






 Name of participant: _______________________________               
To parents/legal guardians: 
Have you read this information sheet about this study, or 

















Have you received enough information about this study? Yes  No  
Do you understand that you are free to withdraw your child 






Do you agree to let your child take part in this study? Yes  No  
Parent/legal guardian: 
          
Name   Signature  Date  Time 
Witness (if applicable): 
          









Participant Information Leaflet and Assent Form 
 
   
 
Title of the Research Project:  A hearing study in children 
Researchers Name(s):   Gouwa Dawood 
Address:     Room 4065, 4th Floor 
Division of Speech, Language and Hearing Therapy 
Faculty of Medicine and Health Sciences 
Stellenbosch University 
Tygerberg 
Contact Number:   (021) 938 9494 / 072 278 8022 
What is Research? 
Research is something we do to find new knowledge about the way things (and people) work. 
We use research projects or studies to help us find out more about disease or illness. Research 
also helps us to find better ways of helping or treating children who are sick. 
What is this Research Project all About? 
The project is about looking at how school children hear. The project will look at the hearing 







Why have I been Invited to Take Part in this Research Project? 
You have been invited because you are under 13 years old, and you have been coming to this 
hospital for assessments. 
Who is doing the research? 
My name is Gouwa Dawood, and I will be doing the research. I am a student at Stellenbosch 
University, and I am very interested in helping children who have hearing problems. I am 
doing this project so that I can see what kinds of hearing problems children have so that I 
know what to do to help them. 
What will happen to me in this Study? 
We will ask you to come and visit us at the clinic two times, and each visit will be about 1 
hour and 30 minutes long. We will give you breaks during the visits so that you do not get 
tired. When you come for a visit, we will check your ears and ask you to listen to some noises 
and talking to check your hearing. We will need to put small earpieces in your ears. 
Can anything Wrong happen to me? 
The earpieces that we use to examine your ears may be a little uncomfortable. You should not 
feel any pain, and if you do, we will stop the test.  
Can anything Good happen to me? 
If you take part in this study, then we will know how well you are listening. You might not 
benefit yourself from being in the study. But you may help scientists learn about ways to help 
other children with hearing problems. If we find anything is wrong with your ears, we can 
make a plan on how to help you. 






The study staff, your parents and your teacher will know that you are in the study, but your 
name will not be given to anyone else. We will give you a secret code that will be used on all 
papers.  
Whom can I talk to about the Study?  
If you want to talk about the study, you can talk to me. My phone 
number is 072 278 8022. 
What if I do not want to do this? 
You can say NO if you do not want to take part. If you say NO, we will 
not be angry and will care for you as before. 
 
 
Do you understand this research study, and are you willing to take part in it?  
YES  NO 
 
Has the researcher answered all your questions? 
YES  NO 
 
Do you understand that you can pull out of the study at any time? 
YES  NO 
_________________________  ____________________  









Case History Questionnaire 
Date: 
General Information about child 
Participant number:  
Date of birth:   Age:  
Gender:  Race:  
Home language:  School language:  
Birth rank of child: (e.g. first of 3 children) 




General Information about Mother/Caregiver 
Date of birth:  Age:  
Citizenship:  Race:  
Home language:  
Current marital status:  
Highest level of education 
completed: 
 
Approximate annual income of 
the household: 
 
Number of people living in the 
house: 
 








School:  Grade:  
Teacher contact:  Race:  
School performance: Above average / Average / Below average 
Has your child repeated a grade? If 
yes, which grade? 
 
 
Is your child often absent? Why?  
 
 
Do you have any learning concerns? 





Does your child receive special 
education services? 





















Please indicate if you child has experienced any of the following: 
Premature birth  Hearing problems  
Problems before during or after birth  Speech-language problems  
Hyperbilirubinemia or jaundice  Sensory issues  
Congenital or perinatal infections  Autism spectrum disorder  
Meningitis or sepsis  Attention problems or hyperactivity  
Tuberculosis or Malaria  Syndromes  
Lack of oxygen at birth  Serious illness or accidents  
Mechanical ventilation  Ear problems or operations  
High fever  Currently takes medication  
Head or neck abnormalities  Delays in development  



















Behaviours and Characteristics 
Please indicate if you child shows any of the following: 
Sensitive to loud sounds  Disruptive or rowdy/loud  
Appears to be confused in noisy places  Temper tantrums  
Easily upset by new situations  Shy  
Difficulty following directions  Anxious/nervous  
Restless or problems sitting still  Lacks self-confidence  
Short attention span  Lacks motivation  
Impulsive  Disobedient  
Easily distracted  Inappropriate social behaviour  
Daydreams  Easily frustrated  
Forgetful   Tires quickly  
Asks for repetition  Difficulty understanding the meaning of 
words 
 
Reverses words, numbers or letters  Difficulty learning new concepts  
Prefers to play alone  Difficulty with reading  
Looks for attention  Difficulty expressing ideas  

































Data Collection Sheet – Medical File Review 
 
Participant number:  
Date of birth:   Age:  
Gender:  Race:  
Gestation age:  Birth weight:  
Congenital or perinatal 
infections: 
 
When was child’s 
exposure to HIV? 
Perinatal/postpartum (breast milk) 
Did the child receive 
PMTCT? 
 
Child’s current HIV 
status? 
 
Child’s current ARV 
medication: 
(include a start date and 
whether the child is on 1st, 





Child’s previous ARV 
medication: 
(Include date started and 
date stopped. Also 
include whether the child 














Child’s CD4+ count:  CD4%:  
Child’s viral load:   WHO stage of child:  
Mother’s current HIV status:  
Month and year in which mother’s HIV 
status diagnosed: 
 
Mother’s last absolute CD4+ count prior 
to delivery (include date): 
 
What was the mother’s last CD4% prior 
to delivery (date): 
 
ARV medication received by mother: During pregnancy: 
 
During labour: 
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